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“Reciteer in de naam van uw Heer, die geschapen heeft (Qur’an 96:1)” 
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INTRODUCTION 
        
          Members of the genus Babesia cause one of the most common parasitic 
infections worldwide in wild and domestic animals (98, 140). Economically, 
bovine babesiosis, caused by B. bovis, B. bigemina, B. major and B. divergens 
forms a serious problem as it is widely distributed and threatens the health and 
safety of about 500 million cattle in tropical and subtropical regions of the 
world (98). Although no Babesia species primarily infect humans, some of the 
species, like B. divergens, can be transmitted to humans (93). B. bovis infection 
results in high mortality rates among susceptible cattle, and causes a virulent 
disease characterized by fever, anemia, anorexia and hypotensive shock 
syndrome. Parasitized erythrocytes are often sequestered in the capillary beds 
of the brain and lung, resulting in low peripheral parasitemia, but causing 
severe pathology like cerebral babesiosis and respiratory distress, which 
eventually can lead to death. The pathogenicity varies both between and within 
species but in many cases has a high rate of mortality in untreated animals.  
 
THE APICOMPLEXA 
  
          Members of the phylum Apicomplexa cause parasitic diseases from 
which the most important disease, malaria, invokes major health problems in 
human populations in tropical and subtropical countries. Apicomplexan 
parasites are intracellular protozoan organisms that can invade a specific or 
even a wide range of different host cells, depending on the species. The 
characteristic common feature of all members of this phylum is the unique set 
of organelles localised at the anterior end of their invasive forms that have 
showed to play a crucial role in the invasion of the host cell (176). These apical 
organelles are micronemes, rhoptries and dense granules. Besides these 
organelles they also contain polar rings and some species contain a conoid 
which lies within the polar rings. Apicomplexans are transmitted to new hosts 
by different vectors. Malaria parasites for instance, are transmitted by infected 
mosquitoes while Babesia species are transmitted by infected ticks. 
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THE GENUS BABESIA 
 
Babesia organisms are protozoan parasites that are all transmitted by 
ticks to their specific vertebrate host. Completion of a life cycle and therefore 
the maintenance of Babesia spp. is completely dependent on both the tick and 
the vertebrate host (140). The taxonomic classification of Babesia spp. places 
them in the phylum Apicomplexa and the order Piroplasmida. Piroplasms often 
have a pear-shaped appearance inside their host cell. The order of Piroplasmida 
is divided in Babesiidae and Theileriidae (98, 115). Babesiosis and Theileriosis are 
both diagnosed largely on clinical signs and symptoms with confirmation by 
microscopic observation of the parasites with their specific host blood cells and 
often DNA-based tests, like reverse line blot (82). True Babesia species 
exclusively invade erythrocytes, whereas Theileria species undergo a pre-
erythrocytic cycle in lymphocytes. Examination of stained blood films shows 
Babesia organisms within red cells, where single and duplicated parasites are 
found. Babesia species are grouped into the small and large Babesia (98). The 
invasive parasitic stage of Babesia species inside erythrocytes will grow and 
differentiate to trophozoites. The diameter of trophozoites divides Babesia 
species into small and large Babesia. Trophozoites of the small Babesia  are 1.0 
to 2.5 µm and include B. bovis, B. gibsoni, B. ovis and B. divergens. 
Trophozoites of large Babesia are 2.5 to 5.0 µm including B. caballi and B. 
canis. All apicomplexans have a complex life cycle with both asexual and 
sexual reproduction. Pathogenesis of Babesia species results from the asexual 
erythrocytic stage, where the parasite undergoes multiple rounds of invasion 
and replication in the host erythrocytes. The distribution of all the different 
Babesia species is governed by the geographical distribution of the tick vectors 
that transmit them.  
 
LIFE CYCLE 
 
The life cycle of B. bovis takes place in two hosts (Fig. 1). Asexual 
development takes place in the bovine host and sexual development in the tick 
vector (140).  
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Fig. 1. Life cycle of 
Babesia spp. in the tick 
vector and vertebrate 
host (140) 
 
 
 
 
 
 
 
 
 
 
 
 
Asexual stage  
Babesia spp. infected ticks have accumulated mature sporozoites in their 
salivary glands.  When an infected tick takes a blood meal on its host it will 
pass the content of its salivary gland, including the parasites, into the host. The 
sporozoite invades a red blood cell and will multiply itself by a single round of 
binary fission.  In contrast to the malaria and Theileria life cycle, where 
sporozoites invade hepatocytes and white blood cells respectively, B. bovis 
sporozoites enter the red blood cell. Inside the red blood cell sporozoites 
differentiate to trophozoites. Babesia multiplies inside the red cell by a single 
round of binary fission after which the red cell ruptures and daughter parasites, 
called merozoites, are released into the bloodstream and directly invade a new 
red blood cell. This cycle is repeated over and over again and is called the 
merogony stage. During the merogony stage the parasite feeds on haemoglobin 
and takes up serum nutrients to be able to synthesize amino acids. Nutrients 
and hemoglobin are taken up by the parasite through pinocytosis at the area 
around the micropore. Once the parasite is inside the erythrocyte it will start 
replicating and at the same time will also modify the host cell making it a more 
suitable place for them. Structural alterations of infected host erythrocytes have 
been shown to take place. These changes are induced by the parasite and lead 
to formation of knob-structures (2). Antigenic variation takes place of the 
proteins (VESA, variant erythrocyte surface antigen) localized on the 
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erythrocyte membranes (5). Besides formation of merozoites, a few percent of 
the merozoites invading new erythrocytes differentiate into gametocytes. In 
apicomplexans like Toxoplasma gondii and Plasmodium spp. male 
(microgametocytes) and female (macrogametocytes) gametocytes have been 
found. In Babesia spp. no clear description has been given of gametocytes in 
the vertebrate host. In ticks that have ingested infected blood several types of 
parasite with long rays and spikes have been described that were originally 
called strahlenkörper. One type does not appear to develop further whereas 
others undergo further multiplication, even after they have emerged from the 
erythrocyte. These forms may represent micro- and macrogametes although 
firm evidence is lacking (140).  
 
Sexual stage 
Sexual development takes place in the gut of the tick, after a feeding tick 
has ingested gametocytes. Gametocytes will develop into gametes when taken 
up by the tick. Two morphologically different strahlenkörper will fertilize and 
form a zygote. The zygote is the only parasite stage that is diploid and directly 
after the first meiotic division the parasite is haploid again. The zygote 
differentiates into a kinete and can now pass the intestinal wall. Once outside 
the gut the kinete may enter the ovarium of an engorged female tick and infect 
the eggs. The eggs with the parasite inside will develop from larvae to nymph 
into adult. In these stages of the tick the kinetes will again infect the organs, 
including the salivary gland. Once a parasite has infected the salivary gland, a 
multinucleate but undifferentiated sporoblast is formed. If the tick will feed, 
sporozoites will mature and finally will bud off of the sporoblast (sporogony 
stage) (140). 
 
SUSCEPTIBILTY TO INFECTION 
 
Babesia spp. can infect various types of vertebrates, however B. bovis 
only infects cattle. In previous studies it was seen that Bos taurus species were 
more susceptible to B. bovis than Bos indicus species (19). In enzootic areas the 
animals clinically affected are mostly susceptible cattle introduced for breeding 
purposes, for slaughter, or in transit. Severe clinical cases which occur in these 
cattle are caused by exposure to stresses such as parturition and starvation (98). 
Animals that are aged, splenectomized or immunocompromised are more 
susceptible to Babesiosis than young and healthy animals. Protective immunity 
occurs after natural infection with most Babesia spp. If the infection recurs 
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repeatedly the immunity is permanent. If it is treated directly after infection and 
the protozoa are killed before antibodies are produced, no immunity occurs. If 
the infection is not treated, the protozoa survive in the host for a variable time, 
usually about six months, and then disappear below detectable levels. Animals 
under one year of age are infected predominantly with B. bigemina and those 
over two years of age by B. bovis (98).  
 
MEDICATION AND VACCINATION 
 
There is an efficient drug developed against B. bovis (Imidocarb 
diproprionate), however it is expensive and not always easily applicable in 
large herds roaming freely in areas of considerable size, especially in third 
world countries (139). Moreover it has a 28-day withholding period for meat 
consumption and restrictions for lactating cattle. There is also a great risk of 
development of resistance against the drug when used extensively. Besides 
medication, life attenuated vaccines are used. Attenuated B. bovis strains used 
in vaccines are produced by multiple syringe passage of field isolates in 
splenectomized calves. Results presented sofar have suggested that a vaccine 
containing a single attenuated strain is not protective against heterologous 
challenge. A vaccine needs at least to contain two or three different isolates to 
be effective (23). While attenuated live vaccines lead to significant decreases in 
mortality, they do not prevent infection or full protection against milder 
symptoms of the disease (54). Live vaccines have been used routinely or 
experimentally in several countries (29, 54). The observed decreasing efficiency 
of this method in some regions, the complicated production methods of live 
vaccines, the major risks involved by using blood-derived live vaccines like 
transmission of contaminating pathogens and the reported heterogeneity 
between and within natural isolates urges the search for efficient recombinant 
vaccines (24). Development of a recombinant vaccine has focused on Babesia 
antigens that are recognized by antibodies or stimulate T-cells in naturally 
infected animals (24). Intracellular parasites cause changes in the host cell by 
releasing and incorporating their own proteins into the host cell environment 
during the invasion and post-invasion steps, leading to conditions which favour 
survival of the parasite. Some of the proteins have already been shown to 
interact with the immune system and may be involved in eliciting a protective 
response. One of the candidate proteins that have been identified in Babesia 
species is rhoptry protein RAP-1 ( rhoptry associated protein)(49, 168, 181, 203). 
RAP-1, MSA-1 (merozoite surface protein) and MSA-2 have been found in B. 
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bovis and antibodies directed against these proteins have shown to inhibit 
invasion of merozoites into host cells (151, 152, 161, 211). However, a recent study 
showed that a vaccination trial with RAP-1 of B. bovis did not result in 
protection (161). 
 
STRUCTURE OF THE MEROZOITE 
 
Babesia merozoites have a typical apicomplexan architecture (Fig. 2) 
and are morphologically similar in particular to Plasmodium merozoites which 
have been studied in much more detail. Mature merozoites are released free 
into the bloodstream by erythrocyte rupture after which they attach to and enter 
new erythrocytes within minutes. B. bovis merozoites are approximately 2 µm 
in length and 1 to 1.5 µm in width. Apicomplexan species have the 
characteristic of a normal eukaryotic cell (endoplasmatic reticulum, 
mitochondria, golgi apparatus, nucleus) and apicomplexa-specific organelles 
such as a conoid, polar rings, pellicles and the apical organelles (150). In 
addition, apicomplexa possess an inner membrane complex (IMC) consisting 
of flattened membrane vesicles located just beneath the plasma membrane (150). 
In the Apicomplexa, the trimembraneous structure (two membranes from the 
IMC and one from the plasma membrane) is called the pellicle. It runs from the 
anterior conoidal rings to the posterior end of the cell (150). At the micropore 
this complex is interrupted. The micropore functions as a canal through which 
nutrients are taken up by pinocytosis. Beneath the IMC membranes 
microtubules are localized. In haploid forms of apicomplexan parasites there 
are two types of microtubules described: subpellicular microtubules and spindle 
microtubules. The subpellicular microtubules originate from the polar ring and 
end just below the nucleus, covering approximately two-third of the parasite 
length. The microtubules also help to form the shape of the parasite. Besides 
the cytoskeletal structures, the parasite also contains unique apical organelles. 
At the anterior end of the parasite rhoptries and micronemes are localized 
together with the conoid. The conoid is a small round-shaped structure 
composed of a spiral of unidentified filaments (150). It is thought to play a 
mechanical role in invasion of host cells and is only found in some 
apicomplexans (150). The conoid is approximately 250 nm in diameter and can 
be extended beyond the apical polar ring. Rhoptries are pear-shaped 
membrane-bound vesicles. Electron microscopy has shown that in their mature 
state rhoptries consist of two distinct parts: an electron-dense basal bulb and a 
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less dense rhoptry duct that ends just beneath the plasma membrane. The 
rhoptry is surrounded by a bilayer membrane. 
 
 
Fig. 2. A schematic picture of a general 
apicomplexan with most of the organelles 
(150). 
 
 
 
 
 
 
 
 
 
 
 
 
In P. falciparum they are about 550 nm long and 250 nm in diameter (18). 
Micronemes are much smaller than rhoptries and are about 120 nm long . 
Dense granules are often about 80 nm in diameter and have a densely granular 
content. They are localized between rhoptries and nucleus. Dense granules are 
known as spherical bodies in B. bovis of which usually only two are observed  
at a more posterior location. Rhoptries and micronemes release their protein 
content before completion of merozoite invasion, whereas dense granules 
release their proteins after invasion is completed. Microneme proteins are 
apparently used for host-cell recognition, binding, and possibly motility, 
rhoptry proteins for parasitophorous vacuole formation and dense granule 
proteins for remodelling the vacuole into a metabolically active compartment.  
Merozoite membranes contain several proteins which are modified and 
largely cleaved off during erythrocyte invasion. The composition of the coat 
has not been clearly identified but in P. falciparum at least eight merozoite 
surface proteins (MSP-1 to MSP-8) have been described of which  MSP-1 is 
the most abundant and best characterized (97, 109, 132, 147, 204). MSP-1 undergoes 
extensive specific proteolytic cleavage after merozoite release, with the result 
that the molecule is cleaved into four fragments. It is inserted into the plasma 
membrane with a glycosylphosphatidylinositol (GPI) anchor (97).  
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HOST CELL INVASION 
 
The first step in invasion is the apparent random interaction between the 
merozoite and the host cell (Fig. 3). Initial attachment is of low binding affinity 
and reversible, followed by reorientation on the erythrocyte surface bringing its 
apical prominence into contact with the host cell. The adhesion between 
parasite and the host cell is strong and irreversible. The apical organelles that 
are also localised at the anterior end of the parasite expel their contents. The 
invasion process is incompletely characterised in Babesia, but it is clear from 
studies performed in the closely related parasite T. gondii that microneme 
secretion takes place first and is probably involved in junction formation. The 
“moving junction” is a zone of attachment where host cell invagination will 
take place. It is characterized by a thickened host cell membrane with increased 
electron density. The parasite enters the host cell by pulling the moving 
junction down its body. Proteins involved during the junction movement are 
not known sofar in Plasmodium spp. Micronemes have been shown to contain 
specific ligands for host cell receptors. The first P. falciparum ligand identified 
in micronemes that binds to erythrocytes with high affinity was the erythrocyte-
binding antigen 175 (30). EBA-175 binds to glycophorin A on the surface of 
erythrocytes, and this interaction depends on sialic acid residues of the receptor 
(199). Another transmembrane protein of this family, EBA-140, binds to 
glycophorin C and is also dependent on the presence of sialic acids (129). Studies 
using a variety of mutant human erythrocytes and enzymatic treatments have 
shown that different isolates of P. falciparum are not totally dependent on sialic 
acid or glycophorin A for invasion (30, 61, 171). Treatment of neuraminidase 
inhibits EBA-175 binding by removal of sialic acid (30). Still some P. 
falciparum strains were able to invade a host cell after treatment with 
neuraminidase (61). At least two pathways for P. falciparum merozoite entry 
into erythrocytes became evident from these investigations. Besides the sialic 
acid dependent pathways also a sialic-acid independent pathway is used by this 
apicomplexan species in order to invade their host cells.   
Microneme secretion is followed by rhoptry release and at the same 
moment the parasite starts to invade the red blood cell. The erythrocyte 
membrane invaginates and the parasite begins to enter an enlarging 
parasitophorous vacuole. Once the parasite is inside the vacuole  the 
erythrocyte and vacuole membrane will reseal (11, 207). In contrast to rhoptry and 
microneme discharge which release their contents only at the apical 
prominence, dense granule release involves movement of the bodies to the 
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anterior lateral surface of the cell where they seem to fuse with the pellicle (9, 
220). In addition, most of dense granule release occurs after completion of 
invasion (220).   
 
MICRONEME PROTEINS: TARGETING AND REGULATED SECRETION 
 
Apart from a few characterized ligands binding to specific receptors on 
the erythrocytes in the case of some Plasmodium species, no such interactions 
have been identified for other apicomplexan species. Nevertheless, a range of 
micronemal proteins has been identified from species like P. falciparum and T. 
gondii. Many of these micronemal proteins contain domains that are conserved 
within species and between different genera, which are likely to serve similar 
functions in the invasion process. Approximately half of the known 
micronemal proteins are predicted to be type I membrane proteins with a single 
membrane spanning sequence situated near the C- terminus. Furthermore many 
microneme (MIC) proteins of T. gondii (MICs1-4 and 6-9) contain adhesive 
domains found in vertebrate proteins such as integrins, thrombospondin, 
kallikrein, and epidermal growth factor (EGF) (219). For example, MIC2 
possesses a single von Willebrand Factor type A domain (vWFA, also known 
as an I-domain of integrin) and five thrombospondin type I-like repeats (230). 
vWFA-domains typically bind a subset of extracellular matrix proteins such as 
collagens, laminins, or heparin sulfate proteoglycans (HSPGs) (223). MIC 
proteins often function in adhesive complexes. For example, TgMIC1 is 
complexed with TgMIC4 and TgMIC6. TgMIC1 and TgMIC4 are both 
essential for binding host cells and are responsible for the adhesive properties 
of the complex (32). Although the host receptor is still unknown, TgMIC1 was 
recently demonstrated to be a lactose-specific lectin that presumably binds 
lactose-containing glycoprotein receptors on the surface of target cells (32). 
TgMIC6 is the only protein in the complex that contains a transmembrane 
sequence and probably anchors the adhesive complex in the membrane. 
TgMIC6 is also required for correct targeting of the adhesive complex to the 
micronemes since genetic disruption of TgMIC6 caused mis-targeting of both 
TgMIC1 and TgMIC4 to the dense granules, which is the default secretory 
pathway in T. gondii and probably in other apicomplexan parasites too 
(reviewed in (32)). This result implicated that TgMIC6 probably contains 
microneme sorting signals. Disruption of the TgMIC2 cytoplasmic domain also 
mistargeted the M2AP protein that attaches to TgMIC2. Sequence data from 
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the cytoplasmic domain of TgMIC2 revealed two conserved motifs that were 
important for targeting of the proteins to micronemes (59). 
 
 
Fig. 3.  Hypothetical model for the invasion by B. bovis as based upon the malaria model. (A) 
attachment; (B) apical reorientation; (C) emptying of micronemes and formation of moving 
junctions; (D) invagination of the membrane and emptying of the rhoptries; (E and F) sealing 
of erythrocyte membrane, formation of the parasitophorous vacuole and discharge of dense 
granules. The maintenance of a parasitophorous vacuole during the intra-erythrocytic life of 
B. bovis  has not been well established. 
 
The motifs contained tyrosine residues and a stretch of acidic residues that 
were also found in the cytoplasmic domain of TgMIC6. Furthermore, replacing 
the GPI anchor of surface antigen 1 (SAG1) of T. gondii by the transmembrane 
and cytoplasmic domain of TgMIC6 showed translocation of SAG1 to 
micronemes instead of dense granules. (20, 32).  
The secretion of proteins from the three different apical organelles is a 
tightly regulated process. The precise mechanism of the secretion process is not 
known so far. Previous studies demonstrated that increases in intracellular 
calcium [Ca2+]i mediate microneme secretion in T. gondii (20, 128) and chelation 
of intracellular calcium blocks microneme secretion and invasion. Furthermore, 
reagents that raise T. gondii [Ca2+]i levels stimulate microneme discharge in the 
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absence of the host cells (31). Also in P. falciparum invasion of merozoites was 
inhibited when Ca2+ was chelated (233). Ca2+ is an essential regulator of 
microneme secretion since the membrane permeant Ca2+ -chelator, BAPTA-
AM, completely blocked exocytosis of micronemes without affecting dense 
granules secretion (32). BAPTA-AM also abrogated parasite attachment to host 
cells, supporting the presumption that micronemes are essential organelles in 
this process.  
Microneme secretion is a regulated process and not just a release of their 
contents following binding of extracellular parasites to erythrocyte membrane 
receptors (89). Apical membrane antigen 1 (AMA-1) and EBA-175 have both 
been found to be localized in micronemes, however the secretion of these 
proteins is differentially regulated. Expression of both proteins takes place at 
the same time during the schizont development. AMA1 is constitutively 
detectable on the merozoite surface (95, 158), whereas EBA-175 has never been 
shown to have a merozoite surface localization prior to invasion.  Previous 
reports have shown that AMA-1 was secreted from the micronemes 
independently of EBA-175. The results indicated that there is a level of 
selectivity involved in microneme protein secretion, perhaps depending on 
specific signaling via the cytoplasmic-tail region. The cytoplasmic tail of 
PfAMA-1 was shown to contain the microneme targeting consensus motif 
YXX (63, 99), although it has not been proven whether this motif is important for 
correct subcellular localization. The cytoplasmic tail of EBA-175 also contains 
this motif but other studies have indicated that an EBA-175 protein, truncated 
at the 3' cysteine-rich domain and thereby lacking the transmembrane and 
cytoplasmic-tail regions was localized apically (59, 81), implying that motifs 
other than those found in the cytoplasmic tail may be involved in its subcellular 
localization. The function of N-terminal processing of PfAMA-1 is not known 
yet. It could be that N-terminal processing may be required to allow AMA-1 to 
move out of the micronemes and so allowing AMA-1 to bind to an escorter 
protein (179) or that this motif present within the N-terminal sequence may act as 
a microneme retention signal. In P. falciparum immature micronemes 
containing AMA-1 are transported from golgi cisternae to the apical region by 
travelling along f-MAST (falciparum merozoites-associated assemblage of 
subpellicular microtubules), whereas rhoptries and dense granules do not 
proceed by microtubules (10). 
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THE MOTOR OF ACTIVE INVASION IN APICOMPLEXAN SPECIES 
 
Merozoite entry into the erythrocyte is clearly an active process that 
requires motility and energy (150). Mature erythrocytes do not show any 
phagocytic or receptor-mediated endocytic activities, indicating that the driving 
force is generated by the parasite. Cytochalasins, which prohibit invasion, 
inhibit actin polymerization suggesting the involvement of cytoskeletal 
structures and/or rearrangements in the transformation of force into movement 
when parasite invades its host cell. Treatment of merozoites with cytochalasins 
prior to invasion prevents invasion, but treatment of erythrocytes does not 
affect invasion, indicating that an actin/myosin motor of the parasite is 
important for invasion (145). After cytochalasin treatment, merozoites are still 
able to attach to erythrocytes and form a tight junction, however movement of 
the merozoite into the erythrocyte is arrested. Fig. 4 shows two hypothetical 
models for which evidence is accumulating. Actin filaments were identified 
under physiological conditions when treated with jasplakinolide, which induces 
actin polymerization, mainly at the apical end of extracellular Toxoplasma 
tachyzoites (194). Apicomplexan myosins are conserved in between species. P. 
falciparum has two actin genes. Pf-actin I is expressed throughout the life 
cycle, but Pf-actin II is expressed only in sexual stages (236). Myosin is a motor 
protein that walks along actin filaments towards the end using energy derived 
from the actin-activated hydrolysis of myosin-bound ATP (173). When an ATP 
molecule is hydrolyzed, a conformational change of the myosin head occurs 
such that force and movement are generated. Myosin motors have three 
domains. The amino terminus that contain a motor domain, the neck domain 
which binds to light chains and a tail domain that targets the MyoA to 
subcellular regions (144). Five T. gondii and four Plasmodium myosins have 
been identified so far, from which MyoA and its homologues in Plasmodium 
species have been localized beneath the plasma membrane of the parasites (133, 
174). In B. bovis several myosin proteins have been described (122).  
In the first model actin filaments remain stationary associated with the 
outer membrane of the IMC by a hypothetical protein (15). The cytoplasmic 
domain of P. falciparum TRAP or T. gondii MIC2 directly or indirectly 
interacts with MyoA tail. The MyoA head domain interacts with actin filaments 
and moves along the actin filaments. As the myosin contracts down the 
spiralling actin filaments, it pulls along the attached protein toward the 
posterior end, where cleavage would occur to release the external portion of the 
protein. The second model is a more likely model considering the proteins that 
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have been identified recently (see below) (106). In P. falciparum a myosin light 
chain homologue was identified and denoted Myosin A tail interacting protein 
(MTIP). MTIP anchors to the outer membrane of the IMC by a hypothetical 
protein that was recently identified as a docking protein in T. gondii and called 
T. gondii Myo-A docking protein (TgMADP) (91). MTIP binds the tail domain 
of MyoA and the head domain of MyoA interacts with short actin filaments 
that are indirectly linked to the cytoplasmic domain of P. falciparum TRAP or 
T. gondii MIC2. Because MyoA is fixed to the IMC, the actin/TRAP complex 
is displaced from anterior to posterior resulting in a forward movement of the 
parasite.  
Since the actin-myosin motor that drives motility is intracellular, at least 
one transmembrane bridge is required for apicomplexan species to link it to an 
extracellular ligand for cell locomotion. Current data suggest that most of the 
abundant proteins normally found on the surface of merozoites are linked to the 
membrane via a GPI moiety (113, 148). Since this linkage only connects the 
proteins to a lipid inserted into the membrane and does not actually cross the 
bilayer, other types of protein probably perform this function. In Plasmodium 
spp. a protein was identified in the sporozoite stage, called the 
thrombospondin-related anonymous protein (TRAP) (182). Plasmodium 
sporozoites and ookinetes, as well as the invasive stages of many other 
Apicomplexa, are also motile organisms that crawl along a substratum. This 
movement along a substratum, or 'gliding motility', is accompanied by the 
deposition of a trail of TRAP (197). Gliding motility presumably involves 
attachment of the parasite ligands (i.e., TRAP) to the substratum. By virtue of 
their transmembrane domain, the TRAP proteins provide a connection from 
outside the cell to the intracellular parasite cytoskeleton. Presumably the C-
terminal domain interacts with the myosin motor, which then associates with 
the actin filaments. The force generated by myosin motors will pull TRAP 
towards the posterior of the parasite and cause a forward movement of the 
parasite. Gene disruption studies confirm that TRAP plays essential role in both 
motility and cell invasion (212, 235). The C-terminal regions of Plasmodium 
TRAP and Toxoplasma MIC2 are functionally homologous, suggesting that 
this type of protein is active in all apicomplexan species (111).  
Recent evidence indicates that TRAP family proteins do not bind 
directly to the cytoskeleton, but rather recruit a complex that provides this vital 
link (106). The C-terminal cytoplasmic domains of TRAP and MIC-2 bind 
specifically to aldolase, a glycolytic enzyme that is also a well-characterized 
actin-binding protein (106). 
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Fig. 4. Two different models proposed for the actin-myosin mechanism in apicomplexans. 
(A) In the first model filamentous actin remains stationary, bound to the outer membrane of 
the IMC by a hypothetical protein and the myosin/TRAP complex moves along those 
filaments. The tail domain of MyoA interacts with the cytoplasmic domain of TRAP/MIC-2. 
The MyoA head domain interacts with actin filaments and moves along posterior end. (B) In 
the alternative model MTIP/Myosin complex remains stationary bound to the outer membrane 
of the IMC by a hypothetical protein (recently found to be MADP in T. gondii). In this model 
actin binds with aldolase which links the complex to the cytoplasmic domain of TRAP. 
Interaction of actin with head domain of myosin A leads to movement of the parasite. 
 
Aldolase binds directly to the C-terminal domain of TRAP proteins and in turn 
recruits actin filaments. The aldolase-TRAP interaction requires the conserved 
tryptophan residue near the C-terminus of the TRAP protein (106). This study 
gives a molecular explanation for the previous observations that malaria 
parasites expressing a mutant form of TRAP lacking the tryptophan residue 
were unable to glide productively (111). Aldolase serves to bridge the 
extracellular adhesive domains of MIC-2 or TRAP to the cytoskeleton, thus 
providing the link that was lacking to generate motility.   
 
PROTEASES AND PROCESSING DURING MEROZOITE INVASION 
 
 In the previous paragraph microneme proteins have been described 
involved in invasion, however, besides these proteins, also parasite proteases 
were shown to be essential for merozoite invasion in Plasmodium spp. and T. 
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gondii.  Protease inhibitors that are specific for serine and cysteine proteases 
have been shown to prevent erythrocyte invasion (17). Protease activity present 
at the surface of the invading merozoite has shown to be involved in the 
processing of the MSP-proteins. The processing events of MSP-1 occur on the 
surface of merozoites at about the time that invasion is taking place (97).  
Microneme proteins undergo proteolytic processing, which has mostly 
been studied in T. gondii. Proteolytic processing plays an important role in the 
maturation and activation of microneme proteins in apicomplexans. TgMIC-2, 
an adhesion proteins secreted during host cell invasion, belongs to the family of 
thrombospondion-related anonymous proteins (TRAP). Some microneme 
proteins are proteolytically processed during their transport and in addition are 
processed post-exocytosis. TgMIC-2 is processed by two types of proteases 
termed MPP1 (microneme protein protease 1) and MPP2 when released from 
the parasite surface (32). The C-terminal cleavage of TgMIC-2 changes the 
adhesive properties of the protein drastically and is even thought to release the 
adhesive complexes from the parasite surface. The MPP1 cleavage site was 
localized near the C-terminus of TgMIC-2 ectodomain. Two different reports 
have shown that cleavage occurred within the transmembrane domain and 
mutations within the conserved TM domain prevented the release of the protein 
into the medium (164, 224). However in a recent study mutations in the exodomain 
of MIC-2 directly upstream of the TM domain were also shown to be involved 
in cleavage and release of the protein from the cell surface. MIC-2 processing 
was dependent on a basic amino acid positioned 11 residues upstream of the 
predicted TM domain. Similar basic residues have been found also around 11-
13 residues upstream of the TM domains of several microneme proteins, 
suggesting a similar process of cleavage (22). These mutants of MIC-2 were still 
normally targeted to the micronemes, secreted upon stimulation and efficiently 
transported to the cell surface. When processing would be blocked, the 
exocytosed TgMIC-2 could create a long-lasting bridge between the host cell 
and parasite surface, and so interfering with sealing of the newly formed 
parasitophorous vacuole leading to blockage of parasite replication inside the 
vacuole. The microneme protein AMA-1 that is considered a vaccine candidate 
has also shown to be proteolytically shed in a soluble form during invasion 
from the parasite surface (101).  
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RHOPTRY AND DENSE GRANULE PROTEINS 
 
 The previous paragraphs have dealt in some detail with the involvement 
of micronemal proteins in the invasion pathway in chronological order. Such 
information is mainly lacking for rhoptry proteins. Rhoptries discharge their 
contents during the internalization of the parasite, releasing their proteins inside 
the parasitophorous vacuole and possibly into the erythrocyte membrane as 
well. Probably these proteins and possibly also lipid material play a role in the 
building of the parasitophorous vacuole. Quite a number of malarial proteins 
have been found to be transported to and stored in the rhoptry organelles (211, 
242). RAP-1 and RAP-2 are two proteins that have been localized in rhoptries 
and both proteins neither have transmembrane domains nor repeated amino 
acid motifs. After invasion the RAP-1/RAP-2 complex is apparently 
incorporated into the parasitophorous vacuole membrane (PVM) and /or the 
parasite plasma membrane of the newly formed ring-stage parasites (242).  
Once the merozoite is inside the RBC, it is enclosed by the PVM and 
dense granules secrete their protein content. The dense-granule proteins 
associate with intravacuolar structures after their release. A few proteins have 
been identified in Plasmodium dense granules. One of these proteins is  called 
RESA (ring-infected erythrocyte surface antigen), which, shortly after its 
release, becomes located under the membrane of the infected erythrocyte in 
association with the cytoskeleton (reviewed in (12)). The fusion of the dense 
granules and the release of their contents correlate with and perhaps trigger 
transformation into a growing intracellular ring-stage trophozoite that begins to 
feed on the hemoglobin of the RBC.    
Despite the wealth of information which is accumulating rapidly, we are 
still far from a complete understanding of these very complex organisms and 
their relationship to the host cell. The close interaction between the parasite and 
host starts from the first moment the merozoites try to enter the host cell. Most 
of the proteins found in micronemes, rhoptries and dense granule proteins 
described are from the two major apicomplexan model systems T. gondii and 
P. falciparum. For B. bovis only one rhoptry protein RAP-1, three dense 
granules proteins (SBP-1 to SBP-3) and two merozoite surface proteins, MSA-
1 and MSA-2, have been identified which were studied in detail and to date not 
a single micronemal proteins nor a receptor have been identified (74, 151, 152, 210, 
211, 242). A start to the identification of such proteins and the study of their role 
in invasion is the subject of this thesis.  
 
General Introduction 
 
26 
OUTLINE OF THE STUDY 
 
To know more about the invasion process of B. bovis, we first developed 
an in vitro invasion assay described in Chapter 2 that is used as model to 
investigate the proteins that are involved during invasion. B. bovis merozoites 
were liberated from red blood cells by high voltage pulses, followed by fresh 
erythrocyte invasion in protein-free buffer. Besides developing the in vitro 
invasion assay, we also investigated the effect on invasion by inhibitors 
affecting cytosolic Ca2+ concentration or actin polymerisation. Chapter 3 
reports the host-specificity of B. bovis parasite and initial experiments have 
been done to know more about the surface receptors and ligands that the 
parasite needs to enter its host cell. Besides invasion in bovine red blood cells, 
we also provided red blood cells of multiple other species, including human red 
blood cells. Very few proteins involved in apicomplexan host cell invasion 
have been conserved across the genus border. Nevertheless, two such proteins 
have been identified from EST data that were generated in the laboratory 
parallel to this thesis. These proteins are considered as candidates to be 
incorporated into a recombinant vaccine for P. falciparum. AMA-1 is shown to 
be a protein that has been transcribed and expressed in the asexual merozoite 
stage. Chapter 4 describes the B. bovis AMA-1 protein. We cloned and 
sequenced the complete AMA-1 gene, identified it in invasion supernatant 
material and total merozoite extracts and demonstrated a putative role in 
erythrocyte invasion. TRAP was also identified in B. bovis and further analysed 
in Chapter 5. The B. bovis proteins identified could only be characterized at 
molecular level and localized within the parasite. However we could not study 
the function of these proteins. The functional analyses of proteins require a 
transfection system of B. bovis. Several attempts and conditions that have been 
tried out to set up a transfection system for B. bovis are described in Chapter 6. 
Although many efforts have been taken, we were not able to develop a 
transfection system. B. bovis merozoites cultures that were transfected with 
human dhfr (dihydrofolate reductase) or T. gondii dhfrm2m3 plasmid were 
selected after weeks of drug pressure. However only spontaneous resistant B. 
bovis cultures for pyrimethamine and WR99210 were selected. These cultures 
were further analysed after observing that these cultures were selected over and 
over again. The dhfr-ts (dihydrofolate reductase-thymidylate reductase) of B. 
bovis wild type and resistant cultures were cloned, sequenced and compared. 
These analyses are described in Chapter 7. We detected a mutation in the dhfr 
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gene of B. bovis likely to be responsible for the resistance. In the final chapter, 
Chapter 8, the findings of the study described here are discussed.  
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ABSTRACT 
 
Apicomplexa are a phylum of obligate intracellular parasites critically 
dependent on invasion of a host cell. An in vitro assay for erythrocyte invasion by 
Babesia bovis was established, employing free merozoites obtained after application of 
high voltage to parasitized erythrocytes. Invasion proceeds efficiently in phosphate 
buffered saline solution without requirement for any serum or medium components. 
Kinetics of invasion can be measured over a time span of 5 to 60 minutes after which 
invasion is completed at an average efficiency of 41%. The fast kinetics and high 
efficiency exceed those of most previously established apicomplexan invasion assays. 
Manipulation of intracellular calcium concentration inhibits invasion. Preincubation of 
merozoites at 37oC also reduces invasion, possibly by the premature secretion of 
protein. Proteins that are shed into the environment during invasion were directly 
detectable by protein staining after 2D gel electrophoresis. Limitations posed by the 
immunological detection of proteins released during in vitro invasion by other 
apicomplexan parasites can therefore be avoided by this method. A unique feature of 
the assay is the reversible uncoupling of invasion and intracellular development, the 
latter only taking place under serum-rich medium conditions. In addition, host cell 
attachment is uncoupled from invasion by cytochalasin B. 
 
INTRODUCTION 
 
  Babesia bovis is an apicomplexan parasite of cattle causing major damage to the 
livestock industry in tropical and sub-tropical areas and is transmitted by ticks of the 
genus Boophilus. Unlike malaria sporozoites, which invade hepatocytes, the 
sporozoites of B. bovis directly invade erythrocytes upon which an asexual 
erythrocytic cycle of duplication, erythrocyte rupture and merozoite reinvasion is 
initiated. Like the plasmodial erythrocytic cycle this can cause severe pathology, 
which can ultimately lead to the death of the host. One clinical feature is cerebral 
babesiosis, characterized by clogging of the cerebral microvasculature with infected 
erythrocytes and associated inflammatory reactions. At least superficially this 
resembles human cerebral malaria caused by Plasmodium falciparum (163). 
  Host cell invasion by apicomplexan merozoites is a conserved and critical step 
that is amenable to intervention by the immune system. For Plasmodium species and 
Toxoplasma gondii the molecular mechanism of invasion has been investigated in 
some detail (31, 67, 196, 205). Rhoptries and micronemes, characteristic apicomplexan 
secretory organelles containing molecules essential to host cell invasion, harbour a 
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complex mixture of proteins but for B. bovis only the rhoptry protein RAP-1 has been 
identified and studied in detail (152, 211, 242). In addition, a function for the merozoite 
surface proteins MSA-1  and MSA-2 has been implied in B. bovis invasion (74, 151, 152) 
  In vitro invasion of host cells by other apicomplexan parasites is accompanied by 
the rapid release of parasitic proteins into the environment (31, 101). A function in the 
invasion process is being assigned to an increasing number of these proteins. Studies 
on erythrocyte invasion by most Plasmodium species are hampered by the low yields 
of viable free merozoites and the long incubation times (up to 48 h) required for 
quantification. This is in marked contrast with the rapid, within minutes, invasion 
observed in vivo. Our aim was to establish an in vitro B. bovis invasion assay that is 
rapidly quantifiable and efficient in numbers of invading merozoites. A novel method 
of merozoite release, followed by erythrocyte invasion in a protein-free buffer, met 
with these criteria and allows direct detection of proteins secreted during invasion, in 
sufficient quantities for further characterisation and sequence identification. It should 
help to close the gap in molecular knowledge as compared to other related parasites 
and provide another apicomplexan model system for studying erythrocyte invasion.  
 
MATERIALS AND METHODS 
 
In vitro culture of B. bovis 
B. bovis clonal line C61411, derived from an Israelian isolate, was cultured in vitro 
according the MASP method with slight modifications (121, 195). Briefly, parasites were 
cultured in a settled layer of bovine erythrocytes at 5% packed cell volume (PCV) in M199 
supplemented with 40% adult bovine serum and 26 mM sodium bicarbonate (M199S) under 
an atmosphere of 5% CO2 in air at 37ºC. Culture volumes were 1200 µl in 24 well plates, 15 
ml in 25 cm2 flasks and 50 ml in 75 cm2 flasks. Cultures were maintained at a parasitaemia 
between 1 and 5% by daily dilution. For invasion studies cultures were harvested in log phase 
at 8 to 12% parasitaemia. 
 
Preparation of bovine serum and erythrocytes and B. bovis immune serum 
Blood was retrieved from a selected Friesian-Holstein heifer, defibrinated by shaking 
for 10 min with glass beads and centrifuged for 30 min at 4ºC at 2000 g for pelleting 
erythrocytes. Serum was centrifuged again, frozen at –20ºC and stored until usage. 
Erythrocytes were washed 4 times in VyMs buffer, kept at 4ºC and used for maximally 14 
days. Immune serum was obtained from a cow that was infected 3 times at three-month 
intervals with B. bovis clonal line C61411 (227). 
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In vitro invasion assay 
B. bovis culture was centrifuged (2000 g, 10 min, 15ºC) after which the pellet was 
resuspended in an equal volume of cytomix (120 mM KCl, 0.15 mM CaCl2, 2mM EGTA, 5 
mM MgCl2, 10 mM KHPO4/KH2PO4 pH 8.0, 25 mM HEPES pH 8.0). Samples of 750 µl 
were subjected to five intermittent (10 seconds, 0ºC) high voltage pulses (2.5 kV, 200 Ohm, 
25 uF) in a BioRad Gene Pulser with pulse controller using 4 mm BioRad cuvettes (165-
2088). For removal of soluble extracellular components from the liberated merozoites and 
erythrocyte ghosts, 120 µl samples were washed 1 to 3 times by resuspension in 1 ml of 
buffer (as indicated in the text and legends) followed by centrifugation (2000 g, 2 min, 15ºC). 
After the last centrifugation the pellet was resuspended to a total volume of 120 µl which was 
subsequently added to 1080 µl of pre-conditioned bovine erythrocytes (in 24-well plates) and 
transferred to an atmosphere of 5% CO2 in air at 37ºC to initiate invasion. Pre-conditioned 
erythrocytes consisted of 50 µl (PCV) bovine erythrocytes (washed in PBS for 3 times in 
addition to the 4 washes in VyMS buffer) suspended in 1030 µl of buffer (buffer indicated in 
the text) and incubated under an atmosphere of 5% CO2 in air at 37ºC for 30 min. Invasion 
was measured at the indicated time points by counting the parasitized erythrocytes out of a 
total of 5000 erythrocytes in Giemsa stained smears. Invasion efficiency was calculated 
relatively to a control invasion performed in triplicates in M199S. For characterisation of the 
invasion process several chemicals were added to the pre-conditioned erythrocytes and/or pre-
incubations of liberated merozoites were performed as indicated in the text and legends. These 
included BAPTA-AM (20 mM stock solution in DMSO, Sigma), Thapsigargin (1 mM stock 
in DMSO, Sigma), Cytochalasin B (400 µM stock in DMSO, Sigma) and Ionomycin (400 µM 
stock in DMSO, Sigma). 
 
Viability determination of merozoites 
Liberated merozoite suspension was added to an equal volume of 20 µg/ml 6-
carboxyfluorescein diacetate (CFDA, Sigma) and incubated for 30 min at 20ºC at a dark 
place. Merozoites were resuspended in PBS after centrifugation (2000 g, 2 min) and examined 
under a UV. 
 
Sample preparation and isoelectric focusing 
The overlaying buffer of the invasion assay incubations was collected and centrifuged 
twice (10 min at 2000g and subsequently for 15 min 12000g) for removal of all cells. The 
final supernatant was concentrated and desalted over 3 kDa filters (YM-3, Millipore), 
precipitated in a final concentration of 10% TCA (dissolved in acetone) and dissolved in 
rehydration solution (7 M urea, 2 M thiourea, 4% CHAPS, 2% carrier ampholyte mixture pH 
3-10NL (IPG buffer) and 20 mM DTT). IEF instrumentation, IPG gels and related reagents 
were from APharmacia Biotech, unless otherwise indicated. Protein (50 µg) with protease 
inhibitor (Complete, Roche) was loaded on 13 cm IPG strips (pH 3-10NL), rehydrated (10-14 
h) and focused overnight (14-17 h) in an automated run (1 min 300 V, 90 min during which 
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voltage rises to 3500 V followed by continued focusing at 3500 V for a total of 35-40 KVh, 
IPGPhorTM).  
 
Second Dimensional Electrophoresis (2DE) 
The strips were incubated in 10 ml of equilibration buffer (50 mM Tris, 6 M urea, 2% 
SDS, 30% glycerol, pH 8.8) containing 30 mM DTT for the first 15 min and replaced by 
equilibration buffer with 2.5% iodoacetamide for another 15 min. The second dimensional 
SDS gel was carried out in a Hoefer SE600 system. Silver staining was used to visualise 
proteins after 2DE. The images of the gels were acquired using LabScan v3.0 software on an 
Umax flatbed scanner and later analysed with Image Master 2D v3.01 software (APharmacia 
Biotech). 
 
SDS-Polyacrylamide Electrophoresis and Western blotting 
Sample proteins were separated on a 10% SDS-PAGE gel and transferred to a 
nitrocellulose membrane, which was blocked with 5% skimmed milk powder in PBS, pH 7.2 
for 1 h at 37ºC. All washes after each incubation step were done 3 times for 5 min with 
PBS/0.1% gelatine/0.05% Tween (PBS-GT). The blots were incubated overnight at 22-24ºC 
in immune sera diluted 1/500 or 1/1000 in PBS with 5% skimmed milk. After washing, the 
strips were incubated with anti-bovine total IgG coupled to alkaline phosphatase (diluted 
1/30000 in PBS-GT) for 1 h at 22-24ºC. The colorimetric reaction was carried out for 10-15 
min with nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate diluted in 100 mM 
Tris/100 mM NaCl/5 mM MgCl2, pH 9.5. 
 
RESULTS 
 
Kinetics of erythrocyte invasion by merozoites liberated by high voltage pulses. 
Free merozoites were obtained by application of five subsequent 2500 V pulses 
to B. bovis infected erythrocytes (8 to 12% parasitaemia) that were resuspended at 
50% PCV. Microscopic examination of Giemsa stained smears showed that 99.5% of 
the erythrocytes are lysed. Infected erythrocytes are hardly ever encountered but a 
substantial number of merozoites (<10%) reside in erythrocyte ghosts. At least 80% of 
the liberated merozoites were viable as defined by their ability to metabolise CFDA. 
The ability to invade host cells was examined by incubation of liberated 
merozoites with erythrocytes (5% PCV) under standard in vitro culture conditions. The 
ratio of free merozoites to erythrocytes was kept identical to the ratio before liberation 
(e.g. 8 to 12%). Fig.1a shows that invasion proceeds rapidly (0.91% parasitaemia at 15 
min) reaching a plateau at 2.20% after 60 min. Invasion efficiency can be defined as 
the observed parasitaemia after reinvasion divided by the maximal number of 
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potentially invasion competent parasites (2x percentage of erythrocytes harbouring a 
duplicated parasite in the culture from which the liberated parasites were obtained). 
Six independent invasion experiments performed over a time span of several months 
yielded a mean invasion efficiency of 41.6 + 15.6% (s.d.), reaching 0.8 to 3.8% 
absolute parasitaemia, after 60 min. Careful examination and focusing under the light 
microscope showed that many parasites were already in contact with erythrocytes 
(juxtaposed to, but often also looking as if being located on top of, an erythrocyte) 
after 15 min. The sum of parasites contacting and having invaded an erythrocyte after 
15 min approximately equals (2.54 + 0.14%) the number of parasites that have actually 
invaded after 60 min. Very few parasites contacting an erythrocyte are left after 60 min 
whereas the parasites that did not invade are laying free or clumped together. Fig.1b 
displays the effect of erythrocyte PCV on invasion. Relative parasitaemia becomes 
highest at a PCV of 1% but the absolute number of invaded merozoites is highest at a 
PCV of 8%, both after 10 min and 1 h. 
B. bovis infections as well as in vitro cultures are asynchronous and methods for 
synchronisation are lacking. The span of a lifecycle has only been estimated from the 
average multiplication rate. In the current invasion assay it can be assumed that 
immature merozoites, liberated by high voltage, do not develop any further whereas 
only mature merozoites are invasion competent, thus providing a synchronised start. 
This does not result in synchronous growth (Fig.1c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. A. Percentage of invasion plotted against time. B. Effect of packed cell volume on invasion. 
White bars represent percentage of invasion after 10 min, grey bars after 1 h. Lines indicate invasion 
in absolute numbers of parasites after 10 min (triangles) and 1 h (squares). C. Development of 
parasitaemia after invasion. Black bars indicate total percentage of invaded erythrocytes. White bars 
indicate the percentage of invaded erythrocytes harbouring a duplicated, double pear-shaped 
merozoite. Error bars indicate S.D. of triplicates. Invasion performed in M199S in all panels. 
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Upon the appearance of the first duplicated double-pear shaped parasites after 5 h, the 
onset of a gradual increase in parasitaemia is observed. This defines the minimal time 
span of a complete lifecycle at ~6 hours but a sudden burst of duplicated and 
subsequently reinvaded parasites is not observed, indicating a wide spread in lifecycle 
duration between individual parasites. In Fig.1c a 3.8-fold multiplication is reached 
after 24 h, which is within the range (3.5 to 5-fold in 24 h) that is observed in a 
continuously growing culture. 
 
Effects of medium composition and merozoite pre-treatment on erythrocyte invasion 
Dependence of B. bovis in vitro growth on a rich culture medium supplemented 
with 40% adult bovine serum (M199S) complicates dissection of the components 
involved in invasion, intra-cellular establishment and growth. Fig.2a shows that 
invasion can take place in absence of serum and medium. A 35% reduction in invasion 
efficiency was observed when performed in PBS instead of M199S (bar 1). Addition 
of 1 mM CaCl2 restored relative invasion efficiency to 96% (bar 4). Washing of 
merozoites in PBS prior to invasion had no significant effect on efficiency (bars 2 and 
5) whereas washing in presence of 1 mM CaCl2 enhanced invasion by ~40% (bar 3 
and 6). Repeated washing caused a gradual decline in efficiency but a three-fold wash 
and subsequent invasion in PBS/CaCl2 still permitted comparable invasion levels as 
observed with non-washed merozoites in M199S (not shown). A pH from 7.5 to 9.0 
was compatible with invasion with an optimum at pH 8.0 (Fig.2b). A sharp drop in 
invasion efficiency was seen at pH to 7.0. Invasion was abolished at 32oC or 42oC (not 
shown). Preincubation of merozoites for 5 min at 37oC completely prevents invasion 
although no merozoite agglutination or changes in shape were observed by 
microscopy. 30 min preincubation of merozoites at 20oC or 30oC was much better 
tolerated as compared to 37oC (Fig.2c). Light microscopy of Giemsa stained smears 
showed invaded parasites (either in PBS or in M199S) as condensed (pycnotic) intra-
erythrocytic particles (Fig.1c, insert a). In M199S parasites rapidly (2 to 3 h) develop 
into trophozoite forms with a clear blue cytoplasm (Fig.1c, insert b), but after 
performing invasion in PBS any further development is blocked and parasites remain 
pycnotic. Normal development is rapidly restored when PBS is replaced by M199S 
after 2 or 4 h (Fig.2d). Addition of M199S after 24 h restored parasite growth only 
after a 24 h to 72 h lag phase (not shown). 
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Effects on invasion by inhibitors affecting cytosolic Ca2+ concentration or actin 
polymerisation. 
Cytochalasins prevent actin polymerisation by capping the barbed end of actin 
and their inhibitory effect on host cell invasion of several apicomplexan parasites 
suggested the involvement of an actin/myosin motor system (25, 44, 60, 145). B. bovis 
invasion is completely inhibited by 5 µM cytochalasin B (Fig.3a) and examination of 
Giemsa stained preparations identified many merozoites contacting an erythrocyte. Of 
these, many are spread out on the stained preparation as if the tip of the merozoite is 
contacting the erythrocyte (Fig.1c, insert c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. A. Effect of medium composition on invasion. Merozoites are washed once in PBS (white bars) 
or in PBS + 1 mM CaCl2  (black bars) or were not washed (grey bars) after lysis by high voltage. 
Immediately after washing merozoites were allowed to invade erythrocytes for 1 h in PBS pH 8.0 or in 
PBS pH 8.0 + 1 mM CaCl2 as indicated. Invasion was plotted relative to invasion performed in M199S 
(control performed in triplicate), which was taken as 100%. B. Effect of pH on invasion. Invasion was 
performed for 30 min in PBS that was adjusted to the indicated pH and plotted relatively against 
invasion performed in M199S. C. Effect of preincubation of merozoites on invasion. Merozoites were 
incubated for 30 min in PBS pH8.0 prior to invasion at the indicated temperature, after which invasion 
was performed for 30 min in PBS pH8.0. Efficiency was plotted against invasion in PBS pH8.0 by 
merozoites that were not pre-incubated. D. Development of invaded parasites after addition of growth 
medium. Invasion was performed for 2 h in M199S (bar 1) or in PBS pH8.0 (bars 2 to 5).  M199S or 
PBS pH8.0 was either not replaced (bars 1 and 2) or replaced by M199S after 2 h (bar 3), 4 h (bar 4) or 
24 h (bar 5). Infected erythrocytes were counted after 4 h and 24 h as indicated. Replacement of PBS 
after 24 h (bar 5) showed at that time point abnormally developed parasites but within 72 h normal 
growth rate is restored (not shown). All assays were performed in triplicate and error bars indicate 
S.D. 
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merozoites were preincubated with ionomycin (a Ca2+ ionophore giving rise to 
increased cytosolic Ca2+ by influx from the extracellular millieu or intracellular Ca2+ 
stores), BAPTA-AM (a specific chelator of cytosolic Ca2+) or thapsigargin (an 
inhibitor of sarco/endoplasmic reticulum Ca2+-ATPases that transport cytosolic Ca2+ 
back into the sarco/endoplasmic reticulum) (214). Fig.3b shows that preincubation with 
100 µM BAPTA-AM reduces invasion more than 10-fold whereas 1 µM thapsigargin 
reduces invasion 5-fold. Ionomycin had a moderate effect in presence or absence of 
extracellular Ca2+, resulting in 40% inhibition after 30 min preincubation (Fig.3c). In 
all cases the viability of merozoites was not affected by the inhibitor treatment as 
indicated by their capacity to metabolise CFDA. 
 
Invasion is accompanied by the rapid release of parasite specific antigens into the 
surroundings 
B. bovis proteins shed at different time points during invasion were separated by 
SDS-PAGE, blotted and labelled by with B. bovis antiserum. Antigenic proteins of 60 
and 64 kDa are released within 5 minutes upon transfer of the incubation mixture from 
0 to 37oC (Fig.4). The same bands are also observed in a control experiment in which 
no erythrocytes were added to the liberated merozoites (Fig.4, compare lanes 3 and 8 
to 4 and 9). During 60 minutes of invasion, shedding of antigenic proteins was 
continued, resulting in detection of additional antigenic bands with a gradually 
increasing intensity over time (lanes 9 to 12). In a control experiment where invasion 
is prohibited by the absence of erythrocytes, no gradual increase in the intensity and 
number of bands was observed (lanes 5 to 7). 
Most of the protein in the samples is still derived from erythrocyte ghosts in the 
form of cytoskeletal proteins and associated haemoglobin that could not be removed 
by repeated washes at 0oC but partly became solubilized during the incubation at 37oC.  
This limits the amount of B. bovis derived proteins that can be loaded on a SDS-
polyacrylamide gel and, in combination with the limited resolution obtained by 1D-
SDS-PAGE, restricts identification of secreted/shedded proteins by direct protein 
staining. Employing the capacity and resolving power of 2D-protein gel 
electrophoresis, a large number of B. bovis specific major and minor protein spots 
could be detected after electrophoresis of in vitro invasion supernatants (Fig.5). Panel 
A shows the proteins present in 2 ml of supernatant derived from an experiment in 
which merozoites were allowed to reinvade for 1 h. Panel B shows a control 
experiment in which uninfected erythrocytes were lysed by high voltage and further 
washed and used for invasion under identical conditions as in Panel A. Thus, panel B 
shows all the erythrocyte proteins (mainly monomeric and multimeric haemoglobin B  
 
In vitro invasion assay of Babesia bovis 
 
38 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. A. Inhibition of invasion by cytochalasin B. Invasion was performed in M199S after 15 min 
preincubation of merozoites with cytochalasin B at the indicated concentration and determined after 
1h. B. Effect of BAPTA-AM and thapsigargin on invasion. Invasion was performed for 1 h in M199S 
without preincubation (C) or after preincubation for 90 min at 20ºC in PBS + 0.5% DMSO, 90 min 
preincubation at 20ºC with 100 µM BAPTA-AM or 30 min preincubation at 20ºC with 1 µM 
thapsigargin. C. Effect of ionomycin on invasion. Invasion was performed for 1 h in M199S without 
preincubation (C) or after preincubation for 5 and 30 min respectively with ionomycin in PBS pH 8.0 
or PBS pH 8.0 + 1 mM CaCl2. Error bars indicate standard deviation (SD) of triplicates.  
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Fig. 4. Western blotting of proteins released during  invasion of  erythrocytes. Lanes 3 to 7, control 
incubations for determination of proteins released by free merozoites in the absence of erythrocytes. 
Lanes 8 to 12, invasion in PBS pH 8.0. Released proteins were harvested after 0, 5, 15, 30 and 60 min 
(lanes 3 and 8, 4 and 9, 5 and 10, 6 and 11, 7 and 12, respectively). Lane 2 is a control with non-
infected erythrocytes used for invasion for 1 h. Lanes 2 to 12 were incubated with immune serum, 
Lane 1 is identical to lane 12 but incubated with preimmune serum. 
 
 
 
Fig. 5. 2D gel electrophoresis (12.5%) of proteins released during invasion. Panel A, supernatant of 
invasion of erythrocytes with liberated merozoites. Panel B, supernatant of “invasion” with high-
voltage lysed extract of mock-infected erythrocytes. Invasion was performed for 1 h in PBS pH 8.0 in 
a volume of 15 ml. Merozoites were washed in PBS pH 8.0 for three times prior to invasion. 
Parasitaemia after invasion was determined at 0.84%. Arrows indicate prominent spots that cannot be 
detected in control of panel B. The boxed area contains many “invasion specific” spots. 
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and cytoskeletal proteins) that were not solubilized during the washing steps but only 
after incubation for 1 h at 37ºC (not any resemblance can be detected with a proteome 
map of cytosolic bovine erythrocyte proteins available at http://www.expasy.ch 
/ch2dothergifs/publi/rbc.gif, indicating that no significant lysis of erythrocytes takes 
place during invasion). Panel A shows in addition a large amount of spots that 
represent merozoite proteins released into the supernatant during 1 h of invasion. 
Merozoite derived proteins were particularly abundant in the boxed region of panel A. 
Arrows mark other prominent spots that are not present in the control. At least 110 
spots are present in panel A that could not be detected in panel B (some of the fainter 
spots are close to the detection limit and may thus just have been missed in panel B).
  
 
DISCUSSION 
 
Studies on B. bovis erythrocyte invasion may help in pinning down conserved 
and species specific aspects of the molecular mechanisms of apicomplexan host cell 
invasion (133, 156). Here we have presented an invasion assay, based on the liberation of 
B. bovis merozoites by high voltage pulses, with the following hallmarks. (I) ~40% of 
the liberated “invasion-competent” merozoites invade an erythrocyte within 1 h. (II) 
Invasion proceeds efficiently in PBS thereby providing an excellent model system for 
studying the effects of exogenously added components without having to take into 
account the effects of the many undefined substances present in serum-rich media. (III) 
During invasion proteins are released that can be concentrated without using selective 
procedures like immunoprecipitation that otherwise have to be used to remove the 
excessive amounts of protein present in serum-rich media. (IV) The assay uncouples 
invasion and intracellular development, enabling systematic reconstitution of medium 
components required for intracellular growth. 
These features allow more accurate and specific in vitro studies of B. bovis 
erythrocyte invasion than currently is the case for most Plasmodium species. Light 
microscopy indicates that within 5 minutes most parasites that will invade within the 
next hour have become attached to an erythrocyte whereas 41% of the maximum level 
of invasion is already reached after 15 min. A qualitative description of erythrocyte 
invasion by P. knowlesi has shown that invasion can be accomplished within minutes 
after initial contact but in contrast, invasion experiments by other Plasmodium species 
are typically performed in a time span ranging from 4 h to 48 h (71, 136, 160). 
Studies on apicomplexans have shown that host cell receptors are rapidly 
secreted from micronemes upon initial cell-cell contact, followed by secretion of 
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additional proteins from rhoptries and release of plasma membrane-bound proteins (31, 
36). The results obtained for B. bovis fit into such a model. Immune recognised proteins 
of 60 and 64 kDa are secreted upon transfer to 37ºC followed by an accumulation of 
additional bands in the next hour of invasion. Immediate secretion of 60 and 64 kDa 
proteins is also seen upon transfer to 37ºC in absence of invasion (control with no 
erythrocytes added). This may be a premature secretion and could explain the reduced 
invasion that is seen after a brief preincubation of merozoites at 37oC. As 
preincubation at 20oC has no detrimental effect on invasion and does not lead to 
protein release, the rapid release of 60 and 64 kDa proteins could result from an 
enzymatically regulated event. This may have been triggered by interaction with host 
cell receptors that might also be present in the control in the form of erythrocyte ghost 
membranes. 
Invasion in medium containing 40% bovine serum is fully productive as is 
shown by the subsequent growth rate. In the first 24 h this lies within the 3.5 to 5-fold 
multiplication range of a continuous growing culture. Invasion performed in PBS 
followed by a change to standard growth medium after 1 h is equally productive from 
which can be concluded that the merozoite carries all the requirements for optimal 
invasion. A large variation in intra-erythrocytic life cycle duration was determined 
with a minimal length of 6 h. After 11 h parasitaemia has increased from 1.55 % (x) to 
2.7 % (y) with 1.7 % (z) of the erythrocytes harbouring a single trophozoite. Thus 35% 
((z-(y-x))/x) of the parasites has not duplicated yet indicating that the time required to 
develop to a duplicated double pear-shaped meront is an important component in the 
asynchronous growth of B. bovis. This can be an inherent property of B. bovis 
development but could also be due to sub-optimal in vitro growth conditions. 
5 µM cytochalasin B gives 95% inhibition whereas 3 µM has no effect. During 
a 48 hours period of growth, 0,4 µM of cytochalasin B inhibits B. bovis growth by 
25%, possibly indicating a stronger effect on the function of contractile microfilaments 
during replication (122). The effect on invasion was not measured by this method. 
Sensitivity is in between the values observed for E. tenella (82% inhibition by 10 µM) 
and P. knowlesi (~90% inhibition by 1 µM) (25, 145). The frequent observation of 
merozoites contacting an erythrocyte by their tip is reminiscent of observations on P. 
knowlesi and T. gondii parasites that were preincubated with cytochalasin (60, 145). 
Cytochalasins may prevent movement of the parasite into an invaginating vacuole by 
blocking an actin/myosin motor system (165) without blocking attachment to the host 
cell after apical reorientation. Studies on the role of Ca2+ in apicomplexan host cell 
invasion gave rise to a model in which protein secretion during invasion is a stimulus-
coupled event with Ca2+ as a second messenger (34, 63, 136, 228, 233). Chelation of 
intracellular Ca2+ by BAPTA-AM inhibits B. bovis invasion but is a harsh tool that will 
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also affect other biological processes. The strong inhibition by thapsigargin points at 
the involvement of the ER as this drug inhibits repletion of this calcium store. This 
effect of thapsigargin has been observed for other apicomplexans too, but recently it 
was shown that incubation with thapsigargin does not give rise to an increase in 
cytosolic Ca2+ making the effect of this drug on invasion still puzzling (4). The 
observed stimulating effect of 1 mM extracellular Ca2+ could indicate the use of 
extracellular Ca2+ for transient increase of cytosolic Ca2+ but it may equally well 
positively affect essential protein interactions between host cell and merozoite during 
invasion. 
During continuous in vitro cultivation of B. bovis, a mixture of proteins is shed 
that has been described as culture-derived exoantigens (107, 149, 170, 191). Their origin and 
function are still largely unknown. The immunogenicity of these proteins provoked 
vaccination studies that have given promising results in other Babesia  species as well. 
Most likely, the immunogenic proteins that are secreted during host cell invasion 
(Fig.4), are part of the proteins present in exoantigens. B. bovis exoantigens, harvested 
over periods of 48 h, will contain a lot of other parasitic proteins (e.g. from decaying 
parasites) and are usually studied with immunological tools as they are masked by an 
excessive amount of serum and host cell proteins. The B. bovis proteins released 
during in vitro invasion in PBS can be identified directly by 2-dimensional gel 
electrophoresis. The number of protein spots detected by far exceeds the number of 
antigenically detected proteins after 1D electrophoresis (10 in Fig.4) and also the 
number of antigenically detected exoantigens (107, 149, 170). Identification and initial 
functional characterization of these additional proteins is now enabled by their 
visualisation by 2D electrophoresis. Identification of the proteins not detected by 
antibodies may also be relevant for vaccine development, the inherent immunogenicity 
of a parasite molecule does not correlate with its protective capacity (238). 
In summary, the strength of the assay is its speed, efficiency and independency 
of medium composition. The effects of specific invasion inhibitors or conditions on the 
kinetics of secretion of individual proteins can be studied on a short time-scale (5 min 
to 1 h) by the use of 2D-electrophoresis in order to unravel the molecular mechanisms 
involved. The protein spots are amenable to identification by a proteomics approach 
considering the amounts that can be produced (the assay can without problems be 
performed in 50 ml quantities). Rare events can be monitored directly as the 
application of 50 ml of invasion supernatant to a 2D gel will allow the detection of 20 
molecules of 60 kDa secreted by a single merozoite (assuming the invasion of 2% of 
the erythrocytes and a detection limit of 1 ng protein by silver staining). 
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ABSTRACT 
 
Babesia bovis infections have only been observed in bovine species in contrast 
to Babesia  divergens that also can infect humans, sheep and rodents. Using an in vitro 
assay that assesses invasion of erythrocytes by free merozoites after an one hour 
incubation period, it was shown that specificity is not determined by host-specific 
interactions associated with invasion. Human erythrocytes were invaded more 
efficiently than bovine erythrocytes whereas erythrocytes of sheep, pigs and horses 
were invaded only slightly less efficient. In contrast, goat erythrocytes were refractory 
to efficient invasion. Significant differences in invasion efficiency into erythrocytes 
from different individuals of the same species were observed. Erythrocytes from all 
species, except for goats, supported intracellular development of newly invaded 
merozoites and high numbers of duplicated parasites, located in a morphologically 
normal accole position, were present. Only in bovine erythrocytes subsequent rounds 
of invasion, leading to increased parasitaemia, took place. This suggests that host 
specificity is determined by factors operating late in the erythrocytic stage of the B. 
bovis lifecycle. Incubation of erythrocytes with neuraminidase prior to invasion led to 
a decrease in invasion efficiency of ~80%. This effect was observed for several 
species. The removal of either α(2-3)-linked or α(2-6)-linked sialic acid residues gave 
similar levels of reduction whereas simultaneous removal did not show an additive 
effect. Pre-incubation of merozoites with n-acetylneuraminyl-lactose decreased 
invasion efficiency by ~45% whereas addition just prior to invasion had no significant 
effect. The results demonstrate that invasion is dependent on the presence of sialic-acid 
containing membrane receptors on erythrocytes that interact with merozoite ligands 
that are probably already accessible during pre-incubation prior to invasion. 
 
INTRODUCTION 
 
Babesia bovis is a tick-borne apicomplexan parasite of cattle and together with 
Babesia  divergens and Babesia bigemina it is responsible for major economic losses 
in the cattle industry over the world. Parasites invade host red blood cells where they 
multiply asexually, rupture the host cell and invade new ones. Invasion is one of the 
critical steps of the life cycle that is vulnerable to the immunological response of the 
host and therefore a potential target for vaccination. Erythrocyte invasion is well 
studied in Plasmodium species and was shown to be composed of an initial phase of 
random cell-cell contact, subsequent reorientation and specific receptor-ligand 
interaction, followed by active movement into a parasitophorous vacuole (8). An 
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increasing number of receptor proteins are being identified (41, 46, 166, 176), some of which 
are being investigated as vaccine candidates (46, 108, 117, 208). EBA-175 and EBA-140 are 
erythrocyte-binding proteins of Plasmodium falciparum that belong to the Duffy-
binding-like-erythrocyte-binding protein family (62, 135, 166). EBA-175 binds sialic acid 
residues on glycophorin A (57, 166) and antibodies raised against the recombinant sialic 
acid binding domain have been shown to block erythrocyte binding and invasion (125, 
157, 169). However, enzymatic removal of sialic-acid residues by neuraminidase leads to 
selection of  P. falciparum laboratory lines that efficiently invade erythrocytes, 
apparently using sialic-acid-independent invasion pathways (13, 61, 68, 157, 178). Other 
binding ligands like EBA-140, a paralogue of EBA-175 that binds glycophorin C, may 
functions in alternative invasion pathways (126, 135). Knowledge about the invasion 
mechanism of B. bovis and proteins that are involved is limited. A rhoptry protein and 
two major merozoite membrane proteins have been implicated in invasion but no 
corresponding erythrocyte surface receptors are known (27, 74, 152, 242). 
Whereas the rodent parasite Babesia microti or the bovine parasite B. divergens 
occasionally can infect humans, B. bovis is host-specific for bovines. In analogy to 
what has been demonstrated for P. falciparum host cell specificity may be dependent 
on highly selective binding of parasite ligands to erythrocyte surface proteins prior to 
invasion. Studies on possible erythrocyte ligands have recently been performed for B. 
divergens and B. bigemina by enzymatic modification of the erythrocyte surface (110, 
245). Pre-incubation of bovine erythrocytes with neuraminidase or trypsin significantly 
decreased in vitro multiplication of B. bigemina, whereas for B. divergens incubation 
with neuraminidase and α-chymotrypsin resulted in decreased growth.  
Recently we established an in vitro invasion assay that uncoupled invasion from 
subsequent intracellular development (76). In contrast to the above mentioned studies on  
B. bigemina, B. divergens and P. falciparum, which examined invasion indirectly after 
in vitro cultivation for up to 48 h, this assay directly determines invasion. In this way 
the requirement for surface receptors with specific properties was investigated by 
enzymatic modification of the erythrocyte surface and by competition for merozoite 
binding between erythrocytes and free glycans. In addition the ability of B. bovis 
merozoites to invade and develop in red blood cells of different species was 
investigated. The results demonstrated that B. bovis merozoites invade and develop in 
multiple species in contrast to the host specificity observed in nature. 
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MATERIALS AND METHODS 
  
B. bovis in vitro culture 
B. bovis Israel isolate (clonal line C61411) was cultured in vitro as previously 
described (121) with slight modifications (76, 121). Briefly, B. bovis cultures were maintained in 
24-well plates (1.2 ml total volume) or in 25 cm2 bottles (15 ml total volume) containing 
medium (M199 with 40% bovine serum and 25 mM sodium bicarbonate) and bovine 
erythrocytes at 5% packed cell volume (PCV). Cultures were incubated at 37°C, 5% CO2 in 
air and parasitaemia was kept between 1% and 12% by daily dilution  
 
B. bovis in vitro invasion assay 
Invasion was performed as described previously (76). In short, B. bovis infected red 
blood cells (6 to 8% parasitaemia) were centrifuged (2000 g, 10 min., 15°C) and resuspended 
in an equal volume of VyMs buffer. 800 µl samples were submitted to five intermittent (10 
seconds, 0°C) high voltage pulses (2.5 kV, 200Ω, 25 µF) in 4 mm BioRad cuvettes (165-
2088) using a BioRad Gene Pulser with pulse controller. Invasion was performed in 24-well 
plates by addition of 0.20 ml of liberated merozoites to 1.0 ml of erythrocyte suspension (6% 
PCV in 25 mM sodium bicarbonate/PBS medium pH 8.0) and incubated under an atmosphere 
of 5% CO2 in air. Giemsa-stained slides were prepared after 1 h invasion and a total of 5000 
erythrocytes were counted to determine the level of invasion. In all invasion experiments that 
have been performed, a control was included of invasion in bovine erythrocytes from a 
standard donor animal. This donor was selected on the basis of a high in vitro growth rate and 
was used to maintain the B. bovis cultures for the last three years. Invasion efficiency was 
calculated relatively to this control invasion performed in triplicate. Intracellular development, 
following upon invasion performed as described above, was monitored for 48 h. After 
invasion for 1 h, PBS (containing 25 mM sodium bicarbonate) was replaced by RPMI 
medium containing 1 mg/ml albumax II, 25 mM HEPES, 25 mM bicarbonate, 1% glutamine 
and 50 µg/ml gentamycin. Medium was changed after 24 h. After 24 h and 48 h giemsa-
stained slides were prepared and counted as described above.  
 
Collection of sera and erythrocytes  
EDTA red blood cells of human, bovine, caprine, ovine, porcine and equine origin 
were obtained and washed 3 times in VyMs. The buffy coat was removed after each 
centrifugation at 2000 g for 10 min and erythrocytes were stored in VyMs at 4°C for 
maximally 2 weeks. Sera were stored at -20 °C for later use.  
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Trypsin, α-chymotrypsin, neuraminidase and addition of N-acetylneuraminyl-lactose (Neu-
Aclac) modification 
Incubation of erythrocytes (50% PCV) with trypsin, α-chymotrypsin or neuraminidase 
was performed by addition of an equal volume of PBS (with 25 mM sodium bicarbonate) 
containing either L-1-Chloro-3-[4-tosylamido]-4-phenyl-2-butanone-treated trypsin (from 
bovine pancreas; Sigma T1426), α-chymotrypsin (Type I-S from bovine pancreas; Sigma 
7762) or neuraminidase (from Vibrio cholerae; Sigma N6514) or neuraminidase (from 
Arthrobacter ureafaciens; Sigma N3642) concentrations indicated in the text followed by 
shaking (175 rpm) for 1 h at 37°C. Experiments were done in 24-well plates. Controls were 
performed under the same conditions in absence of enzymes.   
Effect of bovine Neu-AcLac (Sigma A8681) on B. bovis cultures was investigated. 
The bovine NeuAc-lac consists of 85% of the NeuAc (2-3) Gal (1-4) Glu isoform and 15% of 
the NeuAc (2-6) Gal (1-4) Glu isoform. B. bovis infected red blood cells (6 to 8% 
parasitaemia) were liberated as described above. 200 µl samples were incubated with 1 mg/ml 
bovine NeuAc-Lac for 1 h at 20 °C and added to 1.0 ml erythrocyte suspension (6% PCV). 
Besides pre-incubation of NeuAc-Lac with B. bovis merozoites, NeuAc-Lac was also directly 
added to B. bovis merozoites at the same concentration together with bovine erythrocytes. 
Controls were performed under the same conditions in absence of compounds. After invasion, 
Giemsa-stained slides were prepared and counted as described above.  
 
Statistical analysis 
Invasion of B. bovis merozoites in erythrocytes of different species were tested by 
Kruskal-Wallis H-tests (these treat the values of percent inhibition of invasion in a non-
parametric manner and compares the different groups to each other) and P-values were 
calculated manually (Fig. 1). Invasion in erythrocytes of three different persons collected on 
two different dates were compared with Scheffe’s Post Hoc test (this test was used because 
values were normally distributed and more than 2 variables were compared) (Fig. 2A), 
invasion in three equines were tested with Kruskal-Wallis H-test (Fig. 2B) and invasion in 
three ovines with Sheffe’s Post Hoc test (Fig. 2C). Invasion inhibition with different 
concentrations of trypsin (Fig. 5A), chymotrypsin (Fig. 5B) and 2-3 neuraminidase (Fig. 5C), 
2-6 neuraminidase (Fig. 5D) in bovine erythrocytes was tested with Kruskal-Wallis H-test. 
Invasion inhibition in bovine erythrocytes with different forms of neuraminidase (2-3 or 2-6 
isoforms) separately or combined together with or without α-chymotrypsin and trypsin were 
tested with Sheffe’s Post Hoc test (Fig. 5E). Invasion in human or porcine erythrocytes with 
or without neuraminidase were tested with Mann-Whitney U test (these treat the values of 
percent inhibition of invasion in a non-parametric manner (Fig. 5F). Invasion inhibition in 
bovine erythrocytes modified with or without NeuAc-lac was tested with Sheffe’s Post Hoc 
test (Fig. 6). P-values lower than 0.05 were considered statistical significant. 
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RESULTS 
 
Invasion efficiency in non-bovine erythrocytes 
Invasion of B. bovis merozoites into erythrocytes of different species was 
investigated in order to test the hypothesis that the strict specificity observed in vivo 
for bovine hosts is due to host-specific receptor-ligand interactions between 
merozoites and erythrocytes. Fig. 1 shows the efficiency by which high-voltage pulse 
liberated merozoites invade erythrocytes of human, bovine, caprine, equine, ovine and 
porcine origin relative to invasion in erythrocytes of a standard bovine donor (absolute 
invasion levels in between experiments performed over the year are variable, possibly 
because of variable, but unknown, factors determining the quality of liberated 
merozoites of a typical experiment (76). The presented data are the mean of values 
obtained from at least three different individuals of each species, where each 
individual was tested twice in triplicate. Clearly, B. bovis merozoites are able to invade 
all tested species within 1 h, albeit at a wide range of efficiency. Surprisingly, human 
erythrocytes were invaded, on average, better than bovine erythrocytes. Caprine 
erythrocytes were poorly invaded whereas the relative efficiency of invasion in equine, 
ovine and porcine erythrocytes varied between 47% and 53%. Two sources of 
variation contributing to the standard deviations observed in Fig. 1 are displayed in 
more detail in Fig. 2. A comparison of individuals of the same species (n=3), relative 
to the standard bovine control, was made by performing triplicates with erythrocytes 
from two different blood collection dates. Clearly, the time point of collection has a 
minor effect on the standard deviation observed in Fig. 1.  
In contrast, significant differences were found between individuals of the same 
species. Erythrocytes of three human individuals were invaded at an efficiency ranging 
between 98% and 170% (Fig. 2A). Significant variation in invasion efficiency 
occurred in between individual equines (Fig. 2B) and ovines (Fig. 2C). We conclude 
that B. bovis merozoites invade erythrocytes of all species tested, with significant 
differences in efficiency in between species as well as in between individuals of the 
same species. 
 
Intracellular development in non-bovine erythrocytes 
Having established the ability to invade non-bovine erythrocytes, the capacity for 
further intracellular development was investigated. In PBS no further development 
takes place but as demonstrated recently (76), a change to serum-rich medium 
conditions upon invasion performed in PBS, allows intracellular development resulting 
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in normal subsequent cycles of multiplication. Addition of medium containing the 
autologous serum, 1 h after invasion in erythrocytes of each of the different species, 
resulted in duplication and normal outgrowth only in bovine erythrocytes 
supplemented with bovine serum. The porcine and human autologous combinations 
showed no duplicated parasites after 24 h and a further decline in parasitaemia after 48 
h (Fig. 3).  
 
 
 
 
 
 
 
 
 
 
Fig. 1.  Invasion of Babesia bovis merozoites in bovine, caprine, ovine, equine, porcine and human 
erythrocytes. Percentage invasion is shown relatively to invasion in standard bovine donor 
erythrocytes (control) that was considered as  100% invasion. Error bars indicate standard deviation.  
 
To determine whether serum components are responsible for this lack of further 
development upon invasion in non-bovine erythrocytes, the experiment was repeated 
in artificial medium containing albumax instead of serum. As shown in Fig. 4, addition 
of this medium upon invasion gives rise to normal development and subsequent cycles 
inside bovine erythrocytes. Also, a large percentage of the parasites having invaded 
non-bovine erythrocytes after 1 h, have duplicated after 24 h and appear in the 
characteristic accole position normally observed in bovine erythrocytes. However, no 
increase in parasitaemia is observed after 48 h although most of the parasites still have 
a morphologically normal appearance at this time point. Human erythrocytes having 
been invaded by B. bovis merozoites were kept in in vitro culture for another 16 days 
under daily change of medium but Giemsa-stained smears showed a gradual decline of 
parasitaemia below detection level indicating that no rapid phenotypic adaptation to 
growth in human erythrocytes takes place. 
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Fig. 2. Relative percentage of invasion in erythrocytes of individuals (triplicates) from two different 
time point (black bar versus white bar). Parasite invasion in erythrocytes of three individuals of human 
(A) equine (B) or ovines (C) are shown here. Origin is plotted relative to standard bovine donor 
erythrocytes. Error bars indicate standard deviation. 
 
In conclusion, the albumax supplement contains factors enabling normal duplication 
within bovine and non-bovine erythrocytes whereas the sera of the non-bovine species 
may miss this factor or have inhibitory factors in addition that prevent duplication. 
 
The effect of enzymatic modification of erythrocyte surface molecules prior to invasion 
The effect of cleavage of the peptide backbone of erythrocyte surface proteins 
prior to invasion by proteases with different specificities like trypsin and chymotrypsin 
was examined (Fig. 5). Bovine erythrocytes were incubated for 1 h with a 
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concentration series of trypsin or α-chymotrypsin prior to invasion by B. bovis 
merozoites. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Invasion and development of Babesia bovis merozoites in bovine, porcine and human 
erythrocytes after addition of autologous sera supplemented media. Black bars represent total 
parasitaemia as a relative percentage of the same control after 1 h, 24 h and 48 h. White bars indicate 
duplicated parasites. All values are indicated as parasitaemia relative to the parasitaemia obtained with 
standard bovine donor erythrocytes after 1 h. All experiments were done in triplicate and error bars 
indicate standard deviation. 
 
Incubation with trypsin or α-chymotrypsin resulted in only a slight, but significant 
reduction (resp. 26% ± 2.2%, p< 0.001, 33% + 5.7%, p<0.001) of invasion at the 
highest concentration tested (resp. 300000 U/ml trypsin, 3000 U/ml α-chymotrypsin). 
Removal of sialic acid residues by preincubation of erythrocytes with 
neuraminidase resulted in a maximal reduction of invasion of 75 to 80 % at a 
concentration 30 U/ml. Remarkably, the use of neuraminidases with specificity for 
either NeuAc-α(2-3)Gal linkages (Fig. 5C) or NeuAc-α(2-6)Gal linkages (Fig. 5D) 
gave similar results whereas preincubation of erythrocytes with a combination of both 
neuraminidases or neuraminidase in combination with trypsin or chymotrypsin does 
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not reduce invasion any further (Fig. 5E). The dependence of invasion on surface 
exposed sialic acid groups as observed above was also shown after preincubation of 
erythrocytes of other species with neuraminidase (Fig. 5F). 
 
 
Fig. 4.  Invasion and development of B. bovis merozoites in bovine, porcine, caprine, ovine, equine 
and human erythrocytes after addition of AlbumaxII supplemented medium. Black bars represent total 
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parasitaemia as a relative percentage of the same control after 1 h, 24 h and 48 h. All values are 
indicated as parasitaemia relative to the parasitaemia obtained with standard bovine donor erythrocytes 
after 1 h. White bars indicate duplicated parasites. All experiments were done in triplicate and error 
bars indicate standard deviation. 
 
To obtain further proof for the putative interaction of merozoites with sialic acid 
residues exposed on erythrocytes prior to or during invasion, sugars containing sialic 
acid residues were evaluated for their capacity to compete with invasion. Fig. 6 shows 
that direct addition of a mixture of NeuAc(2-3)Gal(1-4)Glu and NeuAc(2-6)Gal(1-
4)Glu to the invasion assay gives a slight but statistically insignificant (P= 0.074) 
decrease in invasion. However, a 1 h preincubation of merozoites with the same 
mixture gives a significant 44% reduction in invasion. 
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Fig. 5. Invasion in enzyme-modified erythrocytes. Invasion in standard bovine donor erythrocytes 
modified with different concentrations of (A) (0-300000 U/ml) trypsin, α-chymotrypsin (0- 3000 
U/ml) (B), 2-3 neuraminidase (0-100 mU/ml) (C), 2-6 neuraminidase (0-100 mU/ml) (D), and 
combination of 2-3 and 2-6 neuraminidase (50 mU/ml) with or without trypsin (300000 U/ml) and 
chymotrypsin (3000 U/ml) as determined (E). (F) Invasion in human and porcine erythrocytes 
modified with neuraminidase (50 mU/ml) was also performed. All experiments were done in triplicate 
and plotted relative to the level of invasion in erythrocytes preincubated without addition of enzyme. 
Error bars indicate standard deviation. 
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Fig. 6. Inhibition of invasion by N-acetylneuraminyl-lactose. Invasion in standard bovine erythrocytes 
with or without preincubating merozoites with NeuAc-lac (1mg/ml) for 1 h.  All the experiments were 
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done in triplicate and plotted relative to the level of invasion in erythrocytes preincubated without 
addition of NeuAc-lac. Error bars indicate standard deviation. 
 
 
DISCUSSION 
 
B. bovis belongs to a sub-set of apicomplexan parasites that are highly specific for 
host species and cell type. For Plasmodium species, specificity finds a molecular basis 
in selective receptor-ligand interactions involved in erythrocyte binding and invasion. 
For Babesia species, parasite ligands and erythrocyte receptors involved in erythrocyte 
invasion have not been identified. B. divergens is predominantly a parasite of cattle but 
is able to replicate in other hosts like humans (102) sheep (37) and rodents (14). Likewise, 
B.  microti causes disease both in rodents and humans. In contrast, B. bovis is strictly 
host specific for bovine species, with a reported preference for Bos taurus over Bos 
indicus (19). Our current aim was to identify steps in the B. bovis life cycle that are 
incompatible with growth in other species. In vitro growth of B. divergens in 
erythrocytes of different origin was compared by hypoxanthine incorporation over 
periods of 48 h after sub-culturing (244) but the intrinsic inability of B. bovis for 
continuous growth in non-bovine erythrocytes required us to use specific assays in 
which consecutive steps in the life cycle were studied separately. B. bovis merozoites 
were shown to invade erythrocytes of a variety of species albeit at different levels of 
efficiency. On average, human erythrocytes were invaded more efficiently than bovine 
erythrocytes, whereas erythrocytes of goats were invaded at very low levels. Within 
species, considerable variation in the level of invasion was observed. Subsequent intra-
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cellular development and duplication to form characteristic pear-shaped piroplasms in 
the accole position as normally occurring in bovine erythrocytes, was also observed in 
other species except for goat erythrocytes. Despite this apparently normal intra-cellular 
development within erythrocytes of multiple species, only in bovine erythrocytes a 
rapid rise in parasitaemia was observed in serum-free growth medium. As human 
erythrocytes are invaded efficiently, a developmental block in later stages could 
possibly explain this observation. For instance, egress from the host cell after intra-
cellular maturation could be inefficient. For Plasmodium species the involvement of 
proteases has been demonstrated (84, 86) and possibly substrate-specificity contributes to 
species specificity. Alternatively, although morphologically normal duplicated 
piroplasms were observed, less than 50 % of invaded parasites may develop to this 
stage. In contrast to Plasmodium species, B. bovis exhibits only a two-fold 
multiplication per generation during asexual development and consequently, any step 
or combination of steps, less efficient than 50 % will lead to a decline in parasitaemia. 
The fact that no accumulation of duplicated parasites was observed on the long term 
gives some support to the latter option. All the other abnormal host erythrocytes are 
invaded at least 50 % less efficient than bovine erythrocytes implicating that in these 
erythrocytes the sub-optimal invasion would lead to a decline in parasitaemia even 
when subsequent intra-cellular development and egress are highly efficient. It also 
implicates that without the use of a direct method of estimating invasion after 1 h as 
employed here, invasion into abnormal host erythrocytes could not have been detected. 
The recently reported invasion of B. divergens into abnormal host erythrocytes (244) was 
studied by sub-culturing in these cells for extended periods, a method that clearly 
cannot work for B. bovis. Nevertheless a number of similarities can be noted when 
comparing to this work. For instance, subcultures of B. divergens performed slightly 
better in human erythrocytes than in bovine erythrocytes although, in contrast, for B. 
bovis this only holds for invasion and not for subsequent growth. Moreover, addition 
of autologous serum had a negative effect in the case of human and equine serum like 
shown here for B. bovis. On the other hand, ovine serum did support growth of B. 
divergens. A report of in vitro cultivation of B. bovis in bovine erythrocytes supported 
by equine sera showed a decreased parasite growth. The decline in growth observed in 
presence of equine sera could partly be relieved by the addition of hypoxanthine (159). 
However, in vitro growth in abnormal host erythrocytes has never been described and 
in nature no B. bovis infections in non-bovine hosts have been described. The results 
presented here demonstrate that invasion and early intra-cellular development and 
duplication do not share this strict host specificity. The fact that B. divergens and B. 
microti infections are detected in humans, in contrast to B. bovis, might in part also be 
due to specificity of the tick vector. Whereas Ixodes species, transferring B. divergens 
Babesia bovis invades  erythrocytes of different species  
 
58 
and B. microti, feed on humans as well as on other species, Boophilus species 
transmitting B. bovis are highly specific for cattle and seldom feed on humans. 
In vitro growth of B. bigemina and B. divergens has been shown to be affected by 
removal of sialic acid residues by neuraminidase, most likely as a consequence of 
reduced invasion levels (110, 245). Here we have directly established an inhibitory effect 
of removal of sialic acid residues on invasion of B. bovis. Specific removal of terminal 
sialic acid residues attached by an α(2-3) or an α(2-6) linkage to galactose, 
individually or combined, resulted in 75 to 80% inhibition of invasion, suggesting 
invasion by an erythrocyte recognition mechanism requiring the simultaneous presence 
of both linkage types. Neuraminidases of both specificities contain minor amounts 
(less than 0.5%) of the other specificity but the concentration curves of Fig. 5c and d 
indicate that such low level contaminations hardly influence cleavage specificity at the 
concentrations used. Whereas for P. falciparum the existence of parallel sialic-acid 
dependent and independent invasion mechanisms was suggested by an additive 
inhibitory effect of co-incubation with neuraminidase and proteases (68) such an effect 
was not observed for B. bovis. Maximum inhibition was already obtained by 
neuraminidase incubation alone, indicating that invasion is completely dependent on 
sialic acid and suggesting that inhibiton by trypsin and chymotrypsin might be due to 
an incomplete cleavage of erythrocyte membrane receptor protein(s) carrying  sialic 
acid residues involved in invasion. 
Erythrocyte membrane glycophorins carrying sialic acid residues have been shown 
to be specific receptors for P. falciparum merozoite binding ligands and contribute to 
the formation of a tight junction between merozoite and erythrocyte during the initial 
phase of invasion. The binding ligand EBA-175 becomes exposed on the merozoite 
membrane by secretion from micronemes only just before invasion actually takes place 
(200), putatively by a signal triggered by initial contact between erythrocyte and 
merozoite. Here, an inhibitory effect on invasion of B. bovis by a mixture of NeuAc(2-
3)Gal(1-4)Glu and NeuAc(2-6)Gal(1-4)Glu was observed after preincubation with B. 
bovis merozoites but not after direct addition without preceding preincubation. This 
suggests that NeuAc(2-3)Gal(1-4)Glu and NeuAc(2-6)Gal(1-4)Glu binding to a 
putative binding ligand for sialic acid containing receptors on the erythrocyte 
membrane is relatively weak and requires time. Moreover, the putative binding ligand 
must be constitutively present on the merozoite membrane already during 
preincubation and not secreted only upon initial contact with fresh erythrocytes (in the 
latter case no difference in inhibition between invasion with and without preincubation 
should have been observed). Obviously, this does not exclude the presence of 
additional binding ligands secreted from internal organelles as in the case of P. 
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falciparum. In addition, a toxic effect of the added sugars during preincubation cannot 
be excluded due to the lack of a proper control for this possibility. 
Invasion into erythrocytes of other species was also shown to be neuraminidase 
sensitive. This raises the question whether the amount of sialic acid residues present on 
membrane proteins is the main factor determining invasion efficiency. No detailed 
comparison of the total amount of sialic residues on membrane proteins of 
erythrocytes of different species has been reported. A recent report (3) demonstrated 
that from human erythrocytes ~80% more sialic acid could be released as from sheep 
and goat erythrocytes. This could explain the highly efficient invasion of human 
erythrocytes but does not explain why goat erythrocytes are hardly invaded at all. 
Possibly the type of  linkage (e.g. α(2-3) or α(2-6)) also plays a role and might be 
different in between species. A known difference between goat erythrocytes and all 
other erythrocytes tested is their small size with an average diameter of 3.2 µm which 
is approximately half the size of bovine and human erythrocytes. Besides interspecies 
differences in invasion we also found significant and reproducible differences in 
between individuals of the same breed and species. Exploring differences in 
erythrocyte properties between such individuals offers the opportunity for a more 
detailed characterization of erythrocyte receptors employed for invasion by B. bovis. 
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ABSTRACT 
Apical membrane antigen 1 (AMA-1) is a micronemal protein secreted to the 
surface of merozoites of Plasmodium species and Toxoplasma gondii tachyzoites in 
order to fulfil an essential but non-characterized function in host cell invasion. Here 
we described the cloning and characterization of a Babesia bovis homologue denoted 
BbAMA-1. Overall similarity with P. falciparum AMA-1 was low (18%) but 
characteristic features like a transmembrane domain near the C-terminus, a predicted 
short cytoplasmic C-terminal sequence with conserved sequence properties and an 
extra-cellular domain containing 14 conserved cysteine residues putatively involved in 
disulfide bridge formation are typical for AMA-1. Rabbit polyclonal antisera were 
raised against three synthetic peptides derived from the N-terminal region and domain 
II and III of the putative extracellular domain and were shown to recognize specifically 
recombinant BbAMA-1 expressed in Escherichia coli. Immunofluorescence 
microscopy showed labelling of the apical half of merozoites with these antisera. 
Preincubation of free merozoites with all three antisera reduced invasion efficiency 
into erythrocytes by maximally 65%. Antisera raised against the N-terminal peptide 
detected a protein of 82 kDa on western blots and a protein of 69 kDa in the 
supernatant that was harvested after in vitro invasion, suggesting proteolytic 
processing and secretion to take place during or shortly after invasion. A combination 
of 2D-western blotting and metabolic labelling allowing the direct identification of 
spots reacting with the BbAMA-1 peptide antisera in combination with the very weak 
silver staining intensity of these spots indicates that AMA-1 is present at very low 
levels in Babesia merozoites. 
 
INTRODUCTION 
 
Babesia bovis is an obligatory intraerythrocytic bovine parasite that belongs to 
the phylum of apicomplexa. Although members of the apicomplexa infect different 
host and cell types, they share similar host cell invasion processes. In the case that 
extracellular merozoites enter erythrocytes, they form an initial reversible attachment, 
leading to reorientation of the merozoite to bring the anterior apical pole in contact 
with the plasma membrane of erythrocytes (67, 205). A tight junction is formed through 
which the parasite will invade the red blood cell. The process is completed when the 
parasite is inside a parasitophorous vacuole of the red blood cell. From the first 
attachment till completion of the invasion process the parasite secretes proteins from 
apical organelles to the merozoite membrane and into the environment. Proteins 
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secreted from micronemes, rhoptries and dense granules are thought to play a central 
role in invasion and the establishment of infection of apicomplexan parasites (31, 205). 
This supposed critical function and their exposure to the immune system, when 
localized on the surface of the merozoite, has marked them as potential vaccine 
candidates (7). One of the candidates is the apical membrane antigen-1 (AMA-1) (63, 89, 
101, 117, 158, 221), which is expressed in the late schizont stage of the asexual life cycle of 
the Plasmodium falciparum parasite (158). AMA-1 is a type I integral membrane protein 
with three characteristic structures: (i) a N-terminal, cysteine-rich, ectodomain, (ii) a 
single transmembrane domain and (iii) a C-terminal cytoplasmic tail. The ectodomain 
is organized into domains I, II and III by the formation of disulfide bridges between 
conserved cysteine residues. Full-length P. falciparum AMA-1 (83 kDa) is a 
micronemal protein (100) that is transported to the merozoite surface membrane as a 66 
kDa protein upon proteolytic cleavage in the N-terminal ectodomain (100). During 
invasion of merozoites, P. falciparum AMA-1 is further processed to 44 kDa and 48 
kDa soluble fragments (100, 101). Although the biological function of AMA-1 is 
unknown, the subcellular localization, stage-specific expression and secretion during 
host cell invasion suggest that it is involved in merozoite invasion. A strong 
correlation was found between protection and P. falciparum AMA-1 antibodies that 
were generated against different peptide sequences (186). Furthermore, passive transfer 
of rabbit AMA-1 antibodies protected mice against P. chabaudi infection (6) and 
antibodies against P. reichenowi (116) and P. vivax AMA-1 (115) were shown to inhibit 
red blood cell invasion. Recently, eight peptides of the P. falciparum AMA-1 protein 
were mapped that have specific erythrocyte binding activity (77, 225). An AMA-1 
homologue is present in all Plasmodium species studied and T. gondii, which supports 
the suggestion that this protein is involved in an essential function (39, 63, 70, 116, 131)  
Here we report the complete sequence of the B. bovis AMA-1 cDNA. We have 
studied the protein on 1D and 2D western blots, by immunofluorescence microscopy 
and analysed inhibition of in vitro invasion by antisera directed against specific 
regions.  
 
MATERIALS AND METHODS 
 
B. bovis in vitro culture 
B. bovis Israel isolate (clonal line C61411) was cultured in vitro in bovine erythrocytes 
as previously described (76). Briefly, B. bovis cultures were maintained in 24-well plates (1.2 
ml total volume) or in 25 cm2 bottles (15 ml total volume) containing medium (M199 with 
40% bovine serum and 25 mM sodium bicarbonate and bovine erythrocytes at 5% packed cell 
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volume (PCV). Cultures were incubated at 37°C, 5% CO2 in air and parasitaemia was kept 
between 1% and 12% by daily dilution.   
 For metabolic labelling, B. bovis culture (8 to 10 % parasitaemia) was centrifuged 
(2000 g, 10 min, 15°C) washed once with PBS and resuspended in RPMI 1640 medium 
without methionine and cysteine containing 20 mM TAPSO (Sigma) and 1% Glutamine 
(Sigma). 35S labelled methionine and cysteine (167 µCi/ml) were added followed by 
incubation for 18 h at 37ºC in 5% CO2 in air.    
 
B. bovis in vitro invasion 
Invasion was performed as described previously (76) with slight modifications. B. bovis 
infected red blood cells (6 to 8% parasitaemia) were centrifuged (2000 g, 10 min, 15°C) and 
resuspended in an equal volume of VyMs buffer (4°C). Samples (800 µl) were submitted to 
five intermittent (10 seconds at 0°C in between pulses) high voltage pulses (2.5 kV, 200Ω, 25 
µF) in 4 mm cuvettes (BioRad) using a BioRad Gene Pulser with pulse controller. The lysed 
samples (800 µl) were washed with 8 ml of PBS containing 25 mM sodiumbicarbonate 
((PBSbc) pH 8.0, 20°C) followed by centrifugation (1800 g) for 10 min at 15°C. A second 
similar wash was performed except that centrifugation speed was lower (1300 g). The final 
merozoite pellet was resuspended in 800 µl PBSbc. Invasion was initiated by addition of 1 
volume of resuspended merozoites to 9 volumes of suspended bovine erythrocytes (5.5% 
PCV in PBSbc pH 8.0, preincubated for 60 min at 37°C in 5% CO2 in air) and was performed 
in 24-well plates (final volume 1.2 ml), in 25-cm2 flasks (15 ml) or in 80-cm2 flasks (50 ml) at 
37°C, 5% CO2 in air. Giemsa-stained slides were prepared after 1 h and parasitized 
erythrocytes out of a total of 5000 erythrocytes were counted. 
 
In vitro inhibition of invasion by rabbit antisera 
B. bovis merozoites (200 µl), liberated by high voltage pulsing and resuspended in 
PBSbc as described above, were incubated with 40 µl of rabbit antisera for 1 h at 20°C. After 
1 h, 960 µl of suspended bovine erythrocytes (6.25% PCV in PBSbc, preincubated for 60 min 
at 37°C in 5% CO2 in air) were added, followed by 1 h of incubation after which Giemsa-
stained slides were prepared and counted to determine the level of invasion. The used rabbit 
antisera were raised against synthetic peptides derived from the BbAMA-1 sequence and a 
control serum raised against an unrelated peptide (YAGRLFSKRTAATAYKLQ), named 
peptide C. Peptides were linked to Maleimide activated Keyhole Limpet Haemocyanin (KLH; 
Pierce) prior to immunization. Pre-immune sera were also included in the test. 
 
Preparation of total merozoite protein extracts and proteins solubilized upon invasion 
Samples of merozoites (800 µl), prepared as described above for in vitro invasion, 
were partially separated from erythrocyte ghosts by filtration over 1.2 µM polypropylene 
prefilters (Millipore). Filtered merozoites were pooled and washed twice in 20 volumes of 
PBSbc followed by centrifugation at 2000 g for 20 min at 4°C. After the second wash the 
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pellet was resuspended in an equal volume of PBSbc  and divided in aliquots of 200 µl that 
were centrifuged (10000 g, 5 min at 4°C) and stored as 100 µl cell pellets (2×109 merozoites) 
at -20°C after removal of supernatant. Frozen merozoite pellets were thawed just before use 
and lysed, reduced and alkylated by using a total protein extraction kit (Proteoprep, Sigma) 
according to the manufacturer’s instructions and finally obtained in 1.7 ml of buffer 
compatible with direct application on SDS-polyacrylamide gels or isoelectrofocusing (IEF) 
strips. Insoluble material was removed by centrifugation at 16000 g for 3 min at 4°C. As the 
extracts contained considerable amounts of erythrocyte proteins, control extracts were 
prepared in the same way but starting with a culture of non-infected erythrocytes. 
Proteins solubilized upon invasion were obtained by gently removing the overlaying 
buffer after 1 h of in vitro invasion as described above. The samples were centrifuged (2000 g, 
10 min, 4 °C) after which the supernatant was centrifuged again at high speed for removal of 
membrane fragments (20 min, 12000 g, 4°C). The final supernatant was dialysed (Pierce; 
Snakeskinpleated dialysis tubing) overnight against 10 mM Tris NaCl, pH 7.5.  
 
Construction and screening of a B. bovis  cDNA library 
A cDNA library was constructed from 5 µg B. bovis mRNA using the λZAP-cDNA 
Synthesis Kit (Stratagene) according to the manufacturer’s instructions. cDNA fragments of 
0.5 to 4 kb were collected by gel filtration on a sepharose CL-4B column and ligated into the 
EcoRI / XhoI site of λ uniZAP-XR Express vector. Giga pack III Gold was used for 
packaging into phage particles followed by transformation of Escherichia coli XL-1 Blue 
MRF’cells. A total of  3 × 105 plaques were obtained of which an amplified library was made. 
The cDNA library was screened with probe F1. Oligonucleotides p1 (5’–
ccacggctctggaatctatgtc-3’) at position 329 and p2 (5’-caaaaggatacctatatttggtac-3’) at position 
703 (derived from an EST available at www.sanger.ac.uk and numbered here according to the 
numbering of Genbank Acc. No AY486101) were used to amplify probe F1 by PCR in a 50 µl 
volume containing 0.2 mM dNTP, 20 pmol µl-1 of each primer, 100 ng B. bovis  genomic 
DNA and 0.5 U Taq DNA polymerase in standard buffer (Promega). Amplification was 
performed for 30 cycles (92°C for 30 sec, 58°C for 30 sec, at 72°C for 30 sec) preceded by 
initial denaturation for 3 min at 95°C and a final elongation at 72°C for 10 min. The fragment 
was purified from agarose gel and labelled with 50 µCi [α-32P]dATP (3000 Ci mmol-1), using 
a Random Primer labelling kit (Roche). 1.2×106 plaques were screened by standard 
procedures (187) for obtaining the AMA-1 sequence. After 2 cycles of plaque purification two 
clones were in vivo excised for isolation of the phagemids inserts as described in the 
manufacturer’s instructions (Stratagene) and sequenced on both strands, using automated 
cycle sequencing with the dye terminator method (ABI PRISM dye terminator kit, 
Pharmacia). A full-length AMA-1 cDNA including the non-coding 5’-end was obtained with 
GeneRacer kit with a specific primer 5’-gatgaaatgggatcgaggaagtcg-3’ (Invitrogen) 
according to the  manufacturer instructions and the obtained clone was sequenced on both 
strands. 
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Expression of recombinant BbAMA-1 in E. coli 
A cDNA clone of BbAMA-1 was amplified by PCR using primers that introduced a 
BamHI site prior to base 1 (numbered from the first base of the initiation codon) and a HindIII 
site after base 1504. Primers p3 (5’-cccggatccatgcagttacataacaaa-3’) and p4 (5’-
gggaagcttctgagcaaaggaaatagg-3’) with BamHI and HindIII sites were used to clone the AMA-
1 PCR products in vector pET-32a (Novagen) allowing their expression as a fusion product 
with a N-terminal thioredoxin domain and an internal 6-histidine tag. After PCR (1min 94°C, 
1 min 55°C, 1 min. 72°C; 30 cycles) on cDNA clones, the fragment was gel purified, ligated 
in pET-32a vector and used for transformation of E. coli NovaBlue strain. Plasmids 
containing the appropriate insert were used to transform expression host strains, BL21 (DE3). 
Fusion proteins with thioredoxin were obtained after induction with 1 mM of isopropyl-β-D 
thiogalactosidase (IPTG) for 4 hr at 37°C as shown by analysis of total cell samples at 0 and 4 
hr after induction (Fig. 2). Bacterial pellets were heated at 95°C in SDS-polyacrylamide 
(SDS-PAGE) sample buffer containing 2% (v/v) β-mercaptoethanol, run on 10% SDS-PAGE 
minigels, and Coomassie Blue-stained to confirm expression.  
 
Peptide selection and immunisation 
Synthetic peptides for immunisation were derived from the full length BbAMA-1 
sequence by selection of amphiphatic alpha-helices having a high probality for surface 
localization and several charged residues using the Protean software package (Lasergene) for 
protein sequence analysis. Peptides were selected from the N-terminal region (aa 46-60; 
cysteine-AFHKEPNNRRLTKRS: peptide 1), domain II (aa 395-409; cysteine-
RGVGMNWATYDKDSG: peptide 2) and domain III (aa 453-467; cysteine-
YVEPRAKNTNKYLDV: peptide 3). The peptides were synthesized and coupled to KLH as 
carrier protein according to manufacturer’s recommendations (Pierce). The peptide-carrier 
conjugate was used to generate rabbit polyclonal antisera.  
Three groups of NZW-rabbits, each group containing two rabbits, were immunized five times 
subcutaneously at 3-week interval for eight months. Before the first immunisation blood 
serum was collected from each rabbit, which was used as negative control. Each rabbit was 
injected with 250 µg peptide that was coupled to 250 µg of KLH and equal volume of 
adjuvant Stimune (ID-DLO, The Netherlands), in a total volume of 1000 µl. Sera were 
tested periodically for reactivity by ELISA. Plasmaforeses were performed one week after the 
immunization starting at month 4. 
  
ELISA 
The production of rabbit antibodies against the peptides was monitored by ELISA. 
Ninety-six-well microtiter plates were coated with 150 ng of peptide 1, peptide 2 or peptide 3 
per well in 0.1 M Tris-HCl pH 8.0, incubated 30 min at 37°C and blocked for 1 h with 
PBS/0.25% BSA at 37°C. Consecutive dilutions (1:50 to 1:50000) of individual rabbit sera 
were incubated for 1 h at 37 °C. The plates were washed and swine anti rabbit-IgG 
Horseradish Peroxidase (HRP)-conjugated (DAKO) (1:2000) secondary antibody was 
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incubated for 1 h. The plates were washed and developed for 45 min with ABTS [2,2’-
azinobis(3-ethylbenzthiazolinesulfonic acid)]- peroxidase substrate (Roche biochemicals). 
The OD405 was recorded, and comparative ELISA titres were calculated.  
  
SDS-polyacrylamide electrophoresis and western blotting 
Total merozoites extracts or proteins solubilized upon invasion  were separated on a 
10% SDS-PAGE and transferred to a PVDF membrane (Immobilon-P, Millipore). The blot 
was blocked with 5% skimmed milk diluted in phosphate-buffered saline containing 0.05% 
Tween (PBST) for 1h at 37°C. The rabbit’s antisera were diluted (1:500) in PBST containing 
2% skimmed milk and incubated overnight at 4°C. The blot was washed with PBST and then 
incubated with anti- rabbit-immunoglobulins HRP (1:10000) (DAKO) for 1 h at 37°C. After 
being washed with PBST, the blot was developed either with TMB MB substrate kit (Lucron 
Bioproducts b.v.) or with enhanced chemiluminescence ECL plus (Amersham).    
 
Two dimensional electrophoresis 
Total merozoite extract (300 µg) and invasion supernatant (100 µg) were dissolved in 
rehydration solution (7M urea, 2 M thiourea, 4% CHAPS, 2% carrier ampholyte mixture pH 
4-7 IPG buffer) and 20 mM DTT) and loaded on 13 cm IPG strips (pH 4-7). The procedures 
for isoelectric focusing (IEF) and subsequent two-dimensional SDS-PAGE electrophoresis 
(2D SDS- PAGE) were performed as described previously (241). Silver staining was used to 
visualise proteins after 2D SDS-PAGE. Images of the gels and blots were acquired using 
LabScan v3.0 software on an Umax flatbed scanner and were digitally analysed using 
ImageMaster 2D v4.01 software (Amersham Biosciences).  
 
Immunofluorescence assay 
The recognition of B. bovis merozoites by anti-AMA-1 antibodies was tested by 
indirect immunofluorescence assay (IFA).  Thin blood smears were fixed with methanol. 
Primary incubation with polyclonal rabbit anti-AMA-1 peptide (1:5 to 1:160) for 35 min was 
followed by three wash steps of 5 min with PBS. Slides were incubated with goat anti-rabbit 
IgG coupled to fluorescein isothiocyanate (1:80, Nordic) for 30 min. The slides were washed, 
and vectashield solution (Vector laboratories) was applied and parasites were visualized using 
a UV fluorescence microscope with FITC filters (455/ 515 nm). IFA titres were determined as 
the last serum dilution with a positive recognition of the parasite compared to the negative 
preimmune serum diluted 1:5.  
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RESULTS 
 
Identification and cloning of a full length cDNA encoding B. bovis AMA-1  
A B. bovis EST, displaying 33.1% identity to domain I of P. falciparum AMA1 
over a stretch of 145 amino acids, was identified by BLAST analysis. Probing a B. 
bovis cDNA library with a 350 bp PCR product derived from this EST resulted in the 
cloning and sequencing of a 2036 bp cDNA containing an open reading frame of 1818 
bp and a 3’non coding region of 189 bp terminating in a polyA-tail. To determine the 
5’ capped end of the full-length mRNA, total mRNA was dephosphorylated after 
which the 5’ caps, which are left intact, were removed by tobacco acid 
pyrophosphatase (TAP) followed by ligation of a specific RNA oligonucleotide. 
Subsequently, nested PCR on first strand cDNA allowed the cloning and sequencing of 
a 755 bp fragment derived from the 5’ end of the B. bovis revealing an 5’ untranslated 
region of 246 bp preceding the first methionine codon of the 1818 bp ORF. 
 
Comparison of B. bovis AMA-1 with T. gondii and Plasmodium AMA-1  
A conceptual translation of the 1818 bp ORF predicted a 67.2 kDa protein with 
a pI of 6.35 which has been aligned with the full-length sequences of P. falciparum, P. 
vivax and T. gondii AMA-1 (Fig. 1). Reminiscent of the known AMA-1 proteins, the 
hydrophobic N-terminal 39 amino acids of B. bovis AMA-1 were predicted to form a 
signal peptide (SignalP2.0) whereas the hydrophobic stretch from Ile-523 to Trp-541 is 
likely to form a transmembrane region with a predicted topology of a type Ia 
membrane protein (TMHMM2.0) leaving a 64 amino acid cytoplasmic C-terminus. 
The signal peptide cleavage sites and terminal residues of the transmembrane segments 
as predicted by SignalP2.0 and TMHMM2.0 for all four AMA-1 proteins have been 
precisely aligned in Fig. 1. The predicted signal peptide of B. bovis AMA-1 is nearly 
twice as long as those of the other species. However, it cannot be excluded that 
translation initiation does not start at the first ATG codon. The transmembrane 
segment of B. bovis AMA-1 is 2 to 4 amino acids shorter as the other transmembrane 
segments whereas the boundaries of the four segments are remarkably conserved. The 
cytoplasmic domains of the displayed AMA-1 molecules are of similar length (53 to 
64 aa) but only the 30 C-terminal residues show considerable similarity (e.g. 43.3% 
identity between B. bovis and P. falciparum). The extracellular domain of P. 
falciparum AMA-1 has been shown to be organized in three structural domains (I to 
III) that are stabilized by 8 intra-domain disulfide bridges (as illustrated in Fig. 1) 
between 16 cysteine residues (12 of which are conserved in T. gondii). Fourteen of 
these cysteine residues are easily aligned with cysteine residues in the B. bovis 
sequence and only the third and sixth cysteine residues of domain III, forming 
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disulfide bridge IIIc, are absent. Whereas domain I (Pro96 to Pro303) and II (Met-304 
to Glu-438) constitute the best conserved regions of AMA-1 (respectively 40.3% and 
29.3% identity between P. falciparum and B. bovis, excluding gap positions) the 
remaining sequences, including domain III, show very little conservation. P. 
falciparum AMA-1 is special when compared with AMA-1 of other Plasmodium 
species and T. gondii in having an N-terminal prodomain that is cleaved off during 
merozoite maturation. B. bovis AMA-1 is the first that also has an extended N-terminal 
sequence although it is shorter than its P. falciparum homologue. Disregarding gap 
regions, the full-length AMA-1 sequences of B. bovis and P. falciparum are only 
slightly more similar to each other (28% identity) as to T. gondii (25% identity in both 
cases) but the alignment of T. gondii AMA-1 to P. falciparum and B. bovis requires 
the introduction of 24 gap regions whereas P. falciparum and B. bovis AMA-1 align 
with 14 gaps.  
 
Recognition of recombinant BbAMA-1 by antisera against short, BbAMA-1 derived, 
peptides 
To enable further studies on the BbAMA-1 protein, rabbits were immunized 
with KLH-linked synthetic peptides (see Fig. 1) that were derived from the N-terminal 
domain (peptide 1, Ala-46 to Ser-60), domain II (peptide 2, Arg-395 to Gly-409) or 
domain III (peptide 3, Tyr-453 to Val-467). All three antisera specifically recognized a 
recombinant fusion product of thioredoxin and the extra-cellular domain of BbAMA-1 
(Met-1 to Ser-501) that was expressed in E. coli BL21 cells (Fig. 2). Polyacrylamide 
gel electrophoresis of total cell lysates obtained before (lane 1) and after (lane 2) 
induction with IPTG identified the recombinant fusion product as an 80 kDa product 
(calculated size 65 kDa) that was recognized by all three immune sera (lanes 5, 8, 11) 
and not by pre-immune sera (lanes 4, 7, 10) on immuno-blots. Immune recognition 
was specific for the BbAMA-1 part of the fusion product as a recombinant fusion 
product of B. bovis rab5 (lane 3) (298 to 1801, Genbank Acc No AY324137) 
expressed in PET32a was not recognized (lanes 6, 9, 12). Also, immune recognition 
was peptide-specific and not due to antibodies induced by the KLH carrier protein 
used for immunization as antiserum raised against a KLH-linked synthetic peptide 
unrelated to AMA-1 did not recognize the BbAMA-1 recombinant fusion product 
(lane 13). 
 
Immunofluorescence microscopy  
To localize BbAMA1, immunofluorescence studies using rabbit antisera against 
the three KLH-linked peptides were performed on B. bovis in vitro cultures attached to 
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glass slides by methanol fixation (Fig. 3). Incubation with pre-immune sera (panels A, 
C, E) did not result in any specific staining of parasites above a background signal of 
faint fluorescence derived from infected as well as non-infected erythrocytes. In 
contrast, immune sera resulted in specific staining of parasites in any microscope field 
examined (panels B, D, F). Fluorescent parasites were detectable with antisera against 
all three peptides at a dilution of 1:5. The strongest fluorescence was obtained with the 
anti-domain III peptide serum, which still gave a signal at a 1:20 dilution at which the 
other two sera only gave rise to a background signal. Although intra-erythrocytic B. 
bovis parasites and free merozoites are small (~1 by 2 µm) a maximal magnification 
allowed a clear visualization of the staining pattern. Especially the duplicated, double 
pear-shaped, parasites showed more intense staining at the apical side of the parasite 
(see typical example in panel G).  
 
 
 
Fig. 1. Multiple sequence alignment AMA-1 of B. bovis (BbAMA-1) with T. gondii (TgAMA-1), P. 
vivax (PvAMA-1) and P. falciparum (PfAMA-1). Similar and identical residues are shaded. Black 
shading indicates similarity in all four species, gray shading in three species. Synthetic peptides 1, 2 
and 3 (black bars) are indicated. The signal peptide cleavage site is depicted with an arrow and the 
transmembrane region is indicated by a grey bar. Cysteine residues forming disulfide bonds in 
PfAMA-1 are indicated according to their domain (I, II or III) and the bond (a, b, c).  
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Inhibition of in vitro invasion by peptide-specific antisera  
AMA-1 of P. falciparum and T. gondii is secreted from apically located 
micronemes and thought to be involved in host cell invasion (77, 90) . A B. bovis in vitro 
invasion assay, allowing to study the invasion of erythrocytes by free merozoites in a 
protein free buffer within a timespan of 1 h, was used to assess the effect of antisera 
directed against the three peptides derived from different domains of BbAMA-1. Free 
merozoites were pre-incubated for 1 h at 20oC with the three anti-BbAMA1 sera and 
the control serum directed against a non-related peptide after which invasion was 
started by the addition of erythrocytes. All three antisera against the BbAMA-1 
specific peptides gave rise to significant inhibition of invasion whereas pre-immune 
sera and a control antiserum had no significant effect on invasion efficiency. The 
strongest effect (65% + 13% inhibition) was observed by the antiserum directed 
against the n-terminally located peptide whereas antisera directed against domain II or 
III peptides showed less inhibition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Western blots of recombinant BbAMA-1 probed with polyclonal rabbit antisera against 
synthetic peptides. Coomassie Blue-stained SDS-polyacrylamide gel containing E. coli lysates of 
uninduced cells (lane 1) and induced (lane 2, 3) cells expressing B. bovis AMA-1 (lane 2) and B. bovis 
rab5 (lane 3). Immunoblots of recombinant BbAMA-1 (lanes 4,5,7,8,10,11,13) were incubated with 
pre-immune serum (lane 4, 7, 10), immune serum against peptide 1 (lanes 5, 6), peptide 2 (lanes 8, 9) 
and peptide 3 (lanes 11, 12) or with B. bovis rab5 antisera (lane 13). Lane 6, 9 and 12 shows 
immunoblots of B. bovis recombinant protein rab5 with the different AMA-1 antisera. Molecular 
weights are indicated.   
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Detection of BbAMA1 secreted into the surroundings during erythrocyte invasion 
Despite the easy recognition of recombinant BbAMA1 on Western blots by 
antisera against all three BbAMA1 derived peptides (Fig.2), only minor amounts could 
be detected directly in B. bovis extracts by sensitive chemoluminescence staining 
methods. The best antiserum for this purpose appeared to be the one raised against 
peptide 1 (N-terminal peptide) that detected a B. bovis specific band of 82 kDa in total 
merozoite extracts (Fig. 5, panel A, lane 1) and a smaller band of 69 kDa in the protein 
pool secreted after invasion of liberated merozoites into fresh erythrocytes for a period 
of 1 h (lane 2). Antisera against the other two peptides occasionally recognized bands 
of comparable size, but with very weak signal. In addition variation in between 
repeated experiments also included the occasional detection of other minor bands 
(results not shown) by sera against peptides 2 and 3, making the results obtained on 
western blotting by the latter two antisera as yet inconclusive. A reaction of anti-
peptide 1 serum against proteins of 55 kDa to 60 kDa was observed in lanes 1 and 3 
containing the merozoite extract and invasion supernatant as well as in control lanes 
containing only erythrocyte proteins (Fig.5, lanes 2 and 4). Additional controls showed 
that several other unrelated peptides, when linked to KLH, induced rabbit antisera 
reacting with a group of erythrocyte cytosolic proteins at this position (result not 
shown). Merozoite extracts still contain erythrocyte cytosolic proteins derived from a 
fraction of erythrocytes not lysed during isolation of merozoites whereas proteins 
secreted during invasion have been shown to be contaminated with erythrocyte 
cytosolic proteins (76) as a small number of erythrocytes become lysed during invasion. 
To obtain additional proof for the erythrocytic nature of these bands and the  
B. bovis-specific nature of the 69 kDa band secreted upon invasion, two-dimensional 
(2D) gel electrophoresis was employed. Western blots of 2D gels were probed with 
anti-peptide 1 (Fig. 5, panel B) and anti-peptide 3 (panel D) sera and matched to a 
silver-stained image of another gel (panel F).  
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Fig. 3. Immunofluorescence reactivity of antiserum against B. bovis AMA-1 incubated with methanol-
fixed B. bovis infected bovine erythrocytes. Slides were incubated with immune serum against peptide 
1 (B), peptide 2 (D) and peptide 3 (F) and the corresponding preimmune sera (A, C, E). An 
enlargement of duplicated B. bovis merozoites showing immunofluorescence is shown (G). For 
coloured picture see page 112 
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Fig. 4. Inhibition of erythrocyte invasion by B. bovis merozoites with antisera raised against four 
different synthetic peptides. The black bar indicates invasion of B. bovis merozoites that were directly 
added to medium after liberation and is considered as the 100% value against which all incubation are 
plotted. White bars represents invasion of erythrocytes by B. bovis merozoites after pre-incubation 
with immune sera against anti-peptide 1, anti-peptide 2, anti-peptide 3 and anti-peptide C, whereas 
grey bars shows invasion of B. bovis merozoites after pre-incubation with pre-immune serum. Each 
bar represents the average value of six individual experiments and error bars indicate standard 
deviation. Data were tested by the non-parametic test of Kruskal-Wallis. Pairwise comparisons of the 
groups were calculated by post-hoc analysis as advised by Kruskall-Wallis and p-values are indicated. 
 
 
Subsequent metabolic labelling of parasites with 35S prior to invasion allowed the 
localization of B. bovis specific spots (Panel G). Erythrocytic proteins of 55 kDa to 60 
kDa (non-labelled) were recognized by both antisera and were also present in controls 
carrying only erythrocyte cytosolic proteins (panels C and E). In addition, spots 
specifically reacting with anti-peptide 1 serum (panel B, arrow) and anti-peptide 3 
serum (panel D, arrow) were detected on the 2D western blots, matching the most 
abundant spot of a row of four metabolically labelled spots of 69 kDa that in turn 
matched a row of weak spots on the silver-stained gel. We conclude on basis of this set 
of data that AMA-1 is a low abundance protein of which a 69 kDa form is secreted 
upon invasion of erythrocytes by B. bovis merozoites. 
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Fig. 5. Western blot analysis of total merozoites and invasion supernatant, incubated with sera raised 
against AMA-1 peptides after SDS PAGE 1D (panel A) and 2D SDS PAGE (panel B-G). Panel A; 
total merozoites (lane 1) and invasion supernatant (lane 3) were incubated with anti-peptide 1 
antiserum. The arrows indicate bands of respectively 82 kDa (lane 1) and 69 kDa (lane 3).  Lanes 2 en 
4 represents an erythrocyte control incubated with anti-peptide 1 antiserum. Panel B and D represents 
western blot of 2D gels loaded with invasion material and incubated with respectively anti-peptide 1 
and anti-peptide 3 antisera. Panel C and E represent erythrocyte controls incubated with the same two 
antisera. A silver-stained image of a 2D gel loaded with invasion supernatant using metabolically 
labelled B. bovis was run in parallel (panel F) and was subsequently exposed to film (panel G). The 
arrows indicate B. bovis AMA-1 specific spots in total merozoite and invasion supernatant. 
 
DISCUSSION 
 
Apicomplexan organisms are defined by a common set of apically located 
secretory organelles required for host cell invasion by a mechanism displaying many 
conserved features. Despite the conserved nature of the invasion process, only very 
few proteins involved show significant similarity when comparing T. gondii with 
Plasmodium species. AMA-1 represents one such protein conserved between T. gondii 
and P. falciparum and here we report the cloning of the B.  bovis homologue that we 
named BbAMA-1. Overall, B. bovis AMA-1 is only slightly more similar to P. 
falciparum AMA-1 as to T. gondii AMA-1 (resp. 28%, 25%). Most notably, these 
proteins share 10 conserved cysteine residues that have been shown to form disulfide 
bridges and were suggested to stabilize the proposed domains I and II of the PfAMA-1 
ectodomain (96, 155). However, a few conserved residues like the four cysteine residues 
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forming two of the three disulfide bridges present in domain III of PfAMA-1 may 
represent a functional feature conserved between B. bovis and Plasmodium species that 
is lost in T. gondii. Also the number of insertions/deletions is much smaller in a 
pairwise comparison of B. bovis and P. falciparum as in comparison to T. gondii. 
Sofar, molecular phylogenetic analyses have not unambiguously resolved the 
evolutionary relationship between the genera of Toxoplasma, Babesia and Plasmodium 
and it is tempting to hypothesize that some features of the AMA-1 ectodomain may be 
slightly more conserved between Babesia and Plasmodium in relation to their identical 
host cell target, the erythrocyte. 
Like other micronemal proteins, AMA-1 has a short cytoplasmic domain 
varying between 64 aa (B. bovis) and 53 aa (P. falciparum) of which the 30 C-terminal 
residues are remarkably similar indicating a conserved function. The cytoplasmic tail 
of micronemal proteins has been suggested to function as an organellar targeting signal  
(59, 99) but a more recent study has shown that removal of this domain still leads to 
correct localization of P. falciparum micronemal proteins like EBA-175 and TRAP (81) 
. The cytoplasmic tail might be involved in binding to other intracellular proteins that 
may govern the timing of secretion, which is not synchronous for different micronemal 
proteins (89). Alternatively it may be involved in transmitting a signal upon contact of 
the ecto-domain with a host cell ligand or be involved in linkage to cytoskeletal 
structures like recently shown for members of the TRAP-family of micronemal 
proteins (106). 
 PfAMA-1 becomes proteolytically processed at several positions giving rise to 
a complicated pattern of bands as recognized by polyclonal and monoclonal antisera 
(10). A type I transmembrane protein with an aberrant mobility of 64 kDa (predicted 
Mw is 83 kDa) is created after cleavage of the signalpeptide. Upon translocation to the 
apical region a propeptide of 72 aa is removed leaving a protein migrating as 66 kDa 
on polyacrylamide gels (100) . TgAMA-1 does not possess such a propeptide whereas 
BbAMA-1 was shown here to contain an N-terminal region intermediate in size 
between TgAMA-1 and PfAMA-1. Peptide 1 directed antisera recognized a 82 kDa 
band in B. bovis total merozoite extracts suggesting an aberrant mobility (predicted 
Mw from signal peptide cleavage site to C-terminus is 62.7 kDa) as observed for 
PfAMA-1. Whether a propeptide is cleaved remains to be solved as Western blots 
probed with anti-peptide 2 and 3 sera yielded inconclusive results, potentially due to 
the small amounts of BbAMA-1 present. 
Several forms of soluble PfAMA-1 are continuously released from the 
merozoite surface into the extracellular milieu. A 48 kDa form results from cleavage at 
a position 29 residues N-terminal to the transmembrane region (100) whereas a 52 kDa 
form probably results from cleavage just besides or within the transmembrane region 
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(100). Further processing gives rise to a 44 kDa protein (100). Here we have shown the 
release of a 69 kDa form of BbAMA-1, recognized by anti-peptide 1 and 3 antisera, 
upon invasion into erythrocytes suggesting the occurrence of cleavage N-terminal to 
the transmembrane region for BbAMA-1 as well. Analysis on 2D gels allowed the 
mapping of this band to a row of spots of low abundance and provided definite proof 
of the Babesial origin of these spots by making use of metabolic labelling. Whereas on 
1D gels only anti-peptide 1 serum consistently recognized this band, also peptide 3 
directed antisera recognized these spots on 2D gels, probably due to the higher amount 
of protein loaded onto a 2D gel and arguing against the cleavage of a propeptide. 
Immunofluorescence showed that BbAMA-1 was localized at the merozoites 
surface, specifically distributed around the apical region, like the N-terminal processed 
form of PfAMA-1. PfAMA-1 has been shown to be localized near the periphery of 
micronemes in developing schizonts, most likely as a transmembrane protein (10) . 
Upon release of mature merozoites secretion from micronemes results in spreading of 
PfAMA-1 over the external side of the plasma membrane. Immunofluoresence studies 
indicated that PfAMA-1 remains mainly confined to the apical half of the merozoite. 
Upon erythrocyte invasion traces of PfAMA-1 were shown to be carried into the host 
cell but immunofluorescence soon fades away (69). Immunofluoresence studies with 
BbAMA-1 anti-peptide sera resulted in staining of the apical part of B. bovis parasites 
present in asynchronous in vitro cultures. Staining showed a punctuate pattern and can 
represent plasmamembrane located BbAMA-1 as well as location in apical organelles. 
This staining pattern as well as the fact that the more intense staining was mainly 
detected on apparently mature and duplicated intra-erythrocytic forms suggest a 
similar localization and temporal expression as observed for PfAMA-1. 
The inability to make knock-out mutants suggests a critical function for AMA-1 
in T. gondii (90) and P. falciparum (221). Several lines of evidence suggest a role of 
AMA-1 in host cell invasion. Monoclonal and polyclonal antisera inhibit host cell 
invasion  (6, 90, 96, 116) as do peptides binding specifically to AMA-1 (114, 123). Also, 
substitution of the PfAMA-1 gene with the P. chabaudi AMA-1 gene results in P. 
falciparum parasites that better invade mouse erythrocytes (221). Antisera directed 
against BbAMA-1 derived peptides specifically reduced the in vitro invasion 
efficiency of B. bovis indicating that AMA-1 is indeed located on the surface of 
merozoites and accessible to antibodies. Invasion inhibition may result of blocking 
some specific function of AMA-1 or may involve inhibition of proteolytic processing 
as recently shown for PfAMA-1 (69) . Alternatively, antibodies may just crosslink 
merozoites although the low dilutions required to obtain an immunofluorescent signal 
argue against this option. Peptides derived from loop 1 of Domain III of PfAMA-1 
have been shown to induce antibodies that inhibit P. falciparum growth (153). The 
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immunodominant epitopes in these peptides are located in the region that is aligned 
with peptide 3 of BbAMA-1 in Fig. 1. 
 The epitopes recognized by other invasion blocking antisera or peptides have 
not been mapped yet. Antisera directed against peptide 1 (from the N-terminus) and 
peptide 2 (from domain 2) also gave rise to invasion inhibition of B. bovis indicating 
that inhibitory antibodies can be directed against epitopes over the full length of the 
ectodomain. The peptides were selected on basis of their prediction as forming 
amphiphatic α-helices with a high surface probability and a considerable amount of 
charged residues. Studies on population genetics of the AMA-1 gene in endemic areas 
have provided evidence for selective pressure operating on domain I and III indicating 
them as a target for protective immunity (45, 175). Remarkably, AMA-1 sequences are 
most conserved between genera in domain I (see Fig. 1), implicating strong functional 
constraints, whereas the population studies mentioned above have indicated this region 
of PfAMA-1 as the most variable. 
PfAMA-1 is considered as one of the prime candidates for incorporation into a 
recombinant vaccine (69) for reasons briefly discussed above. Soluble parasitic antigens 
(SPA) of B. bovis secreted into the environment during in vitro culture have been 
shown to confer protective properties against B. bovis infection in cattle (170) although 
no individual antigens contributing to this effect have been isolated. The results 
presented here have identified BbAMA-1 as such a secreted protein and the inhibition 
of invasion by rabbit antibodies directed against it, indicates it might be one of the 
protective components of SPA. Further proof obviously requires immunization 
experiments of cattle using native or recombinant BbAMA-1. Genetic studies on 
BbAMA-1 diversity in the field will help in determining its potential as a vaccine 
component. 
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“And God Created every living creature from water. Some of them walk on their 
bellies, some walk on two legs, and some walk on four. God creates whatever He 
wills. God is Omnipotent (Qur’an 24:45)” 
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ABSTRACT 
 
Recognition and invasion of host cells is a key step in the life-cycle of all 
apicomplexan parasites. The thrombospondin-related anonymous protein (TRAP) of 
Plasmodium sporozoites is directly involved in both processes and shares conserved 
adhesive domains with micronemal transmembrane proteins of other apicomplexans. 
Here, we report the cloning and characterization of a Babesia bovis TRAP homologue 
(BbTRAP). It was predicted to be a type I transmembrane protein containing a van 
Willebrand Factor A domain (vWFA), a Thrombospondin type 1 domain (TSP1), a 
simple repeat region, a conserved transmembrane region and a conserved cytoplasmic 
C-terminus, thus closely resembling the domain arrangement of Plasmodium berghei 
TRAP (PbTRAP).  In contrast to the sporozoite protein PbTRAP, BbTRAP was 
shown to be present during the asexual erythrocytic cycle, being located mainly at the 
apical side of merozoites. Polyclonal rabbit antisera directed against synthetic peptides 
derived from the TSP-1 domain or the C-terminal end of the ectodomain were shown 
to inhibit erythrocyte invasion in vitro. Both antisera recognized a 75 kDa protein in 
merozoite extracts as well as in a protein fraction that was secreted into the 
extracellular milieu during in vitro invasion of erythrocytes. 
 
INTRODUCTION 
 
Babesia bovis is an apicomplexan parasite of cattle causing major suffering and 
economical loss worldwide. Its biology resembles that of P. falciparum in having an 
asexual erythrocytic cycle of reproduction that is responsible for pathogenesis with 
clinical features like anaemia, renal failure and the development of severe cerebral 
babesiosis characterized by sequestration of parasitized erythrocytes in the 
microvasculature of the brain (98). The asexual life cycle of B. bovis is simple, in 
replicating by a single binary fission and, remarkably, is initiated by direct invasion of 
eyrthrocytes by sporozoites. Thus, B. bovis lacks a pre-erythrocytic lifestage in its 
vertebrate host in contrast to Plasmodium species and the even more closely related 
Theileria species of which sporozoites invade hepatocytes or white blood cells 
respectively. Apicomplexan parasites invade their host cells by employing molecules 
located at the cell surface and in apical secretory organelles. These organelles are 
localized at the anterior end of the invasive stages and are named micronemes, 
rhoptries and dense granules (18, 67, 176). Micronemal proteins are crucial in mediating 
attachment and invasion and some of them become rapidly secreted directly upon 
initial contact with the host cell surface (142). Plasmodium species use different 
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micronemal proteins comparing sporozoite and merozoite invasion of host cells. Apart 
from invading host cells, sporozoites display a characteristic movement called gliding 
motility (112, 142, 212), as demonstrated in vitro by analysis of motion on artificial 
surfaces. The processes of invasion and gliding motility of sporozoites may depend on 
the same set of molecules. In Plasmodium sporozoites thrombospondin-related 
anonymous protein (TRAP) (134, 212) is a candidate ligand for interaction with host cell 
or substrate receptors. TRAP is a type I transmembrane protein that carries two 
adhesive domains in its extracellular region, an A-domain of von Willebrand (vWFA) 
factor and a motif similar to the type 1 repeat of thrombospondin (TSP1). 
Recombinant TRAP of P. falciparum (PfTRAP) binds to sulphated 
glycosaminoglycans (GAGs) and human hepatocytes (154, 182) using the TSP1 domain 
for adhesion and heparin is a binding ligand for the vWFA domain (137). Disruption of 
the P. berghei TRAP gene by transgenetics resulted in loss of gliding motility and 
invasion of mosquito salivary glands and to reduced infection of host hepatocytes (212). 
Expression of mutated forms of PfTRAP in transgenic P. berghei sporozoites led to 
similar conclusions and also implicated the importance of the vWFA domain in this 
process (235). However, specific mutagenesis of the vWFA and TSP-1 domains of P. 
berghei only impaired cell invasion without affecting gliding motility (134).  
Several micronemal proteins of other apicomplexan genera contain vWFA 
and/or TSP-1 domains in variable numbers of tandemly repeated copies. These 
include Toxoplasma gondii MIC-2 (75, 230), Eimeria tenella Etp100 (218) and 
Cryptosporidium parvum TRAPC1 (206). Like Plasmodium sporozoites, T. gondii 
tachyzoites and sporozoites of Eimeria species display gliding motility (25, 72, 197). In 
addition, T. gondii has been shown to adhere to GAGs like Plasmodium sporozoites 
(33). A number of studies have linked this class of micronemal proteins to a critical 
function in host cell invasion and motility (22, 103, 134, 205, 213) and inspired a search for 
proteins containing similar domains in B. bovis. Only three B. bovis proteins have 
sofar been associated with erythrocyte invasion of which two constitute the MSA-1 
and MSA-2 families of merozoite surface proteins (74, 151, 152, 210) whereas the other is 
the rhoptry protein RAP-1 (152, 211, 242). Here, we report on a B. bovis protein, with 
an architecture remarkably similar to TRAP proteins of Plasmodium, that is present at 
the apical end of B. bovis  merozoites and is a target for invasion inhibitory antibodies. 
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MATERIALS AND METHODS 
 
B. bovis in vitro culture 
In vitro culture of B. bovis (Israël strain, clonal line C 61411) in bovine erythrocytes 
were maintained in 24-well plates (1.2 ml total volume) or in 25 cm2 bottles (15 ml volume) 
as previously described (76).  Cultures were allowed to grow in M199 medium supplemented 
with 40% normal bovine serum and 25 mM sodium bicarbonate together with bovine 
erythrocytes at 5% packed cell volume (PCV)  at 37°C, 5% CO2 in air. The parasitaemia of 
the in vitro culture was kept between 1 and 12% by daily dilution.  
 
B. bovis in vitro invasion 
B. bovis invasion was performed under the conditions that have been described 
previously (76) with some modifications. B. bovis in vitro culture (6 to 8% parasitaemia) was 
centrifuged (2000 g, 10 min, 15°C) and the pellet was resuspended in an equal volume of 
VyMs buffer (4°C). Samples (800 µl) were submitted to five intermittent (10 seconds at 0°C 
in between pulses) high voltage pulses (2.5 kV, 200Ω, 25 µF) in 4 mm cuvettes (BioRad) 
using a BioRad Gene Pulser with pulse controller and washed with 8 ml of PBS containing 
25 mM sodiumbicarbonate (PBSbc, pH 8.0, 20°C) followed by centrifugation (1800 g) for 10 
min at 15°C. The merozoite pellet was resuspended in 8 ml PBSbc and centrifuged again 
(1300 g, 10 min, 15°C). The final merozoite pellet was resuspended in 800 µl PBSbc. 
Invasion was started by addition of 1 volume of resuspended merozoites to 9 volumes of 
suspended bovine erythrocytes (5.5% PCV in PBSbc pH 8.0, 20°C, preincubated for 60 min 
at 37°C in 5% CO2 in air) and was performed in 24-well plates (final volume 1.2 ml), in 25-
cm2 flasks (15 ml) or in 80-cm2 flasks (50 ml) at 37°C, 5% CO2 in air. Giemsa-stained slides 
were prepared after 1 h and parasitized erythrocytes out of a total of 5000 erythrocytes were 
counted. 
 
Inhibition of in vitro invasion by rabbit antisera 
B. bovis merozoites (200 µl),  prepared as described above, were incubated with 40 µl 
of rabbit antisera at 20°C. After 1 h, 960 µl of suspended bovine erythrocytes (6.25% PCV in 
PBSbc, preincubated for 60 min at 37°C in 5% CO2 in air) were added and incubated for 1h 
(37°C in 5% CO2 in air) in 24-well plates (Greiner) after which Giemsa-stained slides were 
prepared and counted (5000 erythrocytes) to determine the level of invasion. Induction of  
rabbit antisera against synthetic peptides derived from the BbTRAP sequence and a control 
serum raised against an unrelated peptide (YAGRLFSKRTAATAYKLQ), named peptide C 
has been described below.  
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Preparation of total merozoite protein extracts and proteins solubilized upon invasion 
Samples of merozoites (800 µl), prepared as described above for in vitro invasion, 
were partially separated from erythrocyte ghosts by filtration over 1.2 µM polypropylene 
prefilters (Millipore). Filtered merozoites were pooled and washed twice in 20 volumes of 
PBSbc followed by centrifugation at 2000 g for 20 min at 4°C. After the second wash the 
pellet was resuspended in an equal volume of PBSbc and divided in aliquots of 200 µl that 
were centrifuged (10000 g, 5 min at 4°C) and stored as 100 µl cell pellets (2×109 merozoites) 
at -20°C after removal of supernatant. Frozen merozoite pellets were thawed just before use 
and lysed, reduced and alkylated by using a total protein extraction kit (Proteoprep, Sigma) 
according to the instructions and obtained in a final volume of 1.7 ml. Insoluble material was 
removed by centrifugation at 16000 g (3 min, 4°C). As the extracts contained considerable 
amounts of erythrocyte proteins, control extracts were prepared by the same procedure, 
starting with a culture of non-infected erythrocytes. Soluble proteins secreted or shed upon 
invasion were obtained by gently removing the overlaying buffer after 1 h of in vitro invasion 
followed by centrifugation (2000 g, 10 min, 4 °C) after which the supernatant was 
centrifuged again at high speed for removal of membrane fragments (20 min, 12000 g, 4°C). 
The final supernatant was dialysed (Pierce; Snakeskinpleated dialysis tubing) overnight 
against 10 mM TrisNaCl, pH 7.5.  
 
Screening a B. bovis cDNA library for TRAP homologues 
PCR primers were derived from a B. bovis EST clone (available from 
www.sanger.ac.uk/Projects/B_bovis/) matching the TRAP-family protein Em100 (Acc. No. 
A48569). Forward primer A1 (5’–tgtggtagatgaatctgctagtatatc-3’) at position 143 and reverse 
primer A2 (5’- ctatgccacggcattcagcaacattta -3’) at position 592 were incubated in 50 µl 
standard buffer (Promega) containing 0.2 mM dNTP, 20 pmol µl-1 of each primer, 100 ng B. 
bovis genomic DNA and 0.5 U Taq DNA polymerase. Amplification was performed for 30 
cycles (92°C for 30 sec, 58°C for 30 sec, at 72°C for 30 sec) preceded by initial denaturation 
for 3 min at 95°C and a final elongation at 72°C for 10 min. A 450 bp fragment was purified 
from agarose gel and labelled with 50 µCi [α-32P]dATP (3000 Ci mmol-1), using a Random 
Primer labelling kit (Roche). The fragment was used for screening 1.2×106 plaques of a B. 
bovis cDNA library (79) by standard procedures (187). After 2 cycles of plaque purification five 
clones were excised in vivo for isolation of the phagemids inserts as described in the 
manufacturer’s instructions (Stratagene). Clones c1 and c2 containing the largest inserts were 
sequenced on both strands, using automated cycle sequencing with the dye terminator method 
(ABI PRISM dye terminator kit, Pharmacia). A full-length TRAP cDNA including the non-
coding 5’-end was obtained with GeneRacer kit (Invitrogen) according the manufacturer’s 
instructions. A single clone g1 was sequenced on both strands. 
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Expression of recombinant BbTRAP  in E. coli 
Genomic DNA of B. bovis was used to amplify part of the BbTRAP gene, from base 
145 (Accession number AY486102, numbering starting at the ATG initiation codon) to base 
1964, by PCR using forward primer A3 (5’-cccgaattcgtggtagatgaatctgct-3’) containing an 
EcoRI site and a reverse primer A4 (5’-cccgtcgactgcctcgccccaaatgttgt-3’) with a SalI site.  
After PCR (1 min 94°C, 1 min 55°C, 1 min. 72°C; 30 cycles) the BbTRAP PCR product was 
purified as described above and ligated into the EcoRI-SalI site of pET-32a vector (Novagen) 
allowing expression as a fusion product with a N-terminal thioredoxin domain and an internal 
6-histidine tag.  Ligation was used for transformation of E. coli NovaBlue strain. As control 
B. bovis rab5 (residues 298 to 1801, Genebank Acc no AY324137) was expressed in pET-
32a. Plasmids containing the appropriate insert were used to transform E. coli BL21 (DE3). 
Fusion proteins with thioredoxin were obtained with maximal yield after induction with 1 
mM of isopropyl-β-D thiogalactosidase (IPTG) for 4 hr at 37°C. Bacterial pellets were heated 
at 95°C in SDS-polyacrylamide (SDS-PAGE) sample buffer containing 2% (v/v) β-
mercaptoethanol, run on 10% SDS-PAGE minigels and stained with Coomassie Blue.  
 
Peptide selection and immunisation 
Peptide sequences were selected from the BbTRAP amino acid sequence by searching 
for amphiphatic alpha-helices having a high probability for surface localization and 
containing several charged residues with the Protean software package (Lasergene) for 
protein sequence analysis. Two peptides were selected: the first from the TSP-1 domain (aa 
255-269; cysteine-: PGKRTRALLDLRMIE: peptide 1) and the second from the C-terminal 
end of the ectodomain (aa 547-561; cysteine-VYDDHPEESENTGIN: peptide 2). The 
peptides were synthesized and coupled to maleimide activated keyhole limpet haemocyanin 
(KLH) as carrier protein according to the manufacturer’s recommendations (Pierce). The 
peptide-carrier conjugate was used to generate rabbit polyclonal antisera. Two groups of 
NZW-rabbits, each containing two rabbits, were immunized subcutaneously at 3-week 
interval for eight months. Before the first immunisation blood serum was collected from each 
rabbit, which was used as negative control. Each rabbit was injected with 250 µg peptide 
coupled to 250 µg of KLH and equal volume of adjuvant Stimune (ID-DLO, The 
Netherlands), in a total volume of 1000 µl.   
Plasmaforeses were performed one week after immunization, starting at month 4. The 
production of rabbit antibodies against the peptides was estimated periodically by ELISA. 
Ninety-six-well microtiter plates were coated with 150 ng of peptide 1 or peptide 2  per well 
in 0.1 M Tris-HCl pH 8.0, incubated 1 h at 37°C and blocked for 1 h with PBS/0.25% BSA at 
37°C. Consecutive dilutions (1:50 to 1:50000) of individual rabbit sera were incubated for 1 h 
at 37 °C. The plates were washed and swine anti rabbit-IgG Horseradish Peroxidase (HRP)-
conjugated (1:2000, DAKO) secondary antibody was incubated for 1 h. The plates were 
washed and developed for 45 min with ABTS [2,2’-azinobis(3-ethylbenzthiazolinesulfonic 
acid)]- peroxidase substrate (Roche biochemicals). The OD405 was recorded, and comparative 
ELISA titres were calculated.  
Chapter 5 
 85
SDS-polyacrylamide electrophoresis and western blotting 
Total merozoite extracts or proteins solubilized upon invasion were separated by 10% 
SDS-PAGE and transferred to PVDF membrane (Immobilon-P, Millipore). The blot was 
blocked with 5% skimmed milk diluted in phosphate-buffered saline containing 0.05% 
Tween (PBST) for 1 h at 37°C. Rabbits antisera were diluted (1:500) in PBST containing 2% 
skimmed milk and incubated overnight at 4°C. The blot was washed with PBST and 
incubated with anti-rabbit-immunoglobulins conjugated to HRP (1:10000, DAKO) for 1 h at 
37°C. After washing with PBST, the blot was developed either colorimetrically with TMB 
MB substrate kit (Lucron Bioproducts b.v.) or with enhanced chemiluminescence ECL plus 
(Amersham).    
 
Immunofluorescence assay 
Indirect immunofluorescence assays were performed with  B. bovis merozoites 
infected red blood cells fixed as thin blood smears with methanol. Slides were incubated for 
35 min with polyclonal rabbit anti-TRAP antisera (1:5) or preimmune serum (1:5), washed 
three times for 5 min with PBS and then incubated for 35 min with goat anti-rabbit IgG 
antibodies coupled to fluorescein isothiocyanate (1:80, Nordic). The slides were washed, and 
vectashield solution (Vector laboratories) was applied and parasites were visualized using a 
UV fluorescence microscope with FITC filters (455/ 515 nm).  
 
RESULTS 
 
Cloning and sequence analysis of a full length cDNA encoding B. bovis TRAP  
Blastx analysis of a B. bovis EST dataset (available from www.sanger.ac.uk) 
identified a single EST of 600 bp matching with the highest Blast score to the Em100 
antigen of Eimeria maxima (Acc. No. AAA29076). Similarity extended over a region 
of 188 amino acids (35% identity) corresponding to the vWFA domain (also referred 
to as the I-domain from integrins) present in the N-terminal part of Emp100 and other 
antigens of the apicomplexan TRAP-family named after P. falciparum PfTRAP. The 
encoded protein was denoted BbTRAP and cDNA sequencing allowed to assemble a 
full-length 2105 bp mRNA sequence from a 1990 bp cDNA clone isolated from a B. 
bovis cDNA library and a 725 bp cDNA clone obtained by specific priming of a RT-
PCR reaction on the 5’ capped end of the BbTRAP mRNA (described in Materials 
and Methods). The BbTRAP mRNA was composed of a 100 bp 5’ UTR, a 37 bp 3’ 
UTR and a 1968 bp open reading frame encoding a protein of predicted MW of 71.3 
kDa. Prediction of a signal peptide using SignalP2.0 (most probable cleavage site  
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Fig. 1. Amino acid sequence aligment of TRAP-family members B. bovis (BbTRAP) was aligned 
with P. berghei TRAP (Pb, Acc. No. AAB63302), P. yoelli TRAP (Py, Acc. No. Q01443), P. 
falciparum TRAP (Pf, Acc. No. CAA31440), P. vivax TRAP (Pv, Acc. No. AAC97485 ), T. gondii 
MIC2 (Tg, Acc. No. AAB63303, N. caninum MIC2 (Nc, Acc.No. AAF01565), E. tenella Etp100 (Et, 
Acc. No. AAD03350) and E. maxima Em100 (Em, Acc. No. AAA29076). Positions sharing eight or 
nine identical or similar residues are shaded dark grey whereas four to seven similarities are shaded 
light grey (similarity groups: VLIM; YF; RK; EQ; DN; ST). The vWFA domain (grey bar, similar to 
pfam domain 00092) and TSP-1 domains (black bar, similar to pfam domain 00090) are indicated as 
well  as the repeat region (open bar) and the predicted transmembrane region (grey bar). 
 
between A26 and F27) was in agreement with similar predictions for other proteins of 
the TRAP family and gives an expected MW of the mature protein of 68.6 kDa. 
Figure 1 presents the predicted amino acid sequence of BbTRAP, as a representative 
of the Piroplasmida, in alignment with TRAP family members derived from the 
Eimeriida (T. gondii, Neospora caninum, E. maxima, E. tenella) and the 
Haemosporida (P. falciparum, P. berghei, P. yoelli, P. vivax).  
Like all Plasmodium TRAP proteins, BbTRAP has one TSP1 domain whereas 
the Eimeriida TRAP proteins have five tandem TSP1 domains. BbTRAP possesses 
the remarkably conserved hydrophobic region, predicted (using TMHMM2.0) to be a 
transmembrane region with a type I membrane protein topology, that was noted before 
(183) and a conserved cytoplasmic domain of 45 amino acids. The region directly N-
terminal to the transmembrane domain is poorly conserved in between the different 
species except for the closely related P. berghei and P. yoelli. These two species also 
have a region of imperfect tri-peptide repeats, directly C-terminal to the TSP1 motif, 
of which the first residue is always a proline. BbTRAP shares this overall protein 
architecture with PbTRAP and PyTRAP in having 11 imperfect hepta-peptide repeats 
at this position of which the majority consensus is given by the sequence 
MSSSH[S/T]D. At positions 2 and 5 of this repeat a proline residue is frequently 
present. 
 
Recombinant BbTRAP is recognized by rabbit antisera raised against synthetic 
BbTRAP peptides 
A recombinant fusion product (rBbTRAP) of thioredoxin and BbTRAP 
(residues Val-49 to Ala-654) or Bbrab5 was expressed in E. coli BL21 cells (Fig. 2). 
Polyacrylamide gel electrophoresis of total cell lysates obtained before (lane 1) and 
after (lane 2) induction with IPTG identified a recombinant fusion product of 80 kDa 
(predicted size 77.8 kDa). Total cell lysate containing rBbTRAP was transferred to 
PVDF membrane that was probed with sera from rabbits that were immunized with 
KLH-linked synthetic peptides derived from the TSP1 domain (Pro-255 to Ser-269) or 
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a region just preceding the transmembrane domain (Val-547 to Asn-561). Both 
immune sera (lanes 5 and 8) recognized rBbTRAP whereas bands around 58 kDa are 
most likely caused by recognition of E. coli proteins as pre-immune serum (lane 4) 
and BbTRAP immune sera against both peptides give the same signal at this position 
with both rBbTRAP (lanes 5 and 8) and recombinant B. bovis rab5 (lanes 6 and 9). 
Sera raised against B. bovis rab5-derived peptide linked to KLH did not recognize 
rBbTRAP (lane 10). 
 
Immunofluorescence microscopy  
BbTRAP was localized by immunofluorescence microscopy using rabbit 
antisera against both KLH-linked peptides on B. bovis in vitro cultures attached to 
glass slides and permeabilized with methanol (Fig. 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Western blots of recombinant BbTRAP probed with  polyclonal rabbit antisera against 
synthetic peptides. Expression of BbTRAP in E. coli is demonstrated on a Coomassie Blue-stained 
SDS-polyacrylamide gel containing E. coli total cell lysate of uninduced cells (lane 1) and induced 
(lane 2) expressing recombinant BbTRAP. As a control expression of B. bovis rab5 in the same vector 
is shown in lane 3. Blots of recombinant BbTRAP (lanes 4, 5, 7, 8, 10) were incubated with pre-
immune serum (lane 4, 7), immune sera (lane 5, 8) raised against peptide 1 (lane 4, 5), peptide 2 (lane 
7, 8) or with B. bovis rab5 antisera (lane 10). Lane 6 and 9 shows immunoblots of B. bovis 
recombinant protein rab5 with TRAP antisera against peptide 1 and peptide 2 respectively. Molecular 
weights are indicated.   
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Incubation with pre-immune sera (panels A and C) resulted in a very weak fluorescent 
signal of equal intensity at infected and non-infected erythrocytes. Immune serum 
directed against peptide 2, derived from the C-terminal region of the ectodomain of 
BbTRAP, resulted in intense staining of parasites in any microscope field examined 
(panels D) whereas incubation with the immune serum directed against peptide 1 
stained parasites at a weaker intensity. The enlargement in panel E shows the staining 
pattern of a duplicated, double-pear shaped, intra-erythrocytic parasite (free 
merozoites are hardly observed in standard in vitro cultures) as observed at maximum 
magnification. Staining was present mainly on the apical end of the parasite and 
shows a somewhat dotted appearance (the faint background staining allows easy 
identification of the apical end as the parasites remain attached by a residual body at 
the opposite end after duplication).  
 
Anti-BbTRAP-peptide antisera inhibit in vitro invasion and detect secreted BbTRAP  
Several lines of evidence suggest that members of the TRAP family are directly 
involved in gliding motility and host cell invasion (134, 212, 235). Fig. 4 displays the 
results of an in vitro invasion study in which free B. bovis merozoites were 
preincubated  for 1 h at 20oC with the two anti-BbTRAP-peptide rabbit antisera 
described above. After preincubation the direct effect of the antisera on invasion of 
erythrocytes by free merozoites, performed for 1 h in a protein free buffer, was 
determined. Preincubation with pre-immuneserum or with a comparable control 
antiserum directed against a non-related peptide had no significant effect on invasion 
efficiency. Both immune sera caused a significant invasion reduction of 55% +  11% 
for the serum directed against the TSP1 domain (anti-peptide 1) and of 36% + 15% for 
anti-peptide 2 (C-terminal end of ectodomain). The direct addition of immune sera to 
the in vitro invasion reaction without prior preincubation did not cause a significant 
inhibition (result not shown).  
Proteins secreted or shed into the surroundings during in vitro invasion, under 
serum-free conditions in a PBS-bicarbonate buffer, were concentrated and analysed by 
western blot (Fig. 5) using the BbTRAP peptide-specific antisera. Both antisera 
recognized a 75 kDa protein in total merozoite extracts (lanes 1 and 5) and a band of 
similar size in the supernatant of the invasion reaction (lanes 3 and 7). Controls using 
similarly cultured uninfected erythrocytes demonstrated some cross-reactivity with 
erythrocyte derived proteins in the invasion supernatant (lanes 4 and 8). 
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Fig 3. Immunofluorescence reactivity of B. bovis infected bovine erythrocytes with antisera against 
BbTRAP derived peptides. Slides were incubated with immune serum against peptide 1 (B), peptide 2 
(D) and the corresponding preimmune sera (A, C). An enlargement of a duplicated B. bovis merozoite 
at maximum magnification (1000×), reacting with anti-peptide 2 serum, is shown in panel E. For 
coloured picture see page 97 
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Fig. 4. Inhibition of erythrocyte invasion by B. bovis merozoites by antisera raised against three 
different synthetic peptides. The black bar shows invasion of B. bovis merozoites without 
preincubation and is taken as the 100% value against which the other incubations are plotted. White 
bars represent invasion of erythrocytes by B. bovis merozoites after pre-incubation with antisera 
against peptide 1, peptide 2 and peptide C (non-related peptide), whereas grey bars shows invasion of 
B. bovis merozoites after pre-incubation with pre-immune serum. Each bar represents the average 
value of six individual experiments and error bars indicate standard deviation.  The groups were tested 
by the non-parametric test of Kruskal-Wallis and considered significant at p<0.05. Pairwise 
comparisons of the groups were calculated by post-hoc analysis as advised by Kruskall-Wallis. 
 
For both antisera the band present in the supernatant was much weaker as the band in 
merozoite extracts. In both cases 15 µg was applied to gel which corresponded to 4.7 
x 106 merozoites for the total merozoite extract and an amount of supernatant 
corresponding to the invasion of 7.6 x 106 merozoites into new erythrocytes (invasion 
efficiency was 25 % in this case) leading to the conclusion that only part of BbTRAP 
has been secreted. 
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Fig. 5. Detection of BbTRAP in total merozoites extracts and invasion supernatant by western 
blotting.  15 µg of total merozoites extract (lane 1 and 5) or invasion supernatant (lane 3 and 7) were 
separated by SDS-PAGE (10%) and incubated after blotting with anti-peptide 1 (panel A) or anti-
peptide 2  (panel B) antiserum. Control extract prepared by identical procedures but derived from 
non-infected cultures were included for total merozoite extract (lane 2 and 6) and invasion supernatant 
(lane 4 and 8). 
 
DISCUSSION 
 
The TRAP-family and apical membrane antigen 1 (AMA-1) (63, 221) represent 
the only transmembrane proteins involved in host cell invasion that are well conserved 
throughout the apicomplexa, indicating an important conserved function. The 
identification of BbTRAP presents the first example of a member of the TRAP-family 
of adhesins within the order of the Piroplasmida, formed by the genera Theileria and 
Babesia. 
Despite the anticipated discovery of a TRAP-family protein in B. bovis, given 
the range of apicomplexan parasites that were previously shown to harbour one or 
several members of this family (127, 183, 206, 230), some remarkable findings were 
obtained. Phylogenetic analyses have not unambiguously grouped the Piroplasmida in 
a clade with either the Haemosporida or the Eimeriida. The modular composition of 
Babesia bovis Thrombospondin Related Anonymous Protein 
 
 94 
BbTRAP is more similar to that of malaria parasites, in particular the rodent parasites 
P. berghei and P. yoelli. Like these, the predicted extracellular domain of BbTRAP 
has a region composed of simple imperfect repeats, in addition to a single vWFA-
domain and a TSP1 domain. In Plasmodium simple repeat regions occur frequently, in 
particular in antigenic proteins (6). A specific function for the tripeptide repeat regions 
in PbTRAP and PyTRAP has not been identified. A Blastp similarity search with the 
repeat region of BbTRAP (11 repeats; consensus MSSSHSD), only identified three 
hypothetical P. falciparum proteins (Acc. No. AAN36420, CAB62891 and 
AAC71881) carrying imperfect heptapeptide repeats. The highest score (E = 2e-8, 
using a BLOSUM 45 scoring matrix and standard gap penalties for searching the 
Genebank nr database) was obtained with hypothetical protein PFL1670c (Acc. No 
AAN36420; consensus of repeat is KSSQHND) that was predicted to have a 
signalpeptide. Whether these repeats represent an evolutionary conserved 
apicomplexan feature, an acquired functional similarity or just coincidental sequence 
similarity remains speculative. 
A highly similar modular architecture of BbTRAP and PbTRAP does not 
translate into involvement in exactly the same biological events. Whereas B. bovis and 
Plasmodium multiply by an asexual erythrocytic cycle involving a similar invasion 
process, TRAP has never clearly been demonstrated to be expressed during this stage 
in Plasmodium. Here, we have obtained proof for an apical location of BbTRAP in B. 
bovis merozoites by immunofluorescence, which is in accordance with the 
micronemal localization of other TRAP-family proteins, and have demonstrated that 
BbTRAP migrates as a 75 kDa protein when extracted from merozoites. Its possible 
presence in sporozoite stages, like for Plasmodium TRAP, has of course not been 
excluded. 
Inhibition of erythrocyte invasion by the two antisera raised against peptides 
derived from the ectodomain of BbTRAP suggests an essential function in invasion. 
The inhibitory effect might be due to specific interference with a crucial mechanistic 
step, like adhesion to a specific host receptor, or to more aspecific effects like the 
immuno-aggregation of merozoites (although this was not observed under the 
microscope). This observation is remarkable as antibodies directed against 
Plasmodium TRAP or T. gondii MIC2 have been reported to be unable to achieve 
invasion inhibition (80). A preincubation of free merozoites with antisera against 
BbTRAP was required (as compared to direct addition of the antiserum to in vitro 
invasion) to obtain the inhibitory effect. This implies that BbTRAP, the antibody 
target, is already exposed on the membrane before contact with the host cell takes 
place. In Plasmodium, TRAP was shown to be constitutively present on the sporozoite 
membrane in only small amounts whereas massive secretion of TRAP stored in the 
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micronemes only takes place upon contact with the host cell or after application of 
artificial stimuli resulting in microneme secretion (80). TRAP located on the 
Plasmodium sporozoite membrane is involved in gliding motility over solid substrates 
and becomes capped from the apical end, where it is presumably constitutively 
secreted, to the posterior end, where it is liberated from the membrane leaving a trail 
of TRAP protein on the substrate (134). Membrane localization of TRAP is required for 
gliding motility which is however insensitive to mutations in the extracellular 
adhesive domains (134). These mutations do impair invasion of sporozoites but not the 
preceding step of host cell adhesion (134), suggesting a tight interaction of the host cell 
with TRAP molecules that become secreted upon initial contact with the host cell. The 
moving junction, attaching the invading sporozoite to the host cell, is reminescent of 
capping and may contain the TRAP molecules. Merozoites do not possess gliding 
motility (nor express TRAP in Plasmodium) but do invade by a moving junction 
mechanism. In Plasmodium the role of TRAP in sporozoites is suggested to be 
performed in merozoite invasion by highly specific binding ligands like DBL, EBA-
175 or EBA-140 (1, 81, 217). A role for TRAP in the invasion of erythrocytes thus 
presents a novelty. One difference between invasion by B. bovis and Plasmodium 
merozoites is the more relaxed specificity observed in vitro for B. bovis merozoites 
which were shown to be able to invade erythrocytes from a wide range of host  species 
(78). This could make the use of BbTRAP in B. bovis erythrocyte invasion plausible as 
TRAP does not seem to be involved in highly specific sequence interactions. Also 
MIC2 of T.gondii is a TRAP family member which is clearly involved in invasion of 
host cells by tachyzoites (22, 103) and it may contribute to the efficient invasion of 
almost any nucleated vertebrate cell type. 
The release of soluble BbTRAP into the medium was demonstrated to take 
place during in vitro invasion. TRAP has been shown to be released from Plasmodium 
sporozoites after capping to the posterior end (80). Also, PbTRAP has been shown to be 
secreted into the culture supernatant by P. berghei sporozoites incubated at 37oC (16). 
Although proteolytic processing is held responsible for secretion, an identical doublet 
of protein bands, of which the upper one was recognized by antiserum directed against 
the cytoplasmic domain, was detected on western blots from total cell lysates and 
from culture supernatant (16). This indicates that a processed form of PbTRAP was 
present in total cell lysates and corresponds to our observation that the secreted form 
of BbTRAP has a similar size as the form detected in total merozoite extracts. 
Release of the extracellular domain of T. gondii MIC2 by proteolysis has been 
shown to be essential to the proceeding of invasion (22, 35, 164). Proteases involved in 
this process have been indicated (22, 35, 164) and several reports described the mapping of 
the proteolytic cleavage site in MIC2 and related proteins (35). The extraordinary 
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sequence conservation of the transmembrane region observed for a number of 
micronemal  proteins including MIC2 and TRAP was also noted here for BbTRAP. 
Apicomplexan homologues of a protease called rhomboid are likely to recognize this 
sequence resulting in intra-membrane cleavage (224). Another cleavage site was 
mapped to a lysine residue of MIC2 located 11 amino acids N-terminal to the 
transmembrane region (22), which might be conserved in BbTRAP (K576). The 
cytoplasmic tail of BbTRAP is also conserved at a number of critical residues. One 
conserved residue is a sub-terminal tryptophane (W651) that has been implicated in 
the binding of aldolase which probably serves as a link between transmembrane 
proteins and the actin/myosin motor that drives invasion and gliding motility (26, 106). 
Another conserved motif, involved in micronemal targeting of proteins (16), consists of 
a tyrosine at position one and a bulky hydrophobic residue at position four and is 
possibly represented by the sequence YAMY (607-610) in BbTRAP. In conclusion, 
BbTRAP displays conserved sequence features shown to be involved in other TRAP 
family members with micronemal targeting, adhesion to host cells, attachment to an 
actin/myosin motor and cleavage of the ecto-domain by conserved proteases. 
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Fig 3. Immunofluorescence reactivity of B. bovis infected bovine erythrocytes with antisera against 
BbTRAP derived peptides. Slides were incubated with immune serum against peptide 1 (B), peptide 2 
(D) and the corresponding preimmune sera (A, C). An enlargement of a duplicated B. bovis merozoite 
at maximum magnification (1000×), reacting with anti-peptide 2 serum, is shown in panel E. 
 
 
 
 
Babesia bovis Thrombospondin Related Anonymous Protein 
 
 98 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
CHAPTER 6 
 
 
A STUDY ON THE POSSIBILITIES FOR OBTAINING GENETIC 
TRANSFORMATION OF BABESIA BOVIS 
 
 
Fasila R. Gaffar, Karlijn Wilschut, Sietze Brandes, Frits F. J. Franssen and 
Erik de Vries 
 
 
 
 
 
Submitted for publication 
Genetic transformation of Babesia bovis 
 
 100
ABSTRACT 
 
A first attempt was undertaken to establish a transfection system for B. bovis. 
Plasmids containing as selectable markers Toxoplasma gondii dhfr-tsm2m3 and 
human DHFR under control of B. bovis dhfr-ts promotor and termination region were 
constructed. Reporter genes for transient and stable transfection were introduced in a 
head to tail position in both plasmids. Different combinations of electroporation 
conditions, plasmid introduction (linear or circular), concentration of plasmid and 
target cells (infected erythrocytes or free merozoites) were tested. Although culture 
lines moderately resistant against pyrimethamine and WR99210 drugs were selected, 
none of these cultures were shown to contain plasmid  constructs by southern blotting. 
Expression of the reporter genes YFP, GFP or β-galactosidase was not detected. Sofar, 
we have not been able to establish a stable or transient transfection for B. bovis.    
 
INTRODUCTION 
 
The ability to alter the encoded amino acid sequences of apicomplexan genes 
or to manipulate their levels or timing of expression in their natural context has in 
recent years become feasible for Toxoplasma gondii and several Plasmodium species 
(51, 65, 130, 141, 239). Although the versatility of the various transfection systems that have 
been established is not yet comparable to eukaryotic model systems like yeast, it has 
greatly expanded the knowledge on the biology of this group of important parasites. 
With increasing numbers of Babesia bovis gene and protein sequences becoming 
available from an EST project (www.sanger.ac.uk) and, more specifically, from 
studies aiming at the identification of potential vaccine components (49, 161) or 
delineating the mechanism of erythrocyte invasion (this thesis), transfection is 
becoming a desirable tool for this species too. 
Here we briefly describe the first steps that were undertaken to transfect B. 
bovis by aiming either at establishing stable transformation by using a drug resistance 
gene as selectable marker, or at obtaining the transient expression of a reporter gene. 
From a number of different selectable markers that have been successfully applied for 
apicomplexan transfection (51, 65, 130) we have selected here the human dihydrofolate 
reductase (dhfr) gene as a first option. Human DHFR is highly resistant to the 
antimalarial drug pyrimethamine and another dihydrofolate analogue denoted 
WR99210. Pilot experiments indicated that especially WR99210 was lethal to B. bovis 
in vitro cultures in the nanomolar range (chapter 7). In apicomplexans dihydrofolate 
reductase (DHFR, EC 1.5.1.3) is encoded as part of a single bi-functional protein in 
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combination with thymidylate synthase (TS, EC 2.1.1.45) and its inhibition eventually 
leads to an arrest of DNA replication by depletion of the precursors required for 
pyrimidine de novo synthesis on which apicomplexans are fully dependent. 
Expression of a selectable marker requires the addition of control elements. Hardly 
anything is known for B. bovis about transcriptional regulation and the promoter and 
termination sequences involved. Therefore, the expression of the human dhfr gene 
under the control of the flanking regions of the B. bovis dhfr-ts gene, of which the 
cloning is described in chapter 7, seems a logic choice for an attempt to obtain levels 
and timing of expression of human DHFR similar to the natural situation. As reporters 
the genes encoding green fluorescent protein (GFP), yellow fluorescent protein (YFP) 
and β-galactosidase have been incorporated in the transfection plasmid constructs. 
Electroporation was chosen as the method for introduction of the plasmid DNA.  
 
MATERIALS AND METHODS 
 
Transfection plasmids 
Transfection constructs were designed as schematically depicted in Fig. 1. All 
oligonucleotides used to amplify the PCR fragments described below are listed in table II. 
The T. gondii dhfr-tsm2m3 gene (TgD) or human dhfr (HsD) gene were cloned under control 
of the flanking regions of B. bovis DHFR which functioned as promoter and termination 
regions of transfection plasmids. The HsD fragment was excised from plasmid pD+WT by 
BamHI and NcoI restriction sites digestion, whereas the TgD fragment was digested from 
plasmid pExpress1 with HindIII and NsiI (51, 226). Both fragments were ligated in pUCPCR (55) 
plasmid  digested by the same restriction enzymes giving plasmids pUC-HsD and pUC-TgD. 
The promoter region of the B. bovis DHFR-TS (d5) was ligated upstream of the HsD or TgD 
gene. To create plasmids pUC-d5HsD and pUC-d5TgD, the promoter region of B. bovis dhfr-
ts was amplified by PCR using primers 5 UTRse and 5UTRnco or primers 5UTRkpn and 
5UTRas, respectively. PCR was performed in a 50 µl volume containing 0.2 mM dNTP, 20 
pmolµl-1 of each primer, 100 ng B. bovis  genomic clone g6 (chapter 7) and 0.5 U Taq DNA 
polymerase in standard buffer (Promega). Amplification was performed for 30 cycles (92°C 
for 30 s, 55°C for 30 s and 72°C for 30 s) preceded by initial denaturation for 3 min at 95°C 
and a final elongation at 72°C for 10 min. The 2.83 kb amplified promotor fragment was 
cloned into pUC-HsD digested with NcoI and PstI or into pUC-TgD digested with AgeI and 
KpnI. The 3’UTR of B. bovis DHFR-TS was amplified from clone g2 with primers 3UTRse 
and 3UTRkpn or primers 3UTRse and 3UTRas giving 1.35 kb products that were introduced 
after cleavage with respectively KpnI and BamHI or HindIII in plasmids pUC-d5HsD and 
pUC-d5TgD digested by the same enzymes creating pUC-d5HsDd3 and pUC-d5TgDd3. For 
introduction of a reporter gene into the plasmids, a terminator and promoter region were 
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ligated. The intergenic region between ABC and 12D3 (a312d5) gene of B. bovis was 
amplified for genomic DNA with primers ABCse and 12D3as. The amplified fragment was 
used for nested PCR with primers 3UTRabc and 5UTR12d3. The resulting 450 bp fragment 
was digested with BglII and BamHI and ligated into pUC-d5HsDd3 and pUC-d5TgDd3 
(vectors were digested with BamHI) creating pUC-d5HsDa312d5d3 and pUC-d5TgDa312d5d3. 
Next the reporter genes GFP, YFP and β-galactosidase were amplified. GFP was amplified 
from plasmid pdhfrCAT-GFP with primers GFPxho and GFPnsi or primers GFPxba and 
GFPnsi. The 730 bp amplified fragments were digested (with BamHI and NsiI or XbaI and 
NsiI) and ligated into pUC-d5HsDa312d5d3 or pUC-d5TgDa312d5d3 plasmids (vectors were 
digested with the same restriction enzymes) resulting in pUC-d5HsDa312d5GFd3 and pUC-
d5TgDa312d5GFd3. YFP was amplified from tubYFPYFP-sagCAT with primers YFPxho and 
YFPnsi or primers YFPxba and YFPnsi. The 740 bp amplified fragments were digested (with 
BamHI and NsiI or XbaI and NsiI) and ligated into pUC-d5HsDa312d5d3 or d5TgDa312d5d3 
plasmids (plasmids digested with the same enzymes) creating pUC-d5HsDa312d5YFd3 and 
pUC-d5TgDa312d5YFd3. Finally β-galactosidase was amplified from χgt11 with primers 
βLACnsi and βLACxho. The 3.0 kb amplified fragment was digested with XhoI and NsiI and 
ligated into pUC-d5HsDa312d5d3 plasmid (plasmid digested with the same enzymes) resulting 
in pUC-d5HsDa312d5GALd3. All constructs described above were partially sequenced in 
order to confirm the sequences of PCR primers and proper ligation of restriction sites. 
 
In vitro cultivation and electroporation of B. bovis 
B. bovis Israël strain (clonal line C61411), was maintained in vitro by serial passage of 
bovine  red blood cells (RBCs) as described  in chapter 5. Medium changes were carried out 
every 24 h and parasitaemia was kept between 1 and 12 % by dilution. The parasitaemia was 
measured by counting 3000 RBC in giemsa stained smears.  
For transfection, ~2.109 B. bovis infected red blood cells (50% packed cell volume, 7% to 
10% parasitaemia) were electroporated in a Gene Pulser II system (Biorad) with 100µg DNA 
construct in a final volume of 500 µl in cytomix (120mM KCl, 0.15 mM CaCl2, 2 mM 
EGTA, 5 mM MgCl2, 10 mM K2HPO4/ KH2PO4 pH 7.6, 25mM Hepes pH 7.6). Besides 
directly electroporating B. bovis red blood cells with DNA we also liberated the merozoites 
first with electroshock (5 times under the same conditions described below) before adding 
plasmid DNA. Cells were cooled on ice for 5 min before pulsing at high voltage (1 kV, 
200Ω, 25 µF). 120 µl of electroporated cells were immediately added to 1020 µl pre-warmed 
M199 culture media containing 60 µl bovine red blood cells. For 72 h in vitro cultivation was 
performed in 24 well plates at 1.25 µM pyrimethamine or 2.5 nM WR99210 in 5% CO2 in 
air. After three days the concentration of pyrimethamine was increased to 5.0-10.0 µM and of 
WR99210 to 5.0-20 nM. 
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Table Ia: Nomenclature used for coding and non-coding regions 
 
 Flanking regions   coding regions 
 
 DHFR promotor   d5   Human DHFR     HsD 
 DHFR terminator  d3   T. gondii DHFRTSm2m3 TgD 
 12D3   promotor  12d5   YFP    YF 
 ABC    terminator  a3   GFP    GF 
       β-galactosidase   GAL 
 
 
Table Ib: Conditions and test methods used for transfection 
 
Transfection 
plasmids 
µg Plasmid   
form 
 
Linear 
or 
circulair 
Target  
cell 
 
 
Free  
merozoites 
(F)  
or 
 Intra-
erythrocytic 
(I) 
Stable 
transfection 
 
[Pyrimethamine] 
(PYR) or 
[WR99210] 
(WR) allowing 
normal growth 
rate 
Resistant 
lines 
 
Number 
tested on 
southern 
blot 
Transient 
transfection 
 
Number of 
lines tested 
d5TgDd3 20 
50 
100 
C F, I 5-10 µM PYR 3  
d5HsDd3 20 
50 
100 
C F, I 5-20 nM WR 3  
d5HsDa312d5YFd3 20 
100 
L, C F 5-20 nM WR 2 5 
d5TgDa312d5YFd3 20 
100 
L, C F 5-10 µM PYR 2 5 
d5HsDa312d5GFd3 20 
100 
L, C F 5-20 nM WR 2 5 
d5HsDa312d5GALd3 20 
100 
L, C F N.D. 
 
N.D. 10 
 
Genetic transformation of Babesia bovis 
 
 104
Table II:     Oligonucleotides used in this study with restriction sites being underlined 
 
Name 
 
Nucleotide sequence 
3UTRse 5’- gatcacaagcttttggatcctacagtcttatttggtagaacc 
3UTRas 3’- gctcttggtaacgttccatggatatcgatcgaagcttgaattgagg 
3UTRabc 5’- tgaagatctagcgcgcctgtatagattatgacagtagttac 
3UTRkpn 5’- cggggtaccaacgttaccaagagcaactcc 
12D3as 5’- gcttacccattctgatcgtacat 
5 UTRse            5’- aaactgcagaccggtcatactagttattga gatacagtgccaaattc  
5UTRnco           3 - agtagccatggttaatcatatatg cacttgat ataa 
5UTRkpn          5’- cggggtacccatactagttattgagatacagtgccaaattc 
5UTRas 3’- tgattaaccaagtgcatataatgcagaaaccggtgtgtc 
5UTR12d3         5’- cgggatcctatctagaagcatgcatcttgtatgtcgaatagtatt 
ABCse               5’- gaaacagtggtgaaaaataaggc 
GFPxba            5’- gctctagatagttcatccatgccatgtgta 
GFPnsi              5’- ccaatgcatgctgccggcgctgctgccgtgagtaaaggagaagaactt 
GFPxho             5’- gcggatccttactcgagtagttcatccatgccatgtgtaa 
HsDse   5’- tatgattaaccatggttggttcgcta 
HsDas     5’- atcattcttctcatatacttcaaatttgt 
LACnsi     5’- gggatgcatattacggattcactgg 
LACxho  5’- gggctcgagttatttttgacaccagac 
TgDse             5’- ggtcgtcgcgatgacccccaagaggggc 
TgDas   5’- cggtagagggtagacctaagcaggcacgc 
YFPxba              5’- gctctagacagctcgtccatgccgaga 
YFPnsi               5’- ccaatgcatgctgccggcgctgctgccgtgagccaagggcgaggagc   
YFPxho              5’- gcggatccttactcgagcagctcgtccatgccgaga 
 
 
Cultures were three-fold diluted every day with non-infected RBCs in drug containing 
medium from day 3 onwards. After parasitaemia declined below detection level cultures were 
transferred to 96 well plates and maintained under 5% CO2, 2% O2. In about six weeks the 
parasitaemia increases from undetectable level to more than 1.0 % in ~2% of the wells. For 
examining transient expression of the reporter gene the cultures were harvested 0, 4, 8, 24 
and 40 hr after transfection. 
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Purification of  B. bovis  genomic DNA and transfection plasmids  
B. bovis infected red blood cells (2×109  parasites) were washed two times in PBS and 
lysed in hypotonic buffer (PBS diluted with water to 70mM NaCl concentration and re-
adjusted to 150 mM NaCl) for 2 min. The lysate was washed four times and resuspended in 
lysis buffer ((10 mM Tris, 1mM EDTA, 50 mM sodium chloride, 0.1% SDS) pH 7,4) with 10 
µg/ml Proteinase K and incubated at 37°C for 2 h. Genomic DNA was extracted by phenol-
chloroform (1:1) mixture and precipitated with 0.5 M NaCl and 2 volume of cold ethanol and 
resuspended in TE pH 7.4 (1mM TrisCl, 0,1 mM EDTA pH 7.4).  
Transfection plasmids were transformed into competent E. coli XL1-blue MRF cells 
and selected on ampicillin (100 µg/ml) medium. The clones containing the plasmids were 
grown to large volumes  till OD600 was equal to 0.7. Plasmids were purified on a column 
according to manufacturer’s instructions using Giga prep kit (Qiagen). After column 
purification plasmids were precipitated with 0.5 M sodium chloride and 2 volume of cold 
ethanol and resuspended in TE pH 7.4 (1mM TrisCl, 0,1 mM EDTA pH 7.4).  
 
Screening for GFP and YFP fluorescence and β-galactosidase activity 
B. bovis cultures harvested at 0, 4, 8, 24 and 40 h after transfection, were assayed for 
fluorescence or β-galactosidase activity in merozoites. The transfected cells were washed 
once in PBS and 10µl merozoite suspension (5% PCV) was examined on a microscope slide 
under a cover slide. For detecting GFP and YFP standard FITC excitation emission filters 
(488/507 nm) under a light fluorescence microscope (Olympus) at X 100 magnification was 
used. At least 1000 cells per sample were screened. For β-galactosidase activity, transfected 
parasites were pelleted by centrifugation at 500 g and resuspended in lysis buffer (100 mM 
HEPES, pH 8.0, 1mM MgSO4, 1% Triton X-100, 5 mM dithiotreitol) for 1 h at 50°C. As 
positive control β-galactosidase of pUC19 was induced with IPTG and lysed by sonification. 
The lysate was centrifuged and supernatant was frozen at -20 °C. One volume of cleared 
lysate was diluted with one volume of lysis buffer (total volume 100 µl) and mixed with an 
equal volume of lysis buffer containing 2 mM chlorophenol red-β-D-galactopyranoside 
(CPRG) (Boehringer-Mannheim) as substrate. Reactions were performed in 96-well plates 
for 30 min at 37°C . Absorbtion at 570 nm was measured in a microplate reader (50, 138). 
 
Selection of resistant lines and detection of DNA integration by southern blot 
Pyrimethamine and WR99210 were dissolved at 10 mg/ml in DMSO. To determine 
IC50 values for both drugs, wildtype B. bovis culture was incubated in M199 culture medium 
in 24-microwell plates under standard culture conditions in presence of different 
concentrations of pyrimethamine and WR99210 for a period of 96 h. Serial dilutions of the 
drug were made in culture medium and the concentration of drug tested ranged from 0 nM to 
5 nM WR99210 and 0 to 2.5 µM pyrimethamine. Cultures were diluted 1:3 every day with 
5% fresh RBCs. Giemsa stained smears were made every 24 h. IC50 values were calculated at 
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96 h after counting 3000 RBCs. Drug-resistant cultures were tested by the same method at 
drug concentrations of 5 nM, 10 nM and 20 nM WR99210 or 2.5 µM, 5 µM and 10 µM 
pyrimethamine. All drug-resistant cultures were growing at wild-type rate in 10 nM 
WR99210 and 5 µM pyrimethamine whereas cultures eventually died at 20 nM WR99210 
and 10 µM pyrimethamine prohibiting a more precise determination of IC50. 
Genomic DNA obtained from pyrimethamine or WR99210 resistant lines was 
examined by PCR amplification (PCR conditions as used above) using specific 
oligonucleotides (Table II).  
The presence of HsD or TgD plasmid in resistant culture lines was tested by  southern 
blotting. Ten µg of genomic DNA of the resistant lines  were single or double-digested with 
KpnI, EcoRI or HindIII, separated by electrophoresis on a 1% agarose gel, and transferred to 
positively-charged nylon membrane (Hybond N+, Amersham-Pharmacia Biotech). Plasmid 
containing the T. gondii dhfr-tsm2m3 or human dhfr was used as positive control. A human 
dhfr-specific 500 bp fragment and a T. gondii dhfr-tsm2m3 -specific 1800bp fragment were 
obtained by PCR using primer combinations HsDse and HsDas or TgDse and TgDas 
respectively. PCR reactions were performed under the same conditions as described above. 
Both fragments were purified from agarose gel and labelled with 50 µCi 32P-dATP (3000 
Cimmol-1), using a Random Primer labelling kit (Roche). The membranes were incubated 
overnight with the labelled probe in 6×SSC at 65°C, and washed at a final stringency in 1× 
SSC at 65°C.  
 
RESULTS 
 
Selection of transfected parasite cultures resistant to pyrimethamine and WR99210 
Transfection plasmids carrying the human dhfr gene (insensitive to WR99210 
and pyrimethamine) or the T. gondii dhfr-tsm2m3 gene (a mutant that is insensitive to 
pyrimethamine) as a selectable marker, in addition to a YFP reporter gene, were 
constructed as described in the material and methods section and schematically 
outlined in Fig. 1. The flanking regions of the B. bovis dhfr-ts gene (chapter 7) were 
used as control regions for initiation of transcription of the selectable marker genes 
and transcription termination of the reporter genes respectively. The complete 
intergenic region containing the putative termination signal of a B. bovis ABC 
transporter gene and the putative promoter region of the highly expressed 12D3 
antigen (55) was used as a control region separating the selectable marker and reporter 
genes. 
Electroporation has been a successful method to introduce plasmid DNA into 
Plasmodium (130, 202) and T. gondii (198, 209) parasites. B. bovis parasites were 
demonstrated to remain viable at voltages as high as 2.5 kV (chapter 2). A number of 
variations in the experimental transfection conditions were examined in combination 
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with the different plasmid constructs as indicated in Table Ib. Variables tested 
included the amount of plasmid DNA used (20 µg, 50 µg, 100 µg), the state of the 
plasmid (linear or circular) and the state of the culture to be transfected (infected 
erythrocytes or free merozoites liberated prior to transfection by electroshock). Upon 
electroporation parasites were transferred to 24-well plates and cultivated for three 
days at 5% CO2 in air followed by a transfer to 5% CO2 and 2% O2 in 96-well plates 
after nine days. Cultures were diluted on a daily basis. Drug concentrations were 
increased at day three as indicated in Fig. 2 which shows a growth curve typical for 
the small percentage of electroporated cultures surviving on the long term. 
 
Fig. 1. A schematic representation  of  plasmid contructs  used for transfection of B. bovis.  The two 
selectable markers genes (Human dhfr and T. gondii dhfr-tsm2m3) are placed under promotor and 
terminal regions of B. bovis DHFR-TS gene. The intergenic region of an ABC transporter gene and 
the 12D3 antigen gene of B. bovis was incorporated as a control region in plasmids containing 
reporter genes (YFP, GFP and β-galactosidase). 
 
After an initial phase of growth parasitaemia always decreased below detection level 
after 9 to 17 days. About 2% of the cultures displayed an increase in parasitaemia after 
17 to 24 days of continued in vitro culture. Of these a number were selected and 
propagated for another 4 to 6 weeks under daily dilution at drug concentrations 
increased from 5 to 10 µM pyrimethamine or 5 to 20 nM WR99210. A further 
increase of drug concentrations always resulted in rapid decrease in parasitaemia. 
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Cultures transfected with the constructs containing a YFP reporter gene were 
examined for fluorescence at 488/507 nm under the immunofluorescence microscope. 
No increase above background fluorescence as compared to control cultures was 
observed in any of the selected lines. Total DNA was isolated of parasite lines with 
decreased drug sensitivity that were electroporated with plasmids without a reporter 
gene. Southern blots of the DNA were hybridized with probes derived from the human 
DHFR gene or the T. gondii DHFR-TS gene and compared to positive control lanes 
containing the corresponding plasmids used for transfection. No signal for the human 
dhfr gene or the T. gondii dhfr-tsm2m3 gene was detected in the DNA samples of any 
of the transfected and drug-resistant cultures indicating that no stable integration of 
the plasmid DNA in to the genome has taken place nor that detectable amounts of 
extrachromosomal plasmid are present. 
Fig. 2. Typical parasite growth curve of parasites transfected with one of the different plasmids (Table 
II). Immediately after electroporation parasites were cultured in medium containing 2.5 nM WR99210  
or 1.25 µM pyrimethamine. After three days drug concentrations were increased to 5 nM WR99210 
and 2.5 µM pyrimethamine. After parasitaemia decreases till undetectable levels the culture 
conditions are changed to 96-well plates and low oxygen level (2% O2). In the case shown here, an 
increase in parasitaemia occurred after three weeks (variation from 3 to six weeks for other culture 
lines) upon which drug concentrations were further increased. 
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Screening for transient expression of reporter genes shortly after electroporation 
 In view of the negative results obtained after selection for parasites displaying 
decreased inhibitor sensitivity a new construct was made carrying β-galactosidase 
(Table II) as a reporter gene. Colorimetric enzyme assays for β-galactosidase activity 
in extracts from transfected parasites have been reported as a very sensitive method 
for detecting low levels of expression. In addition, the constructs carrying a YFP 
reporter gene were used for examination of transient expression. Upon electroporation 
parasites were transferred to 24-well plates and cultivated for 0 to 40 h at 5% CO2 in 
air. Wells were harvested at 0, 4, 8 ,24 and 48 h. Microscopic slides were made and 
examined under the fluorescence microscope for YFP expression. Extracts were made 
and assayed for β-galactosidase activity. Negative and positive controls were 
examined as indicated in Material and methods. None of the samples tested gave a 
signal that indicated the occurrence of transient transfection at any of the timepoints 
examined. 
 
DISCUSSION 
 
 In this chapter we describe the construction of plasmid vectors designed for 
stable or transient transfection of  B. bovis parasites. The combinations of two dhfr-
based selectable marker genes and two receptor genes have not yet resulted in the 
generation of such transfectants. Initially our attempts were directed at the 
establishment of stable transfection by making use of WR99210 and/or 
pyrimethamine resistant dhfr selectable marker genes. It was a slightly opportunistic 
approach, aiming to establish most rapidly the type of transfection system that is most 
needed. The success of using electroporation in combination with these markers in 
obtaining stable transfection in T. gondii and Plasmodium inspired this approach. 
Initial tests on experimental conditions for B. bovis electroporation were 
promising, especially when compared with the problems still associated with 
Plasmodium transfection. It appeared to be possible to obtain free merozoites, by 
application of a high-voltage pulse prior to addition of the plasmid constructs, that 
were still highly viable and capable of  efficient reinvasion of freshly added red blood 
cells (see Chapter 2 for a discussion on invasion efficiency of merozoites liberated by 
this method). In this way plasmids only have to pass the merozoite membrane and the 
nuclear envelope and avoid the long journey that has to be taken by crossing also the 
erythrocyte membrane and the parasitophorous vacuole membrane when parasitized 
erythrocytes are electroporated directly. Considering the applicability of the chosen 
Genetic transformation of Babesia bovis 
 
 110
selectable markers it appeared that the IC50 value for WR99210 of B. bovis cultures 
was very low and in the same range as observed for T. gondii and Plasmodium, but for 
pyrimethamine the selection window is certainly narrower as B. bovis is relatively 
resistant to this drug (IC50 is 1.25 µM). Despite these positive indications, only 
parasite lines with moderately increased resistance to either WR99210 or 
pyrimethamine, but without any evidence for having taken up plasmid DNA, were 
obtained. After doing more extensive controls in the absence of any transfection 
plasmids it appeared that such resistance was easily induced. This has been analysed 
in more detail in chapter 7. After this, the initial aim was lowered and an attempt was 
done to achieve transient expression using a sensitive reporter gene in the form of  E. 
coli β-galactosidase, sofar without success. 
Which factors could currently be involved in prohibiting the establishment of 
transfection for B. bovis? 
Regarding the transient expression system that was used it cannot be excluded 
that β-galactosidase is expressed but not in an enzymatically active form, despite 
positive results with this system in other apicomplexans (87, 138). Other reporters could 
be tested in future like luciferase or chloramphenicol transferase. Most likely, there 
has been no or only very low expression of the reporters used. The chosen promoter 
(from the 12D3 antigen gene that is highly expressed in B. bovis merozoites) may not 
have been functional in the context in which it was cloned. Moreover, the constructs 
that were used for examining transient expression were complex in that they, in 
addition to the reporter gene contained a DHFR gene and 5’ and 3’ flanking regions of 
the B. bovis dhfr-ts gene that were later shown to contain (parts of) other genes (see 
Chapter 7). As a consequence, other gene promoters are likely to be present in the 
constructs. They may direct transcription of the genes (of unknown function) behind 
them, which are also cloned in the construct but in a truncated form, with 
unpredictable consequences. Therefore it might be necessary to employ simple 
constructs only expressing a reporter gene, possibly under the control of randomly 
inserted B. bovis DNA as a kind of promoter trap in order to isolate functional 
promoter sequences. 
Obviously, several of the arguments raised above can also be involved in the 
inability to obtain stable transfectants. The arrangement of genes within the construct 
deserves further attention. It has been reported that putting genes in a head to head 
orientation gives better results as compared to a head to tail orientation that was also 
employed here (48, 234). Aiming at stable transfection is usually synonymous to 
achieving integration of (part of) the plasmid constructs into the genome, although 
maintenance of an extrachromosomal plasmid under selective drug pressure is still an 
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option. Intergration can be accomplished by homologous or heterologous 
recombination. For homologous intergration the size of the target sequence available 
for recombination certainly plays a role(47, 64, 234, 239). We, therefore, made a choice for 
incorporation of long flanking sequences of the B. bovis dhfr-ts gene but the 
subsequent discovery of genes within these sequences (see above) may corrupt this 
choice by having a profound effect on the viability of transfectants that have 
recombinated in these regions. 
Transfection efficiency is certainly an important issue in establishing stable or 
transient transfection. Both are reported to be much lower in Plasmodium as compared 
to T. gondii but the reason for this remains speculative. The high AT content of P. 
falciparum has been mentioned as a possible factor (143, 222, 231) in this but on the other 
hand transfection efficiency of P. berghei is also much lower as reported for T. gondii 
despite its more normal GC content (52, 64). For the moment there seems to be no 
obvious rational approach in selecting methods for optimal transformation efficiency  
of  B. bovis, other than trial and error, until the moment that an initial transformation 
level is obtained from which optimization can take a start. 
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Fig. 3. Immunofluorescence reactivity of antiserum against B. bovis AMA-1 incubated with 
methanol-fixed B. bovis infected bovine erythrocytes. Slides were incubated with immune serum 
against peptide 1 (B), peptide 2 (D) and peptide 3 (F) and the corresponding preimmune sera (A, C, 
E). An enlargement of duplicated B. bovis merozoites showing immunofluorescence is shown (G).  
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"Voor iedere ziekte is er een genezing" "God liet zowel ziekte als medicijn ontstaan en 
heeft voor iedere ziekte een medicijn gegeven, gebruik het medicijn zolang dat 
medicijn niet haraam (verboden) is."  
(Abu Dawud) 
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ABSTRACT 
 
The genomic locus and cDNA encoding Babesia bovis dihydrofolate reductase-
thymidylate synthase (DHFR-TS) were cloned and sequenced. A single dhfr-ts gene, 
composed of four exons, encodes a 511 aa protein that is most closely related to 
Plasmodium falciparum DHFR-TS. The genomic locus is characterized by the 
presence of four other genes of which at least three are expressed during the 
erythrocytic cycle. Three of the genes were highly conserved in closely related 
Theileria species and for two of the genes and dhfr-ts, gene synteny was observed 
between B. bovis and T. parva. B. bovis in vitro cultures displaying ~10 to 20-fold 
decreased sensitivity towards the antimalarial drugs WR99210 and pyrimethamine 
were selected repeatedly after prolonged growth in presence of drugs. Five cultures 
examined in detail were shown to encode a DHFR-TS carrying amino acid 
substitution S125F. 3D-modelling, using the P. falciparum DHFR structure as a 
template, suggests that substitution S125F protrudes into the binding site of NADPH. 
The S125F mutant could be isolated by growth under pyrimethamine or WR99210 
pressure conferring cross-resistance to both drugs. Although opposing selection for 
pyrimethamine or WR99210 resistance was reported recently using P. falciparum or 
P. vivax strains carrying wildtype dhfr, the results obtained here are reminiscent of a 
quadruple mutant of  P. falciparum dhfr displaying strong resistance to pyrimetha-
mine and 10-fold enhanced resistance against WR99210. Wildtype B. bovis DHFR 
carries three mutations present in this mutant possibly explaining the low sensitivity to 
pyrimethamine and the ease by which moderately WR99210 resistant mutants could 
be isolated. 
  
INTRODUCTION 
 
In apicomplexans dihydrofolate reductase (DHFR, EC 1.5.1.3) and thymidylate 
synthase (TS, EC 2.1.1.45) are part of a single protein (DHFR-TS) that is subject of 
research in important pathogens like Plasmodium falciparum (28) and Toxoplasma 
gondii (184) for several reasons. At first, dhfr is the target of inhibition for widely 
applicated antimalarial drugs like pyrimethamine, a substrate analogue of 
dihydrofolate. Inhibition of dhfr depletes the reduced folate pool thus blocking de 
novo thymidylate biosynthesis by TS and eventually preventing DNA replication (232). 
Secondly, dhfr has been used as selectable marker for transfection of apicomplexan 
parasites (51, 65, 234, 240). The recent development of systems for stable transformation 
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offers the prospect of genetic approaches to understand the biology of apicomplexan 
parasites. Genetic transformation of Babesia bovis, a tick-transmitted intraerythrocytic 
apicomplexan parasite of cattle causing high mortality rates in many (sub-) tropical 
countries (24, 54, 98), would expand opportunities for research on this important pathogen 
of cattle. 
A range of plasmid vectors designed for accomplishing stable transfection of T. 
gondii or Plasmodium species carry a human dhfr or altered T. gondii dhfr gene 
conferring resistance against the antifolates pyrimethamine and WR99210. The in 
vitro isolation of strains with decreased sensitivity for pyrimethamine, due to 
mutations in the dhfr gene, has been frequently described (105, 167). In contrast, dhfr 
mutants with decreased sensitivity to WR99210 were only obtained after deliberate 
mutagenic procedures followed by selection in a heterologous yeast expression system 
(73). 
We determined the sequence of the B. bovis dhfr-ts gene as a step towards the 
establishment of a transfection system based on dhfr as a selectable marker. Pilot 
experiments, aiming at the establishment of experimental conditions suitable for 
transfecting B. bovis, resulted in the selection of parasites with decreased sensitivity 
for pyrimethamine and WR99210. Such resistant parasite lines were further analysed, 
resulting in the detection of an amino acid substitution in the DHFR-TS enzyme. 
Resistance against antifolates is an important issue regarding anti-malarial 
chemotherapy. Understanding of the molecular interactions of antifolate drugs with 
wild type and mutant DHFR has come from studies on  P. falciparum dhfr-ts as well 
as from T. gondii dhfr-ts (38, 92, 119, 177, 180, 237). The recent description of the crystal-
structure of P. falciparum DHFR in a ternary complex with NADPH and WR99210 
(243) provided and excellent template for model building and was used here as a basis 
for comparing the dhfr sequence of B. bovis with those of other apicomplexans and for 
studying the potential effects of the observed amino acid substitution. 
 
MATERIALS AND METHODS 
 
B. bovis cultures 
     B. bovis cultures (Israel strain, clonal line C 61411 (195) were maintained in vitro by serial 
passage in bovine red blood cells (RBCs) according the previously described MASP method 
with slight modifications (121). Bovine red blood cells used for the culture were collected 
every two weeks. RBCs were separated from serum and washed three times with VYMS 
buffer (227) in presence of 50 µgml-1 gentamycin and stored at 4ºC. B. bovis was cultured at 
37°C in a mixture of 5% CO2 in air in 24 wells plates, 25 cm2 flasks or 80 cm2 flasks 
containing respectively 1200 µl, 15 ml or 50 ml medium composed of M199 with Hanks salt 
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supplemented with 25 mM sodium bicarbonate, 40% normal bovine serum from a selected 
donor and 50 µgml-1 gentamycin. Medium was replaced every 24 h and the culture was 
maintained at a parasitaemia between 1 and 10 %. The parasitaemia was measured by 
counting 3000 RBCs in giemsa-stained smears.  
  
DNA isolation of B. bovis  
B. bovis infected red blood cells (2.109 parasites) were washed 2 times in PBS and lysed 
in hypotonic buffer (2 min. in PBS diluted with water to a final NaCl concentration of 70 mM 
after which the buffer was re-adjusted to 150 mM NaCl). After 4 washes to remove 
haemoglobin, merozoites were resuspended in lysis buffer (10 mM Tris, 1 mM EDTA, 50 
mM NaCl, 0.1% SDS) pH 7.4 with 10 µgml-1 Proteinase K and the lysate was incubated at 
37°C for 2 h. B. bovis genomic DNA was extracted with phenol-chloroform (1:1) and 
precipitated with 0.5 M NaCl and 2 volumes of cold ethanol (187) and resuspended in TE pH 
7.4 (10 mM Tris, 0.1 mM EDTA pH 7.4).  
 
mRNA isolation of B. bovis and Northern Blot 
2.109 merozoites were obtained as described above. After washing twice with PBS, total 
RNA of B. bovis merozoites was extracted by using RNAzolTM according the manufacturer’s 
instructions (Campro). mRNA was isolated using the Poly(A)-PureTM kit according the 
manufacturer’s instructions (Ambion).  
7 µg of mRNA from B. bovis merozoites was separated by electrophoresis on a 1% 
agarose gel, containing 2.2 M formaldehyde and blotted to nitrocellulose membrane (Nytran 
N, Schleicher and Schuell) by capillary transfer following standard techniques (187). For size 
calibration mRNA was run in parallel with a RNA ladder (New England Biolabs). The 
mRNA was fixed on the membrane by baking it for 2 h at 80°C. Probes were labelled and 
hybridised according standard procedures (187). Filters were washed under moderate 
stringency conditions (3 times 15 min in 2×SSPE /0.1% SDS at 65 °C). 
 
Construction of B. bovis genomic and cDNA library 
A cDNA library was constructed from 5 µg B. bovis mRNA using the λZAP-cDNA 
Synthesis Kit (Stratagene) according to the manufacturer’s instructions. cDNA fragments of 
0.5 to 4 kb were collected by gel filtration on a sepharose CL-4B column and ligated into the 
EcoRI/XhoI site of λ uniZAP-XR Express vector. Giga pack III Gold was used for packaging 
into phage particles followed by transformation of Escherichia coli XL-1 Blue MRF’cells. 
1.2 × 106 plaques were obtained of which an amplified library was made. 
For constructing the genomic library, 300 µg of B. bovis DNA was digested with 150 
units EcoRI and another 300 µg of B. bovis DNA was digested with 250 units EcoRI for 1 h 
at 37°C. The digested DNA was pooled and size fractionated on a Sepharose CL-4B column. 
Fragments of 0.5 kb to 8 kb were ligated into the EcoRI site of λ-ZAPII-Express, packaged 
using Gigapack III Gold Packaging extract and transformed in E. coli XL1-Blue 
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MRF’competent cells. 2.5 × 106 plaques were obtained of which an amplified library was 
made.  
 
Cloning of dhfr-ts gene locus and encoded cDNA 
Genomic and cDNA libraries were screened with probes F4 and F3 (Fig. 1A). 
Oligonucleotides P1 (5’–ta[tc]ggitt[tc]ca[ag]tgg[ac]gica[tc]t-3’) and P2 (5’-[ag]tg[ag]caigg 
[tc]a[ag]igccat-3’) derived from conserved ts domain of P. falciparum, were used to amplify 
probe F4 by PCR in a 50 µl volume containing 0.2 mM dNTP, 20 pmolµl-1 of each primer, 
100 ng B. bovis  genomic DNA and 0.5 U Taq DNA polymerase in standard buffer 
(Promega). Amplification was performed for 30 cycles (92°C for 30 s, 55°C for 30 s and 
72°C for 30 s) preceded by initial denaturation for 3 min at 95°C and a final elongation at 
72°C for 10 min. Probe F3 is the 5’-end EcoRI fragment of cDNA clone C1.2 (one EcoRI site 
derived from the vector). Both fragments were purified from agarose gel and labelled with 50 
µCi 32P-dATP (3000 Cimmol-1), using a Random Primer labelling kit (Roche). In total 2.106 
cDNA and 2.105 genomic DNA library plaques were screened by standard procedures (187) for 
cloning the genomic locus and dhfr-ts cDNAs. Subsequently, 3.105 plaques of the cDNA 
library were screened by PCR probes F1 (primers 1se, 5’-ggtagtccactaggttactga-3’ and 1as, 
5’-cccactgcttaagtggcaat-3’), F2 (primers 4se, 5’-cttgacatggaggtactgcg-3’ and 4se, 5’-
gatgatcacgtttatacggttt-3’), F5 (primers 2as, 5’-ggcccgtgttaaatcgctaa-3’ and 2as, 5’-
gattcaagcttccgttcttcaaccctgaaacgttacca-3’) and F6 (primers 3 se, 5’- 
gggaatgccgccaagatgttggatcgt-3’ and 3as, 5’-caagcgttcatagcctccaa-3’). After 2 cycles of 
plaque purification all clones were in vivo excised for isolation of the phagemids inserts as 
described in the manufacturer’s instructions (Stratagene) and sequenced on both strands, 
using automated cycle sequencing with the dye terminator method (ABI PRISM dye 
terminator kit, Pharmacia).  
 
Analysis of sequence data 
DNA sequences or conceptual translations of orf-1 and the cDNAs 1 to 3 were submitted 
for BLAST analysis (www.ncbi.nlm.nih.gov/BLAST/) using blastx and blastp for screening 
the nr protein database and tblastn for screening the EST database (dbEST). BLOSUM 45 
was used as scoring matrix. The Pfam motif database (www.sanger.ac.uk/Software/Pfam/) 
was screened with the conceptual translations of the genes. Preliminary sequence data of the 
Theileria parva genome sequencing project (available from The Institute for Genomic 
Research at www.tigr.org) and the T. annulata genome sequencing project (produced by the 
T. annulata sequencing group at the Sanger Institute and available from 
www.sanger.ac.uk/Projects/T_annulata/blast_server) were screened by tblastx. SignalP 2.0 
was accessed at www.cbs.dtu.dk/services/SignalP using conceptual translations and 
TMHMM v.2.0 was accessed at  www.cbs.dtu.dk/services/TMHMM. Sequence alignments 
of DHFR and TS domains were made using CLUSTALX (216) using the default alignment 
parameters. The DHFR alignment was adjusted manually for optimal alignment of conserved 
secondary structure elements (see Fig. 2). Unrooted phenograms were constructed by the 
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Neighbor Joining algorithm excluding gap regions from the analysis. Bootstrap analyses were 
performed using 1000 replicates. Phenograms were drawn using Njplot (172) 
  
Selection of B. bovis drug resistant culture lines 
Approximately 2.109 B. bovis infected red blood cells (50% packed cell volume, 7% to 
10% parasitaemia) were electroporated in a Gene Pulser II system (Biorad) in absence of any 
DNA construct in a final volume of 500 µl in cytomix (120mM KCl, 0.15 mM CaCl2, 2 mM 
EGTA, 5 mM MgCl2, 10 mM K2HPO4/ KH2PO4 pH 7.6, 25mM Hepes pH 7.6). Cells were 
incubated on ice for 5 min. before pulsing at high voltage (1 kV, 200Ω, 25 µF). 120 µl of 
electroporated cells were immediately added to 1020 µl pre-warmed M199 culture media 
containing 60 µl bovine red blood cells. During the first three days the culture was kept in 24 
well plates at 1.25 µM pyrimethamine or 2.5 nM WR99210 in 5% CO2 in air. After three 
days the concentration of pyrimethamine was increased to 5.0-10.0 µM and of WR99210 to 
5.0-20 nM. Cultures were three-fold diluted every day with non-infected RBCs in drug 
containing medium from day 3 onwards. After parasitaemia declined below detection level 
cultures were transferred to 96 well plates and maintained under 5% CO2 and 2% O2. In about 
six weeks the parasitaemia increases from undetectable level to more than 1.0 % in ~2% of 
the wells.  
 
Drug sensitivity assay 
Pyrimethamine and WR99201 (provided by Jacobus Pharmaceuticals, Princeton, NJ) 
were made as a 10 mgml-1  solution in DMSO. Wild type B. bovis culture was incubated in 
M199 culture medium in 24-microwell plates under standard culture conditions in presence 
of different concentrations of pyrimethamine and WR99210 for a period of 96 h. Serial 
dilutions of the drug were made in culture medium and the concentrations of drug tested 
ranged from 0 nM to 5 nM WR99210 and 0 to 2.5 µM pyrimethamine. Cultures were diluted 
three-fold every 24 h with 5% fresh RBCs. Giemsa stained smears were made every 24 h for 
a period of three days. IC50 values were calculated at 96 h after counting 3000 RBCs. Drug-
resistant cultures were tested by the same method at drug concentrations of 5 nM, 10 nM and 
20 nM WR99210 or 2.5 µM, 5 µM and 10 µM pyrimethamine. All drug-resistant cultures 
were growing at wild-type rate in 10 nM WR99210 and 5 µM pyrimethamine whereas 
cultures eventually died at 20 nM WR99210 and 10 µM pyrimethamine prohibiting a more 
precise determination of IC50. 
 
Homology modelling of B. bovis DHFR 
 DHFR amino acid sequences and 3D-structures of P. falciparum (PDB Accession number 
1J3KA) (243), E. coli (1RX2) (189), Gallus gallus (1DR1) (229), M. tuberculosis (1DG7) (124)and 
Pneumocystis carinii (2CD2) (43) were downloaded from the Brookhaven protein database 
(PDB) and used for constructing the alignment of Fig.2. B. bovis DHFR was modelled on the 
ternary complex of P. falciparum DHFR with NADPH and WR99210 (1J3KA) using Swiss-
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Model (83) (http://swissmodel.expasy.org) on the basis of the alignment of Fig.2. The 
DeepView program (83) was used for refinement and examination of the model. Energy was 
minimized by 25 steps of steepest descent and 15 steps of conjugate gradient using 
GROMOS from within the Deep View package thus finding a balance between minimal 
energy (-6335 kJ/mol) and limited structural drift. The Cα-backbone atoms of residues 
making direct contacts with NADPH or WR99210 of P. falciparum 1J3KA (indicated in Fig. 
2) were superpositioned with corresponding residues in the modelled B. bovis structure. The 
RMS deviation of the all backbone atoms of the superpositioned residues was 0.14 Å. 
Mutation S125F was introduced and inspected for conformational problems using the Deep 
View package. Only one rotamer conformation (rotamer 6) of F125 did not result in 
incompatible interactions with other residues. Very limited energy minimization (-5738 
kJ/mol) was needed (3 steps of conjugate gradient). In brief, modelling on the M. tuberculosis 
template was done as described above using 25 steps of steepest descent and 15 steps of 
conjugate gradient for energy minimization (-4673 kJ/mol). Superpositioning of residues in 
contact with NADP and Br-WR99210 (83) resulted in a RMS deviation of 0.76 Å of  backbone 
atoms of the superpositioned residues. Following mutagenesis 20 steps of steepest descent 
were used for energy minimization (-4329 kJ/mol). 
 
RESULTS AND DISCUSSION 
 
Cloning and sequencing of the B. bovis dhfr-ts genomic locus 
Although functional characteristics of both parts of the bifunctional 
apicomplexan DHFR-TS enzyme are well conserved across species boundaries, only 
TS is highly conserved at the primary amino acid sequence level. PCR primers P1 and 
P2, designed from a conserved region of the TS domain, amplified a 150 bp fragment 
(probe F4, Fig. 1A) that was used to screen a genomic DNA library of B. bovis. 
Hybridising plaques were purified and clones g1.2 and g2.4, containing inserts of 
1660 bp and 3430 bp, were sequenced completely on both strands. Conceptual 
translation and comparison to other apicomplexan dhfr-ts sequences indicated that 
most of the ts domain and 2800 bp of downstream sequence were obtained. Extended 
library screening with a cDNA derived probe (F3, see below), encoding part of the 
dhfr region, resulted in isolation of clones g2, g6 and g7 which, by sequence similarity 
with other dhfr-ts sequences, encode the putative N-terminus of the DHFR domain 
and 2830 bp of upstream sequence (see Fig. 1A for a map). Southern blot results 
indicated that dhfr-ts is encoded by a single copy gene (data not shown). 
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Cloning and sequencing of cDNAs derived from the dhfr-ts genomic locus 
The genomic sequence encoded several regions homologous to dhfr-ts 
interrupted by putative introns containing stopcodons in all reading frames. To obtain 
the coding region of dhfr-ts a B. bovis cDNA library was screened with probe F4. 
Several cDNA clones were obtained of which clones C1.2 and C1.3 were sequenced. 
C1.3 contained 3 deletions (40 bp, 134 bp and 40 bp) in comparison with the genomic 
sequence that all conformed to the GT/AG rule for splice donor and acceptor sites of 
introns. The 3 introns are located at identical positions as introns I, II and VIII in the 
T. gondii dhfr-ts gene (184). 
 Conceptual translation of the cDNA revealed a 1431 bp open reading frame 
starting at the first nucleotide followed by a 3’-untranslated region of 592 bp ending 
with a poly A-tail. The first methionine codon in the 1431 bp orf was located at 
position 678 in a region encoding the TS domain indicating that the cDNA was 
truncated at the 5’-end lacking the start codon. Despite several efforts no longer 
cDNAs were isolated. A comparison with the genomic sequence suggested the 
presence of a start codon 102 bp upstream of position 1 of cDNA clone C1.3 resulting 
in an open reading frame encoding 511 amino acids. The proximity of another 
expressed gene only 121 bp upstream of this putative startcodon (see below) excludes 
with near certainty the possibility that any other ATG codon can be the actual 
initiation codon of dhfr-ts. A northern blot using purified mRNA of in vitro cultured 
B. bovis showed a single band of ~2500 nucleotides (Fig. 1B). Without the introns and 
assuming a polyA-tail of ~150 nucleotides this size just fits in between the upstream 
and downstream located genes of dhfr-ts that have been mapped below. 
 In addition to the dhfr-ts coding sequence, the 7.4 kb genomic locus contains 
several long open reading frames, none of which is characterized by a BLAST hit of 
high probability within the NCBI nr protein database (see below). Four probes (F1, 
F2, F5, F6) were used to screen for cDNA clones mapping to the flanking regions of 
the dhfr-ts gene, resulting in the cloning and sequencing of 3 cDNAs indicated in 
Fig.1A. Table 1 gives an overview of the location of cDNAs and putative start and 
stop codons on the genomic locus. All cDNAs encoded a putative stop codon and 
terminated in a poly-A tail. cDNA-2 appears to be encoded by a gene without introns 
and a putative startcodon is present at position 20 of the cDNA. The 129 bp genomic 
region present between the poly-adenylation site of dhfr-ts and the start of cDNA-2 
does not appear to contain additional exons indicating that a cDNA encoding the full-
length protein has been obtained. Open reading frames encoded by cDNA-1 and 
cDNA-3 initiate at their very 5’-end and alignment with the genomic sequence (not 
shown) indicates the presence of putative startcodons at respectively 20 and 181 
nucleotides upstream of their 5’-end. Both genes contain 2 introns but the presence of 
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more introns in the cDNA-3 clone cannot be excluded as the cDNA extends 1326 
nucleotides beyond the genomic sequence (Fig.1A). 
 Comparison of the 5’-splice donor sequences of the seven introns of dhfr-ts, 
cDNA-1 and cDNA-3 with the 20 B. bovis intron sequences that have been obtained 
to date (accession numbers AJ289247, U70130, U34076, AAC27389, AF027149, 
AAC2788, AF331455) indicate that B. bovis 5’-splice sites have an extended 
consensus in comparison to universal GT consensus at positions 1 and 2. All seven 
introns reported here have a consensus GTNNGT, whereas 23 out of all 27 introns 
conform to this consensus. Such a feature is potentially useful for a more reliable 
prediction of B. bovis 5’-splice donor sites in genomic sequence data. The 3’-splice 
acceptor sites of the B. bovis introns all have the dinucleotide motif AG at the last two 
nucleotides of the intron but the preceding pyrimidine-rich tract seen in most 
eukaryotic 3’-splice sites is rarely present in B. bovis introns. 
 The above findings demonstrate a dense head-to-tail packing of genes in the 
dhfr-ts genomic locus, all of which are expressed during the asexual erythrocytic cycle 
of the parasite. Transcription start sites have not been mapped but the three intergenic 
regions have sizes of respectively 121 bp, 148 bp and 108 bp, measuring from the 
poly-adenylation site to the ATG startcodon of the adjoining downstream gene. This 
includes the 5’-untranslated regions containing the ribosome binding sites and 
therefore the basal promoter regions of the dhfr-ts, cDNA-2 and cDNA-3 genes will 
have a maximum size of about ~90 bp, ~120 bp and ~80 bp respectively. Using probe 
F1, no cDNA clones (out of 2.106 plaques) were obtained for the 1383 bp orf-1 (Fig. 
1A) arranged in a head-to-head orientation with cDNA-1 at an intergenic distance of 
486 bp. If a gene at all (see below), orf-1 may not be expressed, or only at a very low 
level, in the erythrocytic stage of which the cDNA library was made. 
 Three genomic loci of B. bovis have been examined in some detail to date, all 
encoding surface antigens and additional genes of unknown function (74, 210, 211). The 
11 intergenic regions of the msa-1 locus (4 genes), the msa-2 locus (6 genes) and the 
rap-1 locus (4 genes) have an average size of 926 bp and only two are smaller than 
650 bp (322 bp and 324 bp). The intergenic regions of the dhfr-ts locus have an 
average AT-content of 61.3% which is comparable to the average AT-content of the 
seven introns (62.9%) and not significantly higher than the average AT-content of the 
coding regions (55.6%). The latter is similar to the 54.8% AT-content which we 
observed for 44,331 bp of coding region derived from 30 B. bovis coding regions 
available from NCBI genbank. 
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Fig. 1. Genomic and transcriptional organization of the dhfr-ts locus. (A) Restriction map and 
organization of the dhfr-ts gene. Positions of genomic (lines) and cDNA (arrows) clones used for 
sequencing are indicated. Probes used for library screening are also indicated (F1 to F6). E=EcoRI, 
H=HindIII, X=XhoI. (B) Northern blot of 7 µg B .bovis mRNA isolated, run on 1% gel and hybridized 
with TS probe F4 as described in materials and methods.  
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Comparison of B. bovis DHFR-TS with other apicomplexan DHFR-TS proteins 
B. bovis DHFR-TS contains a moderately conserved 5’end DHFR domain (190 
aa), a non-conserved linker region (33 aa) and a highly conserved 3’end TS domain 
(288 aa). A sequence alignment of the B. bovis DHFR domain with three 
apicomplexan species (P. falciparum, T. gondii and C.  parvum), another unicellular 
eukaryote (Pneumocystis carinii), a vertebrate (Gallus gallus) and two prokaryotes 
(Mycobacterium tuberculosis, Escherichia coli) is shown in Fig.2. Only 16 amino 
acids are identical among all species. At five positions (shaded in blue) the B. bovis 
sequence deviates from a highly conserved consensus sequence as defined by the 
other seven sequences in the alignment (see next section for detailed discussion of 
several individual amino acids in the context of their potential effects on co-factor and 
substrate binding). In comparison to other DHFR sequences, T. gondii and P. 
falciparum DHFR have insertions of several stretches of amino acids. These are 
lacking from the 20% to 25% smaller B. bovis DHFR domain that is similar in size to 
vertebrate and C. parvum DHFR. A simple pair wise analysis of aa identities or 
similarities of the DHFR domain indicates that B. bovis dhfr is most closely related to 
P. falciparum dhfr although conservation between apicomplexan species (e.g. B. bovis 
and P. falciparum: 28% identity, 45% similarity) or between prokaryotic species (e.g. 
E. coli and M. tuberculosis: 33% identity and 48% similarity) is hardly larger than 
between an apicomplexan and a prokaryote (e.g. B. bovis and E. coli: 25% identity, 41 
% similarity). A more accurate phylogenetic comparison, either by neighbor joining or 
maximum parsimony methods (results not shown) resulted in trees in which 
eukaryotes and prokaryotes cluster in separate branches with good bootstrap values. 
Also apicomplexans cluster together within the eukaryote branch but a further 
resolution of the apicomplexan branch is not supported by  strong bootstrap values.  
 
Analysis of the other proteins encoded by the dhfr-ts genomic locus  
orf-1, cDNA-1, cDNA-2 and cDNA-3 were submitted to BLAST analysis 
(GenBank nr, dbEST and T. parva and T. annulata genomic sequence databases) and 
motif searches (Pfam, SignalP, TMHMM). High similarities were only observed with 
putative proteins of T.  parva or T. annulata and orf-1 (8.2e-20), cDNA-2 (3.7e-23) and 
cDNA-3 (2.7e-103) indicating that these genes might encode piroplasm-specific 
proteins. orf-1, dhfr-ts and cDNA-2 homologues of T. parva were all located within a 
~5 kb region in equal relative orientation and position as their counterparts on the B. 
bovis dhfr-ts genomic locus. Gene synteny was restricted to these three genes. In T. 
annulata a cDNA-2 homologue is also located directly downstream of dhfr-ts. orf-1 
was found to encode a conserved Ser/Thr protein kinase motif by screening the Pfam 
motif database (PF00069; 1e-4). cDNA-1 encodes a putative single-pass 
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transmembrane protein of which the short C-terminal domain is predicted to have a 
cytoplasmic location.  
 
Selection and analysis of drug-resistant mutants 
Pilot studies, aiming at determination of suitable conditions for the 
establishment of in vitro transfection procedures, led to the isolation of B. bovis 
culture lines with decreased sensitivity to anti-folate drugs. For B. bovis an IC50 value 
for pyrimethamine of 1.2 µM has been reported (162) and was determined here at 1.25 
µM for B. bovis clonal line C61411 whereas an IC50 of 1.0 nM for WR99210 was 
obtained (described in materials and methods, results not shown). For both drugs steep 
inhibition curves were observed with no inhibition by 0.5 µM pyrimethamine or 0.5 
nM WR99210 and culture death within 48 h by 2.5 µM pyrimethamine or 2.5 nM 
WR99210. In vitro cultures, growing at normal rate under increased concentrations of 
pyrimethamine or WR99210, were selected repeatedly (about 1 out of every 50 
cultures) in about six weeks after electroporation in absence of DNA constructs. 
Culture lines selected for continuous growth (in different experiments) in presence of 
5 µM pyrimethamine (lines R1 and R2) or 10 nM WR99210 (lines R3, R4 and R5) 
were studied in more detail. Growth, 96 h, experiments showed that all five lines grew 
well at 5 µM pyrimethamine and 10 nM WR99210, no matter by which drug they 
were initially selected. Fig. 3 displays the growth curves of a typical experiment. All 
lines were tested in parallel several times (with comparable outcome) after re-
initiation of cultures from stabilates stored under liquid nitrogen. These repeated 
experiments demonstrated that differences in multiplication factors between the drug-
resistant lines within a typical experiment, as observed in Fig. 3 after 96 h, are not 
significant. Continuous growth requires a standard 3-fold dilution every 24 h. This 
procedure contributes to a variation in growth rate comparable to the variation 
observed for triplicates of wild-type cultures grown in absence of inhibitors. 
Prolonged growth curves are required as during the first 24 h the parasitaemia of the 
wild-type culture increases as well, suggesting that pyrimidine levels are sufficient to 
complete several ounds of multiplication. After 48 h wild-type cultures consistently 
die. Resistant lines display growth at levels of 10 µM pyrimethamine or 20 nM 
WR99210 for 3 to 6 days but eventually die at these concentrations (not shown). In 
conclusion, B. bovis lines that are cross-resistant against ~10 to 20-fold increased 
levels of pyrimethamine and WR99210 can be selected under selective pressure of 
either one of the drugs. 
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Fig. 2. Amino acid sequence alignment of  B. bovis DHFR.The B. bovis (Bb) sequence was aligned 
with those of P. falciparum 3D7 (Pf, GenBank Accession No. NP_702821), T. gondii (Tg, A46005) 
and C. parvum (Cp, AAC47230). In addition the dhfr sequences and structural elements of 3D-
structures (from the PDB database) were aligned from P. falciparum (1J3KA), Pn. carinii (Pc, 2CD2), 
G. gallus (Gg, 1DR1), M. tuberculosis (Mt, 1DG7) and E. coli (Ec, 1RX2). The P. falciparum 
structure was determined from the quadruple mutant (N51I, C59R, S108N and I164L; boxed in red on 
the 3D7 sequence that is otherwise identical to 1J3KA) that gives rise to high levels of pyrimethamine 
resistance. Alpha-helices (blue letters) and beta-strands (red letters) are indicated. The S125F 
mutation in B. bovis is shaded in red whereas five positions of B. bovis that deviate from the 
consensus shared by the other seven species are shaded in blue. Absolutely conserved positions are 
shaded in black, positions at which six or seven sequences are identical are indicated in white and 
Babesia bovis Dihydrofolate Reductase Thymidylate Synthase 
 
 126
shaded gray. Positions with at least five similar amino acids are shaded in light gray (similarity 
groups: ILMV; KR; DE; ST; YF). Positions at which the P. falciparum 3D-structure revealed 
hydrogen bonds or hydrophobic interactions between NADPH (N) or WR99210 (W) and DHFR are 
indicated above the sequence (upper case characters indicate positions of contact also observed in the 
1DG7 structure of M. tuberculosis whereas lower case indicates contacts unique for P. falciparum). 
An asterix indicates the position of the two introns. 
 
Table 1.  Summary of genes localised in the up- and downstream region of dhfr-ts gene 
Gene      cDNA start               Positions           Introns   poly-A          product  
                                 ATG         stop                           
                               (bp)                          (bp)                                          (bp)             (kDa) 
orf-1          1383  <1                0 a 
cDNA-1       1889                1869 c 2614        2                    2714   19.2  
dhfr-ts          2933                2831 c 4577        3                     5171            58.3  
cDNA-2          5300                5319          6078                    6097   27.7  
cDNA-3          6486                6305 c        8695            2 b              8727 b          87.6  
 
Legend 
Genes localised in the upstream and downstream region of dhfr-ts gene. Start position of the cDNA 
and genomic clones (also terminal position) are presented here. Furthermore introns, position of poly-
A and molecular weight of the genes are indicated.  
a    no cDNA clone of orf- 1 was isolated. From genomic DNA sequence of orf 1 it was predicted 
that there are no introns in the sequenced region of orf-1. 
b   cDNA clone of cDNA-3 extended beyond the known genomic sequence. Therefore cDNA-3 
contains at least two introns but can contain more. 
c   start methionine from these genes predicted from genomic sequence. 
 
Pyrimethamine resistance in P. falciparum and other apicomplexan parasites 
have been shown to be related to point mutations in the dhfr-ts gene that affect critical 
interactions in the ternary complex (38, 42, 56, 73, 92, 105, 119, 120, 167, 177, 180, 188, 201, 237, 243). In 
the current experiment such mutations could have arisen de novo and been selected for 
during six weeks of propagation under drug pressure (an estimated multiplication 
factor of ~340 has occurred) but, alternatively, drug-resistant mutants may have been 
present in the starting culture (a clonal line being clonal for only few generations). In 
both cases extensive selection for drug-resistance must have taken place, therefore 
yielding equally informative results. The dhfr domain of the five resistant B. bovis 
lines was amplified by PCR and sequenced. In all cases a single point mutation at 
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position 3381 (a C to T transition), giving rise to substitution of serine125 by 
phenylalanine, was identified. Southern blotting detected no rearrangements (single 
and double-digestions with EcoRI, HindIII and XhoI on DNA from resistant cultures 
using probes F3, F4 and C1.2) within the dhfr-ts region whereas the intensity of the 
hybridisation signals remained equal, excluding gene amplification as a cause of drug 
resistance (not shown). Changes in steady-state DHFR-TS protein levels cannot be 
ruled out completely however. 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Inhibition curves for WR99210 and pyrimethamine of wild-type (WT) and resistant culture 
lines (R1-R5). After electroporation, cultured lines were in medium that contained either 
pyrimethamine or WR99210. Parasitaemia was determined every 24 h. Cultures were diluted 1:3 with 
5% RBCs in drug-containing medium every 24 h. Panel A: 5 µM pyrimethamine, panel B: 10 nm 
WR99210.  
 
 
Understanding the molecular interactions by which the S125F substitution 
could lead to increased resistance against pyrimethamine and WR99210 requires 3D 
structural information about the ternary complex of DHFR, NADPH and the 
inhibitors. The recently resolved crystallographic structure of P. falciparum DHFR 
(243) provided the first apicomplexan DHFR structure and, together with the 3D-
structure of M. tuberculosis DHFR (124), the only examples of a ternary complex 
including NADPH and WR99210. Comparative modelling of B. bovis DHFR using 
Swiss-Model (83) was based on the alignment of Fig. 2. Five sequences have been 
included for which a high-resolution 3D-structure of a ternary complex between 
DHFR, NADPH and folate or an antifolate inhibitor has been resolved by 
crystallography. Despite low conservation at the primary sequence level, all five 3D-
structures are highly similar (43, 124, 189, 229, 243). Conserved aa residues were associated 
with all of the conserved secondary structure elements (9 β-strands and 4 α-helices), 
thus guiding an accurate positioning of loop-regions. As could be expected, 
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considering phylogenetic relationships, modelling on the P. falciparum template gave 
a better fit (rms of superpositioned atoms) and required less adaptations than 
modelling on a M. tuberculosis template. Details of modelling on the M. tuberculosis 
template are therefore given in the material and methods section. After energy 
minimization (see material and methods), the model based on P. falciparum DHFR 
has left 4 residues located just outside tolerated areas of a Ramachandran plot. 
Subsequently, in silico substitution and inspection of mutant S125F showed that only 
one rotamer conformation of the phenylalanine side chain required very little energy 
minimization to give tolerable interactions with surrounding residues.  
 
 
 
Fig 4. 3D-model of B. bovis DHFR. (A) Wildtype DHFR. (B) Mutant S125F DHFR. Modeling using 
the P. falciparum ternary complex with NADPH and WR99210 as a template has been described in 
materials and methods. NADPH and WR99210 are displayed, together with a ribbon representation of 
the backbone of beta strand-6, alpha helix-4 and the sharp bend connecting them. Phenylalanine 125 
is shown in orange in B. The other sidechains of interest are shown in yellow for the wildtype in A 
and in white for the mutant in B. Some relevant atoms have been indicated in colour with blue for 
Nitrogen, red for Oxygen, orange for Phosphorus. Interactions described in the text between G124 and 
NADPH, Y128 with WR99210, L122 with WR99210 are indicated by dotted lines labelled with the 
distance in Å (distances are almost identical in A and B). The short distances between Phenylalanine 
125 and NADPH are indicated by red dotted lines in B. Positions where NADPH and WR99210 are 
closely opposed (and where hydrogen transfer takes place when dihydrofolate is bound instead of 
WR99210) are also indicated in B. 
 
Twenty five aa residues of P. falciparum interacting (distance < 3.50 Å) with NADPH 
or WR99210 in the ternary complex (see Fig. 2) were superpositioned with the B. 
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bovis DHFR wild-type and mutant models, followed by merging NADPH and 
WR99210 into their binding sites and comparison of wild type and mutant. In the wild 
type model the side chain hydroxyl of S125 interacts with O1 of the adenine β-
phosphate of NADPH. S125 is located amidst conserved residues (e.g. L122, G124 
and Y128 of B. bovis), all making H-bonds with NADPH and WR99210 (Fig. 2 and 
4). The conserved dipeptide G123G124 has a cis peptide linkage in all resolved 
structures, giving a sharp bend between β-strand 6 and α-helix 4 that causes insertion 
of the backbone nitrogen of G124 between O1 and O2 of the adenine α-phosphate of 
NADP to form H-bonds. In B. bovis DHFR modelled upon the M. tuberculosis 
template, a clash between the aromatic side-chains of mutant S125F and Y126 
induced a translocation of several adjoining residues by 0.2 to 0.3 Å resulting in 
altered contact distances with NADPH and WR99210 (not shown). When modelled on 
the P. falciparum DHFR template, residue Y126 adopts a different conformation (like 
in the P. falciparum structure itself), due to the close proximity of conserved residue 
F155 (corresponding to F197 in P. falciparum and A128 in M. tuberculosis), 
preventing a clash with mutant residue S125F. Interactions of the aromatic ring of 
S125F with F154 or F155 only allow for a rotamer conformation in which the side 
chain is projected towards the surface of the molecule, bending over the shallow cleft 
that binds the NADPH co-factor. This resulted in intolerably short distances between 
the side chain and P and O1 of the adenine β-phosphate of NADPH (Fig. 4). 
Consequently, the binding conformation of NADPH must be altered which can in 
addition lead to induced changes in the local DHFR structure of the S125F mutant. 
Thus, although S125F does not directly interact with WR99210, kinetic parameters 
and the binding of WR99210 or dihydrofolate could be influenced indirectly as the 
hydrogen donation site of NADPH may shift position (see Fig. 4). 
The kinetic effects of numerous single and multiple amino acid substitutions in 
DHFR have been studied in in vitro cultures of Plasmodium, in assays using purified 
native or recombinant enzyme and in assays where mutant dhfr genes are expressed 
and studied in heterologous organisms (42, 53, 88, 201). In general, pyrimethamine resistant 
mutants are easily obtained but sofar the amino acid corresponding to B. bovis S125 
has not been found to be involved in resistance against any inhibitor. The IC50 that we 
and others (162) observed for pyrimethamine on in vitro B. bovis cultures is at least 
1000-fold higher than observed for the most pyrimethamine sensitive P. falciparum 
strains (40) whereas sensitivity towards WR99210 is still in the low nM range for the B. 
bovis wild type as well as the mutant. Promise for WR99210 as a lead for further 
development of anti-folate drugs comes from the observation that a quadruple mutant 
(N51I, C59R, S108N and I164L), displaying a synergistically acting combination of 
four of the most frequently observed mutations (85) has a thousand-fold reduced 
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sensitivity towards pyrimethamine but a only 10-fold reduced sensitivity towards 
WR99210. Three of these mutations (N51I, C59R and I164L, see Fig. 2) are present in 
wild type B. bovis dhfr and might thus explain the comparatively low sensitivity 
towards pyrimethamine. Moreover P. falciparum mutant S108T, having a threonine at 
this position like B. bovis dhfr, displays resistance against the anti-folate drug 
cycloguanil. Possibly, in such a background of natural resistance against 
pyrimethamine, single amino acid substitutions conferring resistance to WR99210 are 
more easily selected in the way demonstrated here for B. bovis in vitro cultures but 
even than WR99210 is still efficient in the lower nM range. For P. falciparum only 
expression in yeast of mutagenized dhfr genes, already carrying two or three of the 
above mentioned resistance mutations, allowed the isolation of a few single amino 
acid substitution mutants displaying a 5 to 10-fold increased resistance against 
WR99210. Interestingly, this study (73) and a similar study on P. vivax dhfr (88)indicate 
that there is a mechanism of opposing selection. Mutants selected for decreased 
sensitivity towards pyrimethamine did become hypersensitive for WR99210, giving 
rise to the hope that a combination-therapy of such drugs will prevent the spread of 
drug-resistant mutants. We conclude that cross-resistance against pyrimethamine and 
WR99210, for P. falciparum or B. bovis, sofar has only been demonstrated to occur in 
a genetic background that already confers high levels of resistance against 
pyrimethamine. Such mutants could easily be obtained from B. bovis in vitro cultures 
but in all cases resistance against WR99210 does not exceed the therapeutically useful 
lower nM range. 
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The aim of this thesis was to obtain a better understanding of the molecular 
processes underlying the invasion of red blood cells by B. bovis merozoites. 
Inevitably, the design of the studies was influenced by the wealth of knowledge that 
has accumulated on the invasion processes of the two genera, Toxoplasma and 
Plasmodium, which have served as the most important model systems for studying the 
fundamental biology of apicomplexan parasites. From this, a generalized model of 
invasion has been deduced (18, 20, 32, 41, 60, 67, 91, 165, 173, 174, 176, 196, 197) (summarized in the 
introduction of this thesis) to which many species-specific deviations have been noted. 
Here it is discussed to what extent the observations that were made in the previous 
chapters fit into this model and contribute to it. Most attention is paid to a comparison 
with the malaria parasite P. falciparum, as it also infects red blood cells causing a 
disease with many features similar to bovine babesiosis caused by B. bovis. 
 
CHARACTERIZING INVASION IN VITRO 
 
We envisaged that the set up of a B. bovis in vitro invasion assay would be 
crucial to future studies and, considering the problems experienced with such assays 
for P. falciparum, would also make a valuable contribution to the study of invasion of 
erythrocytes by apicomplexan parasites. The assay described in chapter 2, evolved as 
a corollary of the electroporation experiments described in chapter 6, is marked by its 
capacity to study invasion in a short timespan, independently from the preceding 
(parasite egress from the red blood cell) and following (intracellular development) 
stages. Thus it allowed demonstrating that the free parasite itself and the red blood cell 
to be invaded carry all factors required for productive invasion without the need for 
any component from the extracellular milieu. Surprisingly, such a synchronized start 
is not followed up by synchronous intra-cellular development, in contrast to what is 
seen for P. falciparum after synchronization by different procedures (118). 
Asynchronicity might be an intrinsic property of B. bovis growth. Inhibitor studies 
suggest that B. bovis invasion follows the general model in its requirement of 
intracellular calcium in signalling the secretory events leading to invasion, although 
we have not yet studied the secretory events itself. Moreover, the use of cytochalasin 
D, presumably inhibiting actin polymerization, arrested invasion and led to the 
observation of merozoites that were apically reorientated and attached to the red blood 
cell. This provided, in agreement with the few electron microscopy pictures of 
invading Babesia parasites that are available (104) evidence that red blood cell invasion 
by B. bovis is more similar to the process described for P. falciparum than to the 
mechanism used by much closer related piroplasm T. annulata. For the latter parasite 
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it has been suggested to zipper tightly into the membrane of the red blood cell without 
apical reorientation (193). 
 
RECEPTORS AND LIGANDS 
 
 Whereas T. gondii can parasitize almost any nucleated cell in a wide range of 
hosts, Plasmodium species show the opposite. For instance, P. vivax exclusively 
invades human reticulocytes. In agreement with this, no specific receptor-ligand 
interactions governing host cell specificity have yet been discovered for T. gondii 
whereas for P. vivax, and to a somewhat lesser extent P. falciparum, host cell 
specificity is due to interaction between highly specific receptors and ligands (68, 81, 108, 
135, 169, 200). B. bovis probably represents an intermediate case (chapter 3). Red blood 
cells of a variety of species were shown to be invaded by B. bovis in vitro. This 
relaxed host specificity is actually observed in vivo for B. divergens, another Babesia 
species infecting cattle that occasionally infects other species including 
splenectomized humans. Possibly a highly sequence specific receptor-ligand 
interaction is not required for erythrocyte invasion by B. bovis. Like for several of the 
alternative P. falciparum receptor-ligand interactions (62, 68, 126), sialic acid residues are 
a requirement for invasion (chapter 3). However, in the case of B. bovis, aminoacid 
sequence motifs may not contribute to binding specificity. It seems unlikely that 
sequence variation of putative receptors in between individuals of the same species 
could lead to differences in invasion efficiency as large as the differences observed 
with red blood cells of different hosts. Intuitively, exclusive attachment to a probably 
essential post-translational modification, occurring on several proteins in various 
organisms, is an optimal evolutionary acquirement for counteracting genetic selection 
in a population for receptor negative host cells, as exemplified by the absence of the 
Duffy blood group receptor for P. vivax in the human population in several endemic 
areas. Nevertheless there is no reason to consider B. bovis as a more successful 
parasite than P. vivax or P. falciparum. 
 
THE INVOLVEMENT OF MICRONEMAL PROTEINS 
 
 The specific host cell binding ligands of Plasmodium species involved in 
attachment upon apical reorientation have been shown to be secreted from the 
organelles called micronemes just prior to invasion. Whereas these proteins clearly 
contain several homologous domains across the different Plasmodium species, this 
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conservation is sofar constricted to this genus. No homologs of EBA175, EBA140, 
DBL, MAEBL (1, 62, 146, 217) have been identified in any other apicomplexan genus 
including the large EST dataset obtained of B. bovis (E. de Vries, unpublished). No B. 
bovis proteins have been localized to the microneme sofar although the organelles 
have been observed by electron microscopy (140). In contrast, other apicomplexans 
have been shown to contain an extended range of micronemal proteins (e.g. denoted 
MIC1 to MIC12 in T. gondii). Some of these form specific complexes but for none of 
the complexes or individual proteins a specific host cell receptor and a specific 
function in invasion have been revealed. Many of the micronemal proteins are 
composed of one or more domains showing similarity to a number of different 
eukaryotic adhesion domains like EGF-domain, thrombospondin-domain, apple 
domain or van Willlebrand factor A-domain, interspersed by non-conserved regions 
(59, 205). Searches within the B. bovis EST database mentioned above have led to the 
identification of only two clear homologous of micronemal proteins. Those were 
studied in more detail in chapters 4 and 5 and have been denoted BbAMA-1 and 
BbTRAP respectively in analogy to their most closely related counterparts in P. 
falciparum. Although both proteins were localized to the apical half of the merozoite 
this is not yet sufficient proof for micronemal localization. Nevertheless BbAMA-1 
shared functional characteristics with PfAMA-1 like a reduction of invasion efficiency 
by anti-BbAMA-1 antisera and secretion of a smaller-sized BbAMA-1 molecule into 
the surroundings. The secondary structure of AMA-1 is likely to be conserved 
considering the almost complete conservation of cysteine residues, spread over the 
length of the ectodomain, that are involved in disulfide-bond formation in PfAMA-1. 
Overall this makes AMA-1 one of the few, and certainly the most conserved, proteins 
involved in invasion. Its detection in Theileria EST datasets (T. parva genome 
sequencing project available from The Institute for Genomic Research at 
www.tigr.org and the T. annulata genome sequencing project available from 
www.sanger.ac.uk) raises questions about its molecular function as these parasites 
seem to follow a mechanism of invasion drastically different from the general model 
(see above). 
 
GLIDING MOTILITY AND INVASION 
 
A P. falciparum TRAP homologue was found somewhat surprisingly in B. 
bovis merozoites. PfTRAP has not been detected in Plasmodium merozoites but is 
expressed in the mature sporozoite stages present in the mosquito salivary gland. 
PfTRAP plays a role during gliding motility, the locomotive process by which 
sporozoites travel on artificial substrates in vitro. Plasmodium TRAP proteins are 
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composed of two adhesive domains (a vWFA-domain and a TSP-domain), a 
transmembrane region and a cytoplasmic domain. Recently a TRAP related 
Plasmodium protein was described and called CS protein-TRAP-related protein 
(CTRP). This protein is composed of five vWFA-domains followed by seven TSP-
domains (58). In other apicomplexans the TRAP-family harbours micronemal proteins 
containing five or more TSP-domains combined with a vWFA domain or an EGF 
domain as in E. tenella MIC-4. Gliding motility of sporozoites and T. gondii 
merozoites is essential for their travel through the host in order to reach new host 
cells. This has been shown to be dependent on the extracellular as well as intra-
cellular domains of proteins like PfTRAP and TgMIC2. Such proteins are capped 
from the apical end to the back of parasites. Previous studies have proposed two 
hypothetical actin/myosin models for gliding motility of P. falciparum sporozoites 
that have been described in the general introduction of this thesis. Recent reports have 
indicated that the second model is the most likely model, showing that aldolase is the 
intracellular ligand connecting TRAP via its cytoplasmic domain indirectly to the 
actin/myosin locomotive machinery (106). Intracellular capping and decapping of actin 
filaments of the motor would support capping of the transmembrane proteins to the 
posterior end. Moving of a dense junction around the parasite as observed during host 
cell invasion could involve a similar gliding mechanism using the same machinery. 
However, results on direct inhibitory effect of antibodies against TRAP on host cell 
invasion are still contradictory (80, 192, 235). The results described in chapter 5 do 
describe such an effect for B. bovis erythrocyte invasion. This would provide an 
example for the use of the TRAP-family of proteins exclusively for host cell invasion 
as merozoites are supposed to be devoid of gliding motility. It remains puzzling why 
PfTRAP does not seem to be involved in erythrocyte invasion.   
 
THE WAY FORWARD TO IDENTIFICATION OF INVASION PROTEINS 
 
Many proteins residing in P. falciparum and T. gondii micronemes, rhoptries 
and dense granules have been identified over the past fifteen years, usually by a one-
by-one process of gene or antigen identification and subsequent sub-cellular 
localization studies. Many more as yet unidentified proteins are expected to be present 
in these three organelles on the basis of sub-cellular fractionation studies performed 
on several apicomplexan parasites (21, 176). For B. bovis only the highly expressed 
rhoptry protein RAP-1 and spherical body proteins SBP-1 to SBP-3 have been 
described (66, 94, 185, 211). A more global identification of such proteins would thus be 
very helpful in order to close the gap in knowledge with P. falciparum and T. gondii. 
One approach would be a thorough sub-cellular fractionation of organelles followed 
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by proteomic methods involving mass spectrometry (MS) for identification of the 
proteins present in these fractions. Such an attempt has recently been described for the 
secretory organelles of sporozoites of Eimeria tenella (21), an economically important 
apicomplexan parasite of poultry. Microneme enriched fractions from E. tenella 
parasites were obtained by sucrose-gradient centrifugation and analyzed by MS. The 
results were disappointing in that most of the identified proteins proved to be derived 
from the parasite cytoskeleton, the endoplasmatic reticulum, the dense granule or the 
plasma membrane. Only two proteins were most likely of micronemal origin. Thus, 
alternative methods are urgently required, in particular for cells like B. bovis 
merozoites that cannot be obtained free of host cell remnants in contrast to E. tenella 
sporozoites. The observation that many, possibly most, micronemal and rhoptry 
proteins (or processed parts of them) are released into the extracellular milieu during 
host cell invasion provides such an alternative method. Two-dimensional PAGE gels 
presented in chapter 2 and 4 that were loaded with invasion supernatant showed many 
parasite specific spots compared to the mock-infected erythrocyte control. The 2 D-
gels presented in these chapters were the first examples of direct staining of proteins 
released during invasion without the need of immunoprecipitation of metabolically 
labeled proteins. Moreover, it circumvents the predominant selection of the most 
immunogenic proteins invoked by the latter method. The use of specific antibodies 
allowed us to demonstrate the presence of AMA-1 in this fraction (Chapter 4), albeit 
at a very low level in comparison to many contaminating proteins of bovine origin. At 
least 100 additional, often weak, spots are thought to be of B. bovis origin. The close 
proximity of many of these spots to much more abundant bovine proteins requires the 
use of an additional purification step in order be able to load enough sample on a gel 
for MS identification of all spots.  
Another interesting group of proteins involved in invasion and likely to be 
present in the extracellular milieu are proteases. Their function is pivotal to the 
continuation of the invasion process. Inhibitor studies have indicated that the 
transmembrane micronemal adhesion proteins involved in invasion have to be shed 
into the medium by proteolytic cleavage as their interaction with the host cell might 
otherwise block further movement. This has been described in Chapter 1 in some 
more detail. Several serine proteases have been implied in shedding such proteins 
from the surface of P. falciparum merozoites (100) but their genes have not been 
identified yet. Protease inhibitors specific for different types of proteases will be a 
valuable tool in identifying such proteins. Their effect on in vitro invasion can be 
determined and they can be used for screening subsequent fractionation procedures in 
order to purify the proteases. Application of specific invasion inhibitors may result in 
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altered protein patterns on 2D gels and thus give indications about the potential 
protease substrates. 
A third group of proteins that have been predicted to function as the specific 
switch for initiating the invasion process, are signal transduction proteins. Sofar 
nothing is known in detail about putative receptor-ligand interactions that take place 
upon initial contact between parasite and host cell for any apicomplexan species. 
Plasmodium host cell binding ligands like EBA-175, EBA-140 and DBL are secreted 
only seconds prior to the onset of invasion and obviously this must be regulated by 
some specific trigger. The first attachment of merozoites to erythrocytes is reversible 
and probably based on charge interactions as erythrocyte membranes are negatively 
charged because of the sialic acid residues whereas merozoites are positively charged. 
This might induce the rolling movement leading to apical reorientation upon which 
irreversible attachment by the just released ligands takes place. Structures 
(transmembrane proteins?) near the apical conoid may transduce the signal. Also the 
nature of the signalling process still remains to be identified. Obviously, interference 
with the hypothesized signal transduction process should have serious consequences 
for erythrocyte invasion and the use of specific inhibitors of signal transduction in the 
vitro invasion assay might give clues on the type of proteins that are involved. 
 
HOST CELL INVASION AS A TARGET FOR VACCINE DEVELOPMENT 
 
Besides the fundamental scientific interest for the molecular mechanisms of 
host cell invasion by parasites belonging to the most important and threatening 
parasites of man and animals worldwide, there is obviously a great deal of attention 
for these studies considering the urge for efficient recombinant vaccines. Good 
vaccine candidates would be proteins that are exposed to the immune system like 
proteins that are secreted from the apical organelles (micronemes and rhoptries) 
during invasion and proteins localized on the membrane of the parasite. However, the 
extracellular timespan of B. bovis outside its host cell is very short, requiring a high 
antibody titre for invasion inhibition. Inside erythrocytes B. bovis multiplies by binary 
fission resulting in two parasites. An effective vaccine for B. bovis only needs to 
reduce invasion about 50% in order to decrease the parasitaemia level in a host. For P. 
falciparum the vaccine needs to inhibit invasion for more than 95% to be able to 
reduce parasitaemia, because P. falciparum merozoites multiplies to 20-30 new 
parasites per cycle during schizogony. In Plasmodium several proteins have already 
been used in vaccination trials. Antibodies raised against AMA-1 protein have shown 
protection of monkeys against the pathological effect of P. falciparum (115, 215). 
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Antibodies against other proteins like RAP-1, TRAP or EBA-175 have shown to 
inhibit invasion in vitro and in vivo studies (152, 157, 192, 212).  
Previous reports of Babesia exoantigens have shown to give protection. 
Exoantigens, also named soluble parasite antigens (SPA) are proteins found in the 
medium of Babesia cultures (107, 170). Culture medium will probably contain secreted 
proteins as well as breakdown products of erythrocytes and parasites. In addition, this 
fraction will most likely also contain proteins that are released during lysis of infected 
erythrocytes during the maturation process of the Babesia parasites. Culture medium 
that was partially purified and concentrated has been developed to a vaccine for B. 
canis in dogs (190). The vaccine protected dogs against the pathological effects of the 
B. canis infection without expelling the parasite, indicating a mode of action directed 
against pathogenic molecules that are not involved with parasite propagation anymore. 
A vaccine based on SPA-containing medium from a European B. canis and a South 
Africa B. rossi isolate induced protective immunity against heterologous B. canis 
infection. Dogs that were vaccinated with the European B. canis isolate showed only 
protection against a homologous challenge infection (190). Whether the observed 
protection can be contributed to the apical organelle proteins secreted during invasion 
or is evoked by other types of proteins is not known yet.  
 
THE NEED FOR TRANSGENETICS 
 
The identification of parasitic proteins involved in the invasion process will 
raise questions on their function and their suitability for inclusion in vaccination trials. 
Transfection systems for T. gondii and P. falciparum have been developed employing 
several selectable markers (48, 51, 65, 130). Transfection has been used to knockout 
specific proteins. However, elimination of some proteins has shown to be lethal for 
the parasite, prohibiting a functional analysis. To overcome this problem, an inducible 
system was set up for T. gondii (141) with the possibility for conditional knockout of 
proteins. For our initial attempts to set up a transfection system for B. bovis we have 
used the methodology that has worked for several Plasmodium species. With the 
constructs and conditions used, this has sofar only resulted in the generation of 
resistant parasites instead of transformants. The resulting high IC50 for pyrimethamine, 
which is already high for wildtype B. bovis, makes this drug probably unsuitable for 
selection. In contrast, even against the isolated mutants, WR99210 is still very 
efficient at a low concentration and therefore usable providing that we can select 
under sufficiently high concentrations of WR99210. Alternatives for these drugs in 
obtaining stable transfection are other selectable markers such as blasticidin S-
deaminase, puromycin-N-acetyltransferase, hypoxanthineguanine-phosphoribosyl-
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transferase or dihydropteroate synthase. These have been employed for other 
apicomplexans and could be evaluated for B. bovis. 
The constructs that have been used to transfect the parasites were under control 
of a B. bovis DHFR-TS promoter and terminal region (see Chapter 7). As was shown 
in chapter 7 these constructs contain (parts of) several other genes. Whether these 
extra genes interfere with stable integration into the genome remains unknown. Sofar 
little is known about promoters in B. bovis. The selection of additional promoters, 
active at a defined period of the life cycle, would expand our options for transfections 
with plasmid constructs.  
On basis of the present dataset, it may be recommendable to setup a transient 
transfection system for B. bovis in order to optimize transfection conditions. At first 
we used green-fluorescent protein and yellow-fluorescent protein to detect 
transformants. Secondly we tried β-galactosidase as a more sensitive reporter gene. 
However, none of the reporters were detected in B. bovis merozoites in the first 48 h 
after transfection. In other apicomplexan species other sensitive reporter genes have 
been used like chloramphenicol transferase and luciferase genes. These reporter genes 
could also help to find specific transfection conditions for B. bovis.  
The observed transformation efficiency for P. falciparum and T. gondii differs 
enormously. For T. gondii it is normally 103 to 105 times higher as observed for P. 
falciparum. If B. bovis also has an efficiency as low as P. falciparum it will not be 
easy to obtain an initial transfection level from which optimization can start. 
Alternative methods to electroporation may induce higher levels of transfection and 
could be investigated. Successful transformation of B. bovis will in future be an 
indispensable tool for further studies. 
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SUMMARY 
 
In this thesis we investigated the invasion of erythrocytes taking place during 
the asexual erythrocytic blood stage of the apicomplexan parasites Babesia bovis 
parasite.  
Host cell invasion by apicomplexan parasites is a complex process requiring 
multiple receptor-ligand interactions, involving association of the merozoite with the 
erythrocyte surface, reorientation and attachment of the apical end of the merozoite. In 
parasites like Toxoplasma gondii and Plasmodium falciparum many proteins have 
been identified that are involved in invasion including proteins present on the 
merozoite surface and proteins present in secretory organelles located at the apical end 
of the merozoite. An in vitro invasion assay of B. bovis was established to be able to 
characterize the mechanisms and the proteins involved in invasion. Invasion of 
liberated merozoites is completed in 1 h in phosphate buffered saline solution. The 
manipulation of intracellular calcium concentration or actin polymerization in the 
merozoite inhibits invasion indicating that B. bovis invades erythrocytes in a similar 
way as Plasmodium merozoites. Proteins that are secreted into the environment during 
in vitro invasion can be detected directly by protein staining after 2D gel 
electrophoresis. This in vitro invasion assay was used to assess the host-specificity of 
B.  bovis. In vivo, B. bovis infections have only been observed in bovine species. In 
vitro,  human, ovine, porcine, equine and caprine erythrocytes were all invaded by B. 
bovis. Human erythrocytes were invaded more efficiently than bovine erythrocytes, 
whereas goat erythrocytes were invaded at very low level. Significant differences in 
invasion efficiency into erythrocytes from different individuals of the same species 
were observed. Besides invasion, intracellular duplication of B. bovis parasites also 
took place in all erythrocyte species, except for goats. Only in bovine erythrocytes 
subsequent rounds of invasion were observed. B. bovis merozoite invasion was shown 
to be dependent on sialic-acid residues present on the host cell. Pre-incubation of 
merozoites with n-acetylneuraminyl-lactose decreased invasion efficiency by ~45%, 
whereas addition prior to invasion had no significant effect. Thus invasion might be 
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dependent on the presence of merozoite membrane proteins already accessible during 
pre-incubation prior to invasion. 
Only two proteins (AMA-1 and TRAP) involved in invasion of other 
apicomplexans were identified from a large B. bovis EST database and these were 
sequenced and characterized. B. bovis invasion was inhibited by antiserum raised 
against peptides from several domains of AMA-1. Antisera raised against domain III 
of AMA-1 give the strongest invasion inhibition. B. bovis TRAP was surprisingly 
found in merozoites. In Plasmodium species TRAP has been found in the sporozoite 
stage. Antibodies directed against BbTRAP inhibited invasion. Immunofluorescence 
showed that B. bovis AMA-1 and TRAP are localized at the apical region of the 
merozoites. P. falciparum AMA-1 and TRAP proteins are known to be cleaved off 
and secreted into environment during invasion. 1D and 2D-gel electrophoresis of total 
merozoites extract and invasion supernatant followed by immunoblotting with B. 
bovis AMA-1 antisera showed that this protein is cleaved from 82 kDa to a 69 kDa 
and secreted into the surrounding environment. B. bovis TRAP also was found in 
invasion supernatant.  
 Transfection of in malaria parasites provides a valuable tool for analyzing gene 
function. An attempt was done to establish a transfection system of B. bovis with dhfr 
as a selectable marker. The B. bovis dhfr-ts genomic locus and cDNA was cloned and 
sequenced. Beside the dhfr-ts gene of 2.83 kb, four other genes were identified in a 
7.41 kb region of  which at least three are expressed during the erythrocytic cycle. 
Three of the genes were highly conserved in closely related Theileria species and gene 
synteny was observed between B. bovis and T. parva. B. bovis merozoite cultures 
electroporated with plasmids containing T. gondii dhfr-tsm2m3 or human dhfr under 
control of B. bovis dhfr regions did not produce stable transfected parasites. Transient 
expression using GFP, YFP or β-galactosidase as a reporter gene was also not yet 
established. Nevertheless, parasite cultures with decreased sensitivity for 
pyrimethamine and WR99210 were repeatly isolated. The dhfr gene of five resistant 
cultures was sequenced and showed to contain a S125F amino acid substitution. 
Homology modelling of B. bovis DHFR by using the P. falciparum DHFR structure as 
a template, suggested that S125F affects the binding site of NADPH. The five 
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resistant cultures that were first selected on either pyrimethamine or WR99210 turned 
out to be cross-resistant for both drugs. Comparable drug sensitivities were only 
observed in a quadruple mutant of P. falciparum dhfr displaying strong resistance to 
pyrimethamine and 10-fold enhanced resistance against WR99210. Wildtype B. bovis 
was similar to this mutant at 3 of the 4 mutated positions possibly explaining its low 
sensitivity for pyrimethamine. 
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SAMENVATTING 
 
 Babesiosis is een veel voorkomende ziekte onder runderen in tropische en 
subtropische gebieden over de hele wereld. De ziekte wordt overgebracht door 
Boophilus microplus teken die geïnfecteerd zijn met de hemoparasiet, Babesia bovis. 
B. bovis behoort tot het phylum Apicomplexa, klasse Sporozoa, subklasse 
Piroplasmida. De replicatie van de parasiet vindt plaats in rode bloedcellen 
(erythrocyten). Dit resulteert meestal in anaemie en kan uiteindelijk organen 
aantasten, wat tot gewichtsverlies en zelfs tot de dood kan leiden. Ondanks de grote 
verliezen in de veestapel en wereldwijde verspreiding van de infecties is er nog geen 
effectieve controle op anaplasmosis en babesiosis in meeste betrokken gebieden.  
 B. bovis is ééncellige intraerythrocytaire parasiet die veel overeenkomsten 
vertoont met de malaria parasiet. B. bovis parasieten hebben een gemiddelde grootte 
van 2.5 bij 1.5 µm en behoren daarom tot de groep van kleine Babesia. Het meest 
opvallende morfologische kenmerk van de B. bovis parasiet zijn de apicale organellen, 
die waarschijnlijk gebruikt worden tijdens rode bloedcel invasie. Uit detail 
onderzoeken die gedaan zijn bij andere Babesia soorten, zoals B. bovis en B. bigemina 
is gebleken dat de parasieten behalve deze apicale organellen ook polaire ringen aan 
het apicale einde bevatten en twee binnen membranen die samen met de plasma 
membraan de pellicle genoemd worden. Nader onderzoek heeft aangetoond dat aan de 
buitenste membraan van het inner membraan complex myosine gebonden is terwijl 
actine met de plasma membraan geassocieerd is. Door hydrolyse van ATP dat bindt 
aan myosine komt energie en kracht vrij dat aanzet tot beweging. Een micropore is 
betrokken bij de voedselopname tijdens de intraerythrocytaire fase van het parasiet. 
De apicale organellen spelen een belangrijke rol bij de invasie van rode bloedcel door 
de parasiet. De apicale organellen worden rhoptries, micronemes en dense granules 
genoemd. 
 De vermenigvuldiging en verspreiding van B. bovis vindt plaats door 
opeenvolgende sexuele multiplicatie in de teek, via transovariële transmissie en 
asexuele multiplicatie van merozoieten in de gastheer. De levenscyclus van de B. 
bovis parasiet begint door een beet van een geïnfecteerde teek. Sporozoieten die zich 
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in de speekselklier bevinden van de teek komen  door de beet in de bloedbaan van het 
rund terecht. De sporozoieten dringen rode bloedcellen binnen en bij lysis van de rode 
bloedcellen komen de merozoieten vrij. De vrijgekomen merozoieten kunnen direct 
rode bloedcellen binnendringen. Binnen  de rode bloedcel, deelt de merozoiet zich tot 
twee peervormige merozoieten en komt door middel van lysis vrij uit de erythrocyten. 
Deze dringen dan weer nieuwe erythrocyten binnen. Naast het herhaaldelijk delen van 
de merozoieten kunnen deze zich ontwikkelen tot mannelijke of vrouwelijke 
geslachtcellen (gametocyten). De gametocyten kunnen door een teek worden 
opgenomen tijdens hun voeding op een gastheer. In de darm van de teek smelten de 
mannelijke en vrouwelijke gametocyt samen tot een zygote. Van zygote transformeert 
de parasiet tot kineet en kan nu verschillende organen infecteren waaronder de 
eierstokken van de vrouwelijke teek en komt zo in de eieren van de teek terecht. 
Ookineten infecteren de speekselklier van de teek en zullen bij de volgende voeding 
van de teek op een gastheer weer ingespoten worden in de bloedbaan.    
Dit proefschrift beschrijft invasie van de B. bovis merozoiet in de rode bloedcel 
van de gastheer (rund). Het eerste contact van de parasiet met de rode bloedcel is 
omkeerbaar. De parasiet reorienteert zich en maakt opnieuw contact met de rode 
bloedcel alleen nu met zijn apicale pool, zodat de rhoptries en micronemes in contact 
komen met het celoppervlak van de erythrocyt. Een zogenaamde tight junction wordt 
gevormd en hierdoorheen zal de parasiet de erythrocyt binnen dringen en stulpt 
daarbij erythrocyt membraan naar binnen die uiteindelijk de vacuole (parasitofore 
vacuole) zal vormen waarin de parasiet zich zal bevinden als hij eenmaal binnen is. 
Bij andere apicomplexa zoals Plasmodium falciparum en Toxoplasma gondii is uit 
onderzoek gebleken dat de drie apicale organellen eiwitten bevatten die verschillende 
functies blijken te vervullen tijdens rode bloedcel invasie. Micronemes zijn de eerste 
organellen die tijdens invasie hun eiwitten uitscheiden en spelen waarschijnlijk een 
functie bij herkenning en aanhechting van de rode bloedcel en waarschijnlijk ook bij 
beweging in de rode bloedcel. Rhoptries zorgen mogelijk voor de vorming de 
parasitofore vacuole en dense granules voor transformatie van de vacuole in een 
metabolisch actief compartiment. 
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Om te voorkomen dat de veestapel besmet raakt met babesiosis kan men of de 
vector (de teek) uitschakelen of ingrijpen in de levenscyclus van de parasiet. Om de 
teek uit te schakelen zouden alle koeien behandeld moeten worden met acariciden. Dit 
is een dure en tijdrovende methode. Voor het stopzetten van invasie in de rode 
bloedcel gebruikt men vaccins met verzwakte levende parasieten. Nadelen die gepaard 
gaan met deze methode zijn de mogelijkheid van contaminatie met andere niet 
bekende ziekteverwekkers. Om deze problemen te omzeilen wordt er onderzoek 
gedaan om een effectief recombinant vaccin te maken. 
In dit proefschrift zijn er onderzoeken beschreven die betrekking hebben op de  
asexuele erythrocytaire fase van de B. bovis parasiet. Allereerst is er een in vitro 
invasie assay opgezet voor B. bovis. Behalve dat de assay snel en efficient is, kan de 
intracellulaire groei en invasie van de parasiet ook gescheiden worden. Daarna is er 
een poging gedaan om receptor typen en liganden die nodig zijn bij invasie nader te 
onderzoeken. Verder zijn er twee P. falciparum homologe eiwittten die betrokken zijn 
bij invasie geidentificeerd, gekloneerd, gesequenced en geanalyseerd in de B. bovis 
parasiet. Als laatste is er een poging gedaan een transfectie systeem voor B. bovis te 
ontwikkelen, maar in plaats daarvan zijn er alleen maar resistente B. bovis cultures 
gekregen die geen plasmide hadden opgenomen. 
De invasie van de merozoiet in de rode bloedcel is een complex proces waarbij 
verschillende receptor-ligand interacties aangegaan worden tijdens reorientatie en 
binding van de apicale pool aan de rode bloedcel. Verschillende eiwitten zijn 
betrokken bij merozoiet invasie die zowel op het merozoiet oppervlak aanwezig zijn 
als gelokaliseerd zijn in de apicale organellen. Een in vitro invasie assay is opgezet 
om het mechanisme van erythrocyt invasie nader te kunnen onderzoeken. Deze assay 
geeft de mogelijkheid om eiwitten die betrokken zijn bij de invasie direct te kunnen 
detecteren en analyseren m.b.v. 2D-electrophorese gevolgd door eiwitkleuring, omdat 
invasie in fosfaatbuffer plaatsvindt. Er is gekeken naar het effect van de intracellulaire 
calcium concentratie door gebruik te maken van verscheidene drugs (BAPTA-AM). 
Uit de resultaten is gebleken dat BAPTA-AM en cytochalasin B (een actine 
polymerisatie remmer) beiden de invasie afremmen. Naast dat de invasie assay snel en 
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efficient is, kan intracellular groei en invasie van de parasiet afzonderlijk bestudeerd 
worden. 
De invasie assay is gebruikt om de gastheer specificiteit van de B. bovis 
parasiet te bestuderen. In de natuur blijkt dat B. bovis alleen runderen infecteert. 
Echter invasie experimenten met erythrocyten van mensen, schapen, varkens, paarden 
en geiten tonen aan dat deze erythrocyten ook geïnvadeerd worden door B. bovis 
parasieten. De humane erythrocyten worden het best geïnvadeerd en de minste 
parasieten werden gevonden in geiten erythrocyten. Verder blijkt er een significant 
verschil in invasie efficiency tussen verschillende individuen van dezelfde diersoort te 
zijn. Behalve invaderen, kunnen de parasieten ook verder uitgroeien in de andere rode 
bloedcel soorten, met uitzondering van geiten erythrocyten. Alleen in runder 
erythocyten kunnen de parasieten na deling nieuwe rode bloedcellen binnendringen  
en zo een verhoogde parasitaemia geven. De resultaten die hier gepresenteerd zijn 
geven aan dat de specificiteit van B. bovis parasieten later in de levenscyclus 
plaatsvindt en niet al tijdens de invasie van de parasiet. B. bovis  merozoieten blijken 
bij erythrocyt invasie sialic acid bevattende receptoren te gebruiken. Neuraminidase 
behandeling van de erythrocyt geeft een invasie inhibitie van ongeveer 80% en 
preincubatie van B. bovis merozoieten met n-acetylneuraminyl-lactose ligand geeft 
een afname van de invasie met ongeveer 45%, maar toevoeging van dit ligand direct 
voor invasie gaf geen significant effect. Dus invasie van de B. bovis merozoiet in de 
rode bloedcel is afhankelijk van een ligand met affiniteit voor sialicacid-bevattende 
erythrocyt membraanreceptoren dat al aanwezig is op de membraan van B. bovis 
merozoieten alvorens invasie optreedt. 
Twee invasie eiwitten die bij P. falciparum bekend staan als vaccin kandidaten 
zijn gesequenced en gekarakteriseerd in B. bovis merozoieten. B. bovis AMA-1 
(Apicale membraan antigen 1) en TRAP (thrombospondin gerelateerd anoniem eiwit) 
komen tot expressie in de erythrocyt fase, terwijl TRAP bij P. falciparum alleen in het 
sporozoiet stadium tot expressie komt en betrokken is bij de beweging van de 
sporozoiet. B.  bovis invasie werd geremd door serum dat tegen peptiden van pre-
domein, domein II en domein III van AMA-1 was opgewekt. Serum tegen domein III 
gaf de meeste inhibitie. Invasie van B. bovis werd ook afgeremd door serum tegen de 
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twee verschillende peptiden van B. bovis TRAP eiwit (serum tegen peptiden van het 
TSP-1 domein of van het C-terminale eind van het ectodomein), alhoewel er met 
serum dat tegen TSP-1 domain de meeste inhibitie gaf. Een immunofluorescentie test 
geeft aan dat B. bovis AMA-1 en TRAP allebei gelokaliseerd zijn rond de apicale 
pool. Echter er kan niets gezegd worden over lokalisatie in een van de apicale 
organellen. Verder is er in P. falciparum bekend dat deze twee eiwitten bij invasie 
geknipt worden en zo terecht komen in het milieu. Door 2-D gel electroforese toe te 
passen op totaal merozoieten extract en invasie supernatant gevolgd door 
immunoblotten met B. bovis AMA-1 antisera hebben we kunnen aan tonen dat dit 
eiwit wordt geknipt en uitgescheiden in het milieu.   
Om de functie te kunnen bestuderen van de eiwitten die een belangrijke rol 
spelen bij invasie is een transfectie systeem nodig. Een poging werd gedaan om een 
transfectiesysteem op te zetten voor B. bovis met als selectie marker het dihydrofolate 
reductase thymidylate synthase gen. De B. bovis dhfr genomische locus en cDNA 
werden gecloneerd en gesequenced. Naast het dhfr-ts gen van 2.83 kb zijn er in een 
regio van 7.41 kb ook vier andere genen aanwezig van welke er minstens drie tot 
expressie komen tijdens de erythrocytaire cyclus. Drie van de genen hebben een hoge 
conservering met genen van Theileria soorten en de ordening van een aantal van de 
geconserveerde genen is ook tussen B. bovis en Theileria gelijk. B. bovis merozoiet 
culturen die geëelectroporeerd zijn met een plasmied dat T. gondii dhfr-tsm2m3 of het 
humane dhfr bevat onder controle van B. bovis dhfr flankerende gebieden gaf niet 
getransformeerde resistente culturen. Het DHFR gen van vijf resistente culturen werd 
gesequenced en wees uit dat ze een S125F aminozuur substitutie hadden. Modellering 
van B. bovis DHFR met de P. falciparum DHFR 3D-structuur als matrijs, suggereerde 
dat substitutie S125F de binding met NADPH zou kunnen beinvloeden. De vijf 
resistente culturen die geselecteerd waren op pyrimethamine of WR99210 toonden 
kruisresistentie voor beide drugs. Een vergelijkbare resultaat werd ook gevonden bij 
een viervoudige mutant van P. falciparum dhfr dat een sterk verhoogde resistentie 
voor pyrimethamine had en slechts een 10 keer verhoogde resistentie voor WR99210 
gaf. Wild type B. bovis had al drie van de vier mutaties die de P. falciparum mutant 
had. Waarschijnlijk draagt dit bij aan de lage pyrimethamine sensitiviteit van B. bovis.   
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